00018410042021FYfalse0.25P3DP3D00018410042021-01-012021-12-310001841004ataq:UnitsEachConsistingOfOneShareOfClassCommonStockAndOneThirdOfOneRedeemableWarrantMember2021-01-012021-12-310001841004us-gaap:CommonClassAMember2021-01-012021-12-310001841004ataq:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOfDollar1150PerShareMember2021-01-012021-12-3100018410042021-06-30iso4217:USD0001841004us-gaap:CommonClassAMember2022-03-04xbrli:shares0001841004us-gaap:CommonClassBMember2022-03-0400018410042021-12-310001841004us-gaap:CommonClassAMember2021-12-31iso4217:USDxbrli:shares0001841004us-gaap:CommonClassBMember2021-12-3100018410042021-01-112021-12-310001841004ataq:RedeemableClassAOrdinarySharesMember2021-01-112021-12-310001841004ataq:NonRedeemableClassBOrdinarySharesMember2021-01-112021-12-310001841004us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-01-100001841004us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-01-100001841004us-gaap:AdditionalPaidInCapitalMember2021-01-100001841004us-gaap:RetainedEarningsMember2021-01-1000018410042021-01-100001841004us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-01-112021-12-310001841004us-gaap:AdditionalPaidInCapitalMember2021-01-112021-12-310001841004us-gaap:RetainedEarningsMember2021-01-112021-12-310001841004us-gaap:CommonClassAMemberus-gaap:CommonStockMember2021-12-310001841004us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-12-310001841004us-gaap:AdditionalPaidInCapitalMember2021-12-310001841004us-gaap:RetainedEarningsMember2021-12-310001841004us-gaap:IPOMember2021-03-082021-03-080001841004ataq:PublicSharesMemberus-gaap:OverAllotmentOptionMember2021-03-082021-03-080001841004ataq:PublicSharesMemberus-gaap:OverAllotmentOptionMember2021-03-080001841004ataq:PublicSharesMemberus-gaap:IPOMember2021-03-082021-03-080001841004ataq:PrivatePlacementWarrantsMember2021-03-082021-03-080001841004ataq:PrivatePlacementWarrantsMember2021-03-0800018410042021-03-080001841004ataq:PublicSharesMemberus-gaap:IPOMember2021-03-08xbrli:pure0001841004srt:MaximumMember2021-03-080001841004us-gaap:CommonClassAMember2021-01-112021-12-310001841004ataq:PublicWarrantsMemberus-gaap:CommonClassAMember2021-01-112021-12-310001841004us-gaap:CommonClassAMemberataq:PrivatePlacementWarrantsMember2021-01-112021-12-310001841004ataq:RedeemableCommonClassAMember2021-01-112021-12-310001841004ataq:NonRedeemableCommonClassBMember2021-01-112021-12-310001841004us-gaap:OverAllotmentOptionMember2021-03-082021-03-080001841004us-gaap:IPOMember2021-03-080001841004us-gaap:OverAllotmentOptionMember2021-03-080001841004us-gaap:PrivatePlacementMember2021-03-080001841004us-gaap:PrivatePlacementMember2021-03-082021-03-080001841004us-gaap:BeneficialOwnerMemberataq:FounderSharesMember2021-01-152021-01-150001841004us-gaap:BeneficialOwnerMemberataq:FounderSharesMember2021-01-282021-01-280001841004us-gaap:BeneficialOwnerMemberataq:FounderSharesMember2021-03-032021-03-030001841004srt:DirectorMemberataq:FounderSharesMember2021-03-032021-03-030001841004ataq:FounderSharesMemberus-gaap:OverAllotmentOptionMember2021-03-0300018410042021-03-030001841004ataq:FounderSharesMember2021-03-080001841004srt:MaximumMember2021-01-112021-12-310001841004us-gaap:BeneficialOwnerMember2021-01-112021-12-310001841004srt:AffiliatedEntityMember2021-03-032021-03-030001841004ataq:AdministrativeSupportAgreementMember2021-01-112021-12-310001841004ataq:AdministrativeSupportAgreementMember2021-12-310001841004ataq:SponsorMemberataq:PromissoryNoteMember2021-01-150001841004ataq:SponsorMemberataq:PromissoryNoteMember2021-03-082021-03-080001841004ataq:RelatedPartyLoansMember2021-12-310001841004us-gaap:OverAllotmentOptionMember2021-12-31ataq:vote0001841004us-gaap:CommonClassBMember2021-01-112021-12-310001841004ataq:PublicWarrantsMember2021-12-310001841004ataq:PublicWarrantsMemberataq:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member2021-01-112021-12-310001841004ataq:PublicWarrantsMemberataq:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member2021-01-112021-12-310001841004srt:MaximumMemberus-gaap:CommonClassAMember2021-12-310001841004ataq:PrivatePlacementWarrantsMember2021-12-310001841004ataq:CashAndMarketableSecuritiesHeldInTrustAccountMemberus-gaap:FairValueInputsLevel1Member2021-12-310001841004ataq:WarrantLiabilitiesPublicWarrantsMemberus-gaap:FairValueInputsLevel3Member2021-12-310001841004us-gaap:FairValueInputsLevel3Memberataq:WarrantLiabilitiesPrivateWarrantsMember2021-12-310001841004us-gaap:MeasurementInputSharePriceMember2021-12-310001841004us-gaap:MeasurementInputExercisePriceMember2021-12-310001841004us-gaap:MeasurementInputExpectedTermMember2021-12-31utr:Y0001841004us-gaap:MeasurementInputPriceVolatilityMember2021-12-310001841004us-gaap:MeasurementInputRiskFreeInterestRateMember2021-12-310001841004us-gaap:MeasurementInputExpectedDividendRateMember2021-12-310001841004ataq:WarrantLiabilitiesPrivateWarrantsMemberus-gaap:WarrantMember2021-03-080001841004us-gaap:WarrantMemberataq:WarrantLiabilitiesPublicWarrantsMember2021-03-080001841004us-gaap:WarrantMember2021-03-080001841004ataq:WarrantLiabilitiesPrivateWarrantsMemberus-gaap:WarrantMember2021-03-092021-12-310001841004us-gaap:WarrantMemberataq:WarrantLiabilitiesPublicWarrantsMember2021-03-092021-12-310001841004us-gaap:WarrantMember2021-03-092021-12-310001841004ataq:WarrantLiabilitiesPrivateWarrantsMemberus-gaap:WarrantMember2021-12-310001841004us-gaap:WarrantMemberataq:WarrantLiabilitiesPublicWarrantsMember2021-12-310001841004us-gaap:WarrantMember2021-12-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K/A
(Amendment No. 1)
(Mark One)
|
|
|
|
|
|
☒ |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934 |
For the fiscal year ended December 31, 2021
OR
|
|
|
|
|
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
For the transition period from ___________ to
___________
Commission file number 001-40149
ALTIMAR ACQUISITION CORP. III
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
|
|
Cayman Islands |
|
98-1576586 |
(State or other jurisdiction of
incorporation or organization) |
|
(I.R.S. Employer
Identification No.) |
40 West 57th Street
33rd Floor
New York, New York 10019
(Address of principal executive offices, including zip
code)
(212) 287-6767
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Units, each consisting of one Class A ordinary share, $0.0001 par
value, and one-fourth of one redeemable warrant |
|
ATAQ.U |
|
New York Stock Exchange |
Class A ordinary shares, $0.0001 par value |
|
ATAQ |
|
New York Stock Exchange |
Warrants, each whole warrant exercisable for one Class A ordinary
share, each at an exercise price of $11.50 per share |
|
ATAQ WS |
|
New York Stock Exchange |
Indicate by check mark if the registrant is a well-known seasoned
issuer, as defined in Rule 405 of the Securities Act.
Yes
o
No
x
Indicate by check mark if the registrant is not required to file
reports pursuant to Section 13 or Section 15(d) of the
Act.
Yes
o
No
x
Indicate by check mark whether the registrant: (1) has filed all
reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file
such reports); and (2) has been subject to such filing requirements
for the past 90
days. Yes x No o
Indicate by check mark whether the registrant has submitted
electronically and posted on its corporate web site, if any, every
Interactive Data File required to be submitted and posted pursuant
to Rule 405 of Regulation S-T (§232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant
was required to submit and post such files).
Yes x No o
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer,
or a smaller reporting company. See the definitions of “large
accelerated filer,” “accelerated filer” and “smaller reporting
company” in Rule 12b-2 of the Exchange Act. (Check
one):
|
|
|
|
|
|
|
|
|
|
|
|
Large accelerated filer |
o
|
Accelerated filer
|
o
|
Non-accelerated filer
|
x
|
Smaller reporting company
|
x
|
|
|
Emerging growth company
|
x
|
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act.
o
Indicate by check mark whether the registrant is has filed a report
on and attestation to its management's assessment of the
effectiveness of its internal controls over financial reporting
under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b))
by the registered public accounting firm that prepared or issued
its audit report.
o
Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Act).
Yes x No ☐
The Registrant's Units began trading on the New York Stock Exchange
on March 3, 2021 and the Registrant's shares of Class A ordinary
shares began separate trading on the New York Stock Exchange on
April 26, 2021. The aggregate market value of the Registrant's
Class A ordinary shares outstanding at June 30, 2021 was
approximately $151 million.
As of March 8, 2022, there were 15,525,000 Class A ordinary
shares, $0.0001 par value, and 3,881,250 shares of Class B ordinary
shares, $0.0001 par value, issued and outstanding.
ALTIMAR ACQUISITION CORP. III
TABLE
OF
CONTENTS
EXPLANATORY NOTE
Amendment to Annual Report
This Amendment No. 1 to the Annual Report on Form 10-K (the
“Amendment”) is being filed solely to correct the date of the
Report of Independent Registered Public Accounting Firm. No other
changes have been made to Form 10-K as originally filed on March 4,
2022.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Annual Report includes, and oral statements made from time to
time by representatives of the Company may include, forward-looking
statements within the meaning of Section 27A of the Securities
Act of 1933, as amended, and Section 21E of the Exchange Act
and are intended to be covered by the safe harbor created thereby.
The Company has based these forward-looking statements on
management’s current expectations, projections and forecasts about
future events. These forward-looking statements are subject to
known and unknown risks, uncertainties and assumptions about the
Company that may cause its actual business, financial condition,
results of operations, performance and/or achievements to be
materially different from any future business, financial condition,
results of operations, performance and/or achievements expressed or
implied by these forward-looking statements. Factors that might
cause or contribute to such a discrepancy include, but are not
limited to, those described in the Company’s other filings with the
SEC. The words “anticipate,” “believe,” “continue,” “could,”
“estimate,” “expect,” “intends,” “may,” “might,” “plan,”
“possible,” “potential,” “predict,” “project,” “target,” “goal,”
“shall,” “should,” “will,” “would” and similar expressions may
identify forward-looking statements, but the absence of these words
does not mean that a statement is not forward-looking. In addition,
any statements that refer to expectations, projections, forecasts
or other characterizations of future events or circumstances,
including any underlying assumptions, are forward-looking
statements. Forward-looking statements in this annual report may
include, for example, statements about:
•the
potential adverse impact of the COVID-19 pandemic on our
business;
•our
ability to complete our initial business combination;
•our
success in retaining or recruiting, or changes required in, our
officers, key employees or directors following the consummation of
our initial business combination;
•our
potential ability to obtain additional financing to complete our
initial business combination;
•our
public securities’ potential liquidity and trading;
•the
lack of a market for our securities;
•the
use of proceeds not held in the trust account or available to us
from interest income on the trust account balance;
•the
trust account not being subject to claims of third parties;
or
•our
financial performance.
The forward-looking statements contained in this annual report are
based on our current expectations and beliefs concerning future
developments and their potential effects on us. There can be no
assurance that future developments affecting us will be those that
we have anticipated. These forward-looking statements involve a
number of risks, uncertainties (some of which are beyond our
control) or other assumptions that may cause actual results or
performance to be materially different from those expressed or
implied by these forward-looking statements. These risks and
uncertainties include, but are not limited to, those factors
described under the heading “Item 1A. Risk Factors.” Should one or
more of these risks or uncertainties materialize, or should any of
our assumptions prove incorrect, actual results may vary in
material respects from those projected in these forward-looking
statements. We undertake no obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise, except as may be required under
applicable securities laws.
PART I
References in this report (the “Annual Report”) to the
“Company,”
“Altimar
Acquisition Corp. III,”
“our,”
“us”
or “we”
refer to Altimar Acquisition Corp. III, references to
“management”
or “management
team”
refer to the Company’s officers and directors and references to the
“Sponsor”
refer to Altimar Sponsor III, LLC, a Delaware limited liability
company. The following discussion and analysis of the Company’s
financial condition and results of operations should be read in
conjunction with the condensed financial statements and the notes
thereto contained elsewhere in this Annual Report. Certain
information contained in the discussion and analysis set forth
below includes forward-looking statements that involve risks and
uncertainties.
Item 1. Business
Introduction
We are a blank check company incorporated in the Cayman Islands on
January 11, 2021 formed for the purpose of effecting a merger,
amalgamation, share exchange, asset acquisition, share purchase,
reorganization or other similar business combination with one or
more businesses. We have neither engaged in any operations nor
generated any revenue to date. Based on our business activities,
the Company is a “shell company” as defined under the Exchange Act
because we have no operations and nominal assets consisting almost
entirely of cash.
Our executive offices are located at 40 W 57th Street, 33rd Floor,
New York, NY 10019 and our telephone number is (212) 287-6767. Our
corporate website address is ataq.altimaracquisition.com. Our
website and the information contained on, or that can be access
through, the website is not deemed to be incorporated by reference
in, and is not considered part of, this Annual Report. You should
not rely on such information in making your decision whether to
invest in our securities.
Company History
On January 15, 2021, the Sponsor paid $25,000 to cover certain
offering and formation costs of the Company in consideration for
3,593,750 Class B ordinary shares (the “Founder Shares”). On
January 28, 2021, the Sponsor transferred 10,000 Founder
Shares to certain of the Company’s directors, resulting in the
Sponsor holding 3,533,750 Founder Shares. On March 3, 2021,
the Company effected a share capitalization and issued an
additional 287,500 Founders Shares to the Sponsor, resulting in the
Sponsor and the Company’s directors collectively holding 3,881,250
Founder Shares. Prior to the initial investment in the Company of
$25,000 by the Sponsor, the Company had no assets - tangible or
intangible.
On March 8, 2021, we consummated the initial public offering
(the “Initial Public Offering”) of 15,525,000 units (the “Units”),
which included the full exercise by the underwriters of their
option to purchase additional Units (the “Over-Allotment Option”)
in the amount of 2,025,000 Units at $10.00 per Unit, generating
gross proceeds of $155,250,000.
Simultaneously with the consummation of the Initial Public
Offering, we consummated the private placement of an aggregate of
6,105,000 private placement warrants, each exercisable to purchase
one share of the Company’s Class A ordinary shares for $11.50 per
share (the “Private Placement Warrants”), to the Sponsor at a price
of $1.00 per Private Placement Warrant, generating total proceeds
of $6,105,000. The $155,250,000 in gross proceeds received from the
Initial Public Offering and the Private Placement Warrants was
placed in a trust account (the “Trust Account”). The balance of the
Trust Account at December 31, 2021 was
$155,258,024.
On April 23, 2021, we announced that, commencing April 26, 2021,
holders of the Units could elect to separately trade the Class A
ordinary shares and the warrants included in the Units. Those Units
not separated continue to trade on The New York Stock Exchange (the
“NYSE”) under the symbol “ATAQ.U” and the Class A ordinary shares
and warrants that were separated trade under the symbols “ATAQ” and
“ATAQ WS,” respectively. No fractional warrants were issued upon
separation of the Units and only whole warrants trade.
Corporate Information
We are an “emerging growth company,” as defined in Section 2(a) of
the Securities Act of 1933, as amended, or the Securities Act, as
modified by the Jumpstart Our Business Startups Act of 2012, or the
JOBS Act. As such, we are eligible to take advantage of certain
exemptions from various reporting requirements that are applicable
to other public companies that are not “emerging growth companies”
including, but not limited to, not being required to comply with
the auditor attestation requirements of Section 404 of the
Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, reduced
disclosure obligations
regarding executive compensation in our periodic reports and proxy
statements, and exemptions from the requirements of holding a
non-binding advisory vote on executive compensation and shareholder
approval of any golden parachute payments not previously approved.
If some investors find our securities less attractive as a result,
there may be a less active trading market for our securities and
the prices of our securities may be more volatile.
In addition, Section 107 of the JOBS Act also provides that an
“emerging growth company” can take advantage of the extended
transition period provided in Section 7(a)(2)(B) of the Securities
Act for complying with new or revised accounting standards. In
other words, an “emerging growth company” can delay the adoption of
certain accounting standards until those standards would otherwise
apply to private companies. We intend to take advantage of the
benefits of this extended transition period.
We will remain an emerging growth company until the earlier of: (1)
the last day of the fiscal year (a) following the fifth anniversary
of the completion of the Initial Public Offering, (b) in which we
have total annual gross revenue of at least $1.07 billion or (c) in
which we are deemed to be a large accelerated filer, which means
the market value of our Class A ordinary shares that is held by
non-affiliates exceeds $700 million as of the end of the prior
fiscal year’s second fiscal quarter; and (2) the date on which we
have issued more than $1.00 billion in non-convertible debt
securities during the prior three-year period. References herein to
“emerging growth company” shall have the meaning associated with it
in the JOBS Act.
Additionally, we are a “smaller reporting company” as defined in
Item 10(f)(1) of Regulation S-K. Smaller reporting companies may
take advantage of certain reduced disclosure obligations,
including, among other things, providing only two years of audited
financial statements. We will remain a smaller reporting company
until the last day of the fiscal year in which (1) the market value
of our ordinary shares held by non-affiliates exceeds $250 million
as of the prior June 30 or (2) our annual revenues exceeded $100
million during such completed fiscal year and the market value of
our ordinary shares held by non-affiliates exceeds $700 million as
of the prior June 30.
Facilities
We currently maintain our executive offices at 40 West 57th Street,
33rd Floor, New York, NY 10019. The cost for our use of this space
is included in the $10,000 per month fee we pay to an affiliate of
our Sponsor for office space, administrative and support services.
We consider our current office space adequate for our current
operations.
Employees
We currently have two executive officers. These individuals are not
obligated to devote any specific number of hours to our matters but
they intend to devote as much of their time as they deem necessary
to our affairs until the earlier of completion of the business
combination or liquidation. The amount of time they will devote in
any time period will vary based on the stage of the business
combination process we are in. We do not intend to have any
full-time employees prior to the earlier of the completion of the
business combination or liquidation.
Periodic Reporting and Financial Information
We have registered our Units, Class A ordinary shares and warrants
under the Exchange Act and have reporting obligations, including
the requirement that we file annual, quarterly and current reports
with the SEC. In accordance with the requirements of the Exchange
Act, this Annual Report contains financial statements audited and
reported on by our independent registered public
accountants.
We are required to evaluate our internal control procedures for the
fiscal year ending December 31, 2022 as required by the
Sarbanes-Oxley Act. Only in the event we are deemed to be a large
accelerated filer or an accelerated filer and no longer qualify as
an emerging growth company, will we be required to comply with the
independent registered public accounting firm attestation
requirement on our internal control over financial
reporting.
We are a Cayman Islands exempted company. Exempted companies are
Cayman Islands companies conducting business mainly outside the
Cayman Islands and, as such, are exempted from complying with
certain provisions of the Companies Act. As an exempted company, we
have applied for and received a tax exemption undertaking from the
Cayman Islands government that, in accordance with Section 6 of the
Tax Concessions Act (As Revised) of the Cayman Islands, for a
period of 20 years from the date of the undertaking, no law which
is enacted in the Cayman Islands imposing any tax to be levied on
profits, income, gains or appreciations will apply to us or our
operations and, in addition, that no tax to be levied on profits,
income, gains or appreciations or which is in the nature of estate
duty or inheritance tax will be payable (i) on or in respect of our
shares, debentures or other obligations or (ii) by way of the
withholding in whole or in part of a payment of dividend or
other
distribution of income or capital by us to our shareholders or a
payment of principal or interest or other sums due under a
debenture or other obligation of us.
Legal Proceedings
There is no material litigation, arbitration or governmental
proceeding currently pending against us or any members of our
management team in their capacity as such.
Item 1A. Risk Factors.
An investment in our securities involves a high degree of risk. You
should consider carefully all of the risks described below,
together with the other information contained in this Annual
Report, before making a decision to invest in our Units. If any of
the following events occur, our business, financial condition and
operating results may be materially adversely affected. In that
event, the trading price of our securities could decline, and you
could lose all or part of your investment.
Risks Relating to Our Search for, and Consummation of or Inability
to Consummate, an Initial Business Combination
Our shareholders may not be afforded an opportunity to vote on our
proposed initial business combination and, even if we hold a vote,
holders of our founder shares will participate in such vote, which
means we may complete our initial business combination even though
a majority of our shareholders do not support such a
combination.
We may choose not to hold a shareholder vote before we complete our
initial business combination if the business combination would not
require shareholder approval under applicable law or stock exchange
listing requirement. For instance, if we were seeking to acquire a
target business where the consideration we were paying in the
transaction was all cash, we would typically not be required to
seek shareholder approval to complete such a transaction. Except
for as required by applicable law or stock exchange listing
requirement, the decision as to whether we will seek shareholder
approval of a proposed business combination or will allow
shareholders to sell their shares to us in a tender offer will be
made by us, solely in our discretion, and will be based on a
variety of factors, such as the timing of the transaction and
whether the terms of the transaction would otherwise require us to
seek shareholder approval. Even if we seek shareholder approval,
the holders of our founder shares will participate in the vote.
Accordingly, we may complete our initial business combination even
if holders of a majority of our issued and outstanding ordinary
shares do not approve of the business combination we
complete.
If we seek shareholder approval of our initial business
combination, our sponsor and each member of our management team
have agreed to vote in favor of such initial business combination,
regardless of how our public shareholders vote.
Our initial shareholders own, on an as-converted basis, 20% of our
outstanding ordinary shares. Our sponsor and each member of our
management team also may from time to time purchase Class A
ordinary shares prior to our initial business combination. Our
amended and restated memorandum and articles of association provide
that, if we seek shareholder approval, we will complete our initial
business combination only if we obtain the approval of an ordinary
resolution under Cayman Islands law, being the affirmative vote of
a majority of the ordinary shares represented in person or by proxy
and entitled to vote thereon and who vote at a general meeting of
the Company. As a result, in addition to our initial shareholders’
founder shares, we would need 5,821,876, or 37.5% (assuming all
issued and outstanding shares are voted and the over-allotment
option is not exercised) or 970,313, or 6.25% (assuming only the
minimum number of shares representing a quorum are voted and the
over-allotment option is not exercised), of the 15,525,000 public
shares sold in the Initial Public Offering to be voted in favor of
an initial business combination in order to have our initial
business combination approved. Accordingly, if we seek shareholder
approval of our initial business combination, the agreement by our
sponsor and each member of our management team to vote in favor of
our initial business combination will increase the likelihood that
we will receive the requisite shareholder approval for such initial
business combination.
Your only opportunity to affect the investment decision regarding a
potential business combination may be limited to the exercise of
your right to redeem your shares from us for cash.
At the time of your investment in us, you will not be provided with
an opportunity to evaluate the specific merits or risks of any
target businesses. Since our board of directors may complete a
business combination without seeking shareholder approval, public
shareholders may not have the right or opportunity to vote on the
business combination, unless we seek such shareholder approval.
Accordingly, your only opportunity to affect the investment
decision regarding a potential business combination may be limited
to exercising your redemption rights within the period of time
(which will be at least 20 business days) set forth in our tender
offer documents mailed to our public shareholders in which we
describe our initial business combination.
The ability of our public shareholders to redeem their shares for
cash may make our financial condition unattractive to potential
business combination targets, which may make it difficult for us to
enter into a business combination with a target.
We may seek to enter into a business combination transaction
agreement with a prospective target that requires as a closing
condition that we have a minimum net worth or a certain amount of
cash. If too many public shareholders exercise their redemption
rights, we would not be able to meet such closing condition and, as
a result, would not be able to proceed with the business
combination. Furthermore, we will not redeem our public shares in
an amount that would cause our net tangible assets to be less than
$5,000,001 (so that we do not then become subject to the SEC’s
“penny stock” rules) or any greater net tangible asset or cash
requirement that may be contained in the agreement relating to our
initial business combination. Consequently, if accepting all
properly submitted redemption requests would cause our net tangible
assets to be less than $5,000,001 or such greater amount necessary
to satisfy a closing condition as described above, we would not
proceed with such redemption and the related business combination
and may instead search for an alternate business combination.
Prospective targets will be aware of these risks and, thus, may be
reluctant to enter into a business combination transaction with
us.
The ability of our public shareholders to exercise redemption
rights with respect to a large number of our shares may not allow
us to complete the most desirable business combination or optimize
our capital structure.
At the time we enter into an agreement for our initial business
combination, we will not know how many shareholders may exercise
their redemption rights and therefore will need to structure the
transaction based on our expectations as to the number of shares
that will be submitted for redemption. If our initial business
combination agreement requires us to use a portion of the cash in
the trust account to pay the purchase price or requires us to have
a minimum amount of cash at closing, we will need to reserve a
portion of the cash in the trust account to meet such requirements
or arrange for third-party financing. In addition, if a large
number of shares are submitted for redemption, we may need to
restructure the transaction to reserve a greater portion of the
cash in the trust account or arrange for additional third-party
financing. Raising additional third-party financing may involve
dilutive equity issuances or the incurrence of indebtedness at
higher than desirable levels. The above considerations may limit
our ability to complete the most desirable business combination
available to us or optimize our capital structure. The amount of
the deferred underwriting commissions payable to the underwriters
will not be adjusted for any shares that are redeemed in connection
with an initial business combination. The per-share amount we will
distribute to shareholders who properly exercise their redemption
rights will not be reduced by the deferred underwriting commission
and after such redemptions, the amount held in trust will continue
to reflect our obligation to pay the entire deferred underwriting
commissions.
The ability of our public shareholders to exercise redemption
rights with respect to a large number of our shares could increase
the probability that our initial business combination would be
unsuccessful and that you would have to wait for liquidation in
order to redeem your shares.
If our initial business combination agreement requires us to use a
portion of the cash in the trust account to pay the purchase price,
or requires us to have a minimum amount of cash at closing, the
probability that our initial business combination would be
unsuccessful is increased. If our initial business combination is
unsuccessful, you would not receive your pro rata portion of the
funds in the trust account until we liquidate the trust account. If
you are in need of immediate liquidity, you could attempt to sell
your shares in the open market; however, at such time our shares
may trade at a discount to the pro rata amount per share in the
trust account. In either situation, you may suffer a material loss
on your investment or lose the benefit of funds expected in
connection with our redemption until we liquidate or you are able
to sell your shares in the open market.
The requirement that we consummate an initial business combination
within 24 months after the closing of the Initial Public Offering
may give potential target businesses leverage over us in
negotiating a business combination and may limit the time we have
in which to conduct due diligence on potential business combination
targets, in particular as we approach our dissolution deadline,
which could undermine our ability to complete our initial business
combination on terms that would produce value for our
shareholders.
Any potential target business with which we enter into negotiations
concerning a business combination will be aware that we must
consummate an initial business combination within 24 months from
the closing of the Initial Public Offering. Consequently, such
target business may obtain leverage over us in negotiating a
business combination, knowing that if we do not complete our
initial business combination with that particular target business,
we may be unable to complete our initial business combination with
any target business. This risk will increase as we get closer to
the time frame described above. In addition, we may have limited
time to conduct due diligence and may enter into our initial
business combination on terms that we would have rejected upon a
more comprehensive investigation.
The securities in which we invest the proceeds held in the trust
account could bear a negative rate of interest, which could reduce
the interest income available for payment of taxes or reduce the
value of the assets held in trust such that the per share
redemption amount received by shareholders may be less than $10.00
per share.
The net proceeds of the Initial Public Offering and certain
proceeds from the sale of the private placement warrants, in the
amount of $155,250,000, will be held in an interest-bearing trust
account. The proceeds held in the trust account may only be
invested in direct U.S. Treasury obligations having a maturity of
185 days or less, or in certain money market funds which invest
only in direct U.S. Treasury obligations. While short-term U.S.
Treasury obligations currently yield a positive rate of interest,
they have briefly yielded negative interest rates in recent years.
Central banks in Europe and Japan pursued interest rates below zero
in recent years, and the Open Market Committee of the Federal
Reserve has not ruled out the possibility that it may in the future
adopt similar policies in the United States. In the event of very
low or negative yields, the amount of interest income (which we may
withdraw to pay taxes, if any) would be reduced. In the event that
we are unable to complete our initial business combination, our
public shareholders are entitled to receive their pro-rata share of
the proceeds held in the trust account, plus any interest income.
If the balance of the trust account is reduced below $155,250,000
as a result of negative interest rates, the amount of funds in the
trust account available for distribution to our public shareholders
may be reduced below $10.00 per share.
If we seek shareholder approval of our initial business
combination, our sponsor, initial shareholders, directors,
executive officers, advisors or any of their respective affiliates
may elect to purchase public shares or warrants, which may
influence a vote on a proposed business combination and reduce the
public “float” of our Class A ordinary shares or public
warrants.
If we seek shareholder approval of our initial business combination
and we do not conduct redemptions in connection with our initial
business combination pursuant to the tender offer rules, our
sponsor, initial shareholders, directors, executive officers,
advisors or any of their respective affiliates may purchase public
shares or warrants in privately negotiated transactions or in the
open market either prior to or following the completion of our
initial business combination, although they are under no obligation
to do so. However, they have no current commitments, plans or
intentions to engage in such transactions and have not formulated
any terms or conditions for any such transactions. None of the
funds in the trust account will be used to purchase public shares
or warrants in such transactions.
In the event that our sponsor, initial shareholders, directors,
executive officers, advisors or any of their respective affiliates
purchase public shares in privately negotiated transactions from
public shareholders who have already elected to exercise their
redemption rights, such selling shareholders would be required to
revoke their prior elections to redeem their shares. The purpose of
any such transaction could be to (1) vote in favor of the business
combination and thereby increase the likelihood of obtaining
shareholder approval of the business combination, (2) reduce the
number of public warrants outstanding or vote such warrants on any
matters submitted to the warrant holders for approval in connection
with our initial business combination or (3) satisfy a closing
condition in an agreement with a target that requires us to have a
minimum net worth or a certain amount of cash at the closing of our
initial business combination, where it appears that such
requirement would otherwise not be met. Any such purchases of our
securities may result in the completion of our initial business
combination that may not otherwise have been possible. In addition,
if such purchases are made, the public “float” of our Class A
ordinary shares or public warrants may be reduced and the number of
beneficial holders of our securities may be reduced, which may make
it difficult to maintain or obtain the quotation, listing or
trading of our securities on a national securities exchange. Any
such purchases will be reported pursuant to Section 13 and Section
16 of the Exchange Act to the extent such purchasers are subject to
such reporting requirements.
If a shareholder fails to receive notice of our offer to redeem our
public shares in connection with our initial business combination,
or fails to comply with the procedures for tendering its shares,
such shares may not be redeemed.
We will comply with the proxy rules or tender offer rules, as
applicable, when conducting redemptions in connection with our
initial business combination. Despite our compliance with these
rules, if a shareholder fails to receive our proxy solicitation or
tender offer materials, as applicable, such shareholder may not
become aware of the opportunity to redeem its shares. In addition,
the proxy solicitation or tender offer materials, as applicable,
that we will furnish to holders of our public shares in connection
with our initial business combination will describe the various
procedures that must be complied with in order to validly redeem or
tender public shares. For example, we may require our public
shareholders seeking to exercise their redemption rights, whether
they are record holders or hold their shares in “street name,” to
either tender their certificates to our transfer agent prior to the
date set forth in the proxy solicitation or tender offer materials
mailed to such holders, or up to two business days prior to the
vote on the proposal to approve the initial business combination in
the event we distribute proxy solicitation materials, or to deliver
their shares to the transfer agent electronically. In the event
that a shareholder fails to comply with these procedures, its
shares may not be redeemed.
You will not have any rights or interests in funds from the trust
account, except under certain limited circumstances. Therefore, to
liquidate your investment, you may be forced to sell your public
shares or warrants, potentially at a loss.
Our public shareholders will be entitled to receive funds from the
trust account only upon the earliest to occur of (i) our completion
of an initial business combination, and then only in connection
with those Class A ordinary shares that such shareholder properly
elected to redeem, subject to the limitations described herein,
(ii) the redemption of any public shares properly tendered in
connection with a shareholder vote to amend our amended and
restated memorandum and articles of association (A) to modify the
substance or timing of our obligation to provide holders of our
Class A ordinary shares the right to have their shares redeemed in
connection with our initial business combination or to redeem 100%
of our public shares if we do not complete our initial business
combination within 24 months from the closing of the Initial Public
Offering or (B) with respect to any other provision relating to the
rights of holders of our Class A ordinary shares, and (iii) the
redemption of our public shares if we have not consummated an
initial business combination within 24 months from the closing of
the Initial Public Offering, subject to applicable law and as
further described herein. Public shareholders who redeem their
Class A ordinary shares in connection with a shareholder vote
described in clause (ii) in the preceding sentence shall not be
entitled to funds from the trust account upon the subsequent
completion of an initial business combination or liquidation if we
have not consummated an initial business combination within 24
months from the closing of the Initial Public Offering, with
respect to such Class A ordinary shares so redeemed. In no other
circumstances will a public shareholder have any right or interest
of any kind in the trust account. Holders of warrants will not have
any right to the proceeds held in the trust account with respect to
the warrants. Accordingly, to liquidate your investment, you may be
forced to sell your public shares or warrants, potentially at a
loss.
Because of our limited resources and the significant competition
for business combination opportunities, it may be more difficult
for us to complete our initial business combination. If we have not
consummated our initial business combination within the required
time period, our public shareholders may receive only approximately
$10.00 per public share, or less in certain circumstances, on the
liquidation of our trust account and our warrants will expire
worthless.
We expect to encounter intense competition from other entities
having a business objective similar to ours, including private
investors (which may be individuals or investment partnerships),
other blank check companies and other entities, domestic and
international, competing for the types of businesses we intend to
acquire. Many of these individuals and entities are well
established and have extensive experience in identifying and
effecting, directly or indirectly, acquisitions of companies
operating in or providing services to various industries. Many of
these competitors possess greater technical, human and other
resources or more local industry knowledge than we do and our
financial resources will be relatively limited when contrasted with
those of many of these competitors. While we believe there are
numerous target businesses we could potentially acquire with the
net proceeds of the Initial Public Offering and the sale of the
private placement warrants, our ability to compete with respect to
the acquisition of certain target businesses that are sizable will
be limited by our available financial resources. This inherent
competitive limitation gives others an advantage in pursuing the
acquisition of certain target businesses. Furthermore, we are
obligated to offer holders of our public shares the right to redeem
their shares for cash at the time of our initial business
combination in conjunction with a shareholder vote or via a tender
offer. Target companies will be aware that this may reduce the
resources available to us for our initial business combination. Any
of these obligations may place us at a competitive disadvantage in
successfully negotiating a business combination. If we have not
consummated our initial business combination within the required
time period, our public shareholders may receive only approximately
$10.00 per public share, or less in certain circumstances, on the
liquidation of our trust account and our warrants will expire
worthless.
If the net proceeds of the Initial Public Offering and the sale of
the private placement warrants not being held in the trust account
are insufficient to allow us to operate for the 24 months following
the closing of the Initial Public Offering, it could limit the
amount available to fund our search for a target business or
businesses and our ability to complete our initial business
combination, and we will depend on loans from our sponsor, its
affiliates or members of our management team to fund our search and
to complete our initial business combination.
Of the net proceeds of the Initial Public Offering and the sale of
the private placement warrants, only approximately $1,000,000 will
be available to us initially outside the trust account to fund our
working capital requirements. We believe that, upon the closing of
the Initial Public Offering, the funds available to us outside of
the trust account, together with funds available from loans from
our sponsor, its affiliates or members of our management team will
be sufficient to allow us to operate for at least the 24 months
following the closing of the Initial Public Offering; however, we
cannot assure you that our estimate is accurate, and our sponsor,
its affiliates or members of our management team are under no
obligation to advance funds to us in such circumstances. Of the
funds available to us, we expect to use a portion of the funds
available to us to pay fees to consultants to assist us with our
search for a target business. We could also use a portion of the
funds as a down payment or to fund a “no-shop” provision (a
provision in letters of intent designed to keep target businesses
from “shopping” around for transactions with other companies or
investors on terms more favorable to such target businesses) with
respect to a particular proposed business
combination, although we do not have any current intention to do
so. If we entered into a letter of intent where we paid for the
right to receive exclusivity from a target business and were
subsequently required to forfeit such funds (whether as a result of
our breach or otherwise), we might not have sufficient funds to
continue searching for, or conduct due diligence with respect to, a
target business.
In the event that our offering expenses exceed our estimate of
$2,000,000, we may fund such excess with funds not to be held in
the trust account. In such case, unless funded by the proceeds of
loans available from our sponsor, its affiliates or members of our
management team the amount of funds we intend to be held outside
the trust account would decrease by a corresponding amount.
Conversely, in the event that the offering expenses are less than
our estimate of $2,000,000, the amount of funds we intend to be
held outside the trust account would increase by a corresponding
amount. The amount held in the trust account will not be impacted
as a result of such increase or decrease. If we are required to
seek additional capital, we would need to borrow funds from our
sponsor, its affiliates, members of our management team or other
third parties to operate or may be forced to liquidate. Neither our
sponsor, members of our management team nor their affiliates is
under any obligation to us in such circumstances. Any such advances
may be repaid only from funds held outside the trust account or
from funds released to us upon completion of our initial business
combination. Up to $2,000,000 of such loans may be convertible into
warrants of the post-business combination entity at a price of
$1.00 per warrant at the option of the lender. The warrants would
be identical to the private placement warrants. Prior to the
completion of our initial business combination, we do not expect to
seek loans from parties other than our sponsor, its affiliates or
members of our management team as we do not believe third parties
will be willing to loan such funds and provide a waiver against any
and all rights to seek access to funds in our trust account. If we
have not consummated our initial business combination within the
required time period because we do not have sufficient funds
available to us, we will be forced to cease operations and
liquidate the trust account. Consequently, our public shareholders
may only receive an estimated $10.00 per public share, or less in
certain circumstances, on our redemption of our public shares, and
our warrants will expire worthless.
Subsequent to our completion of our initial business combination,
we may be required to take write-downs or write-offs, restructuring
and impairment or other charges that could have a significant
negative effect on our financial condition, results of operations
and the price of our securities, which could cause you to lose some
or all of your investment.
Even if we conduct extensive due diligence on a target business
with which we combine, we cannot assure you that this diligence
will identify all material issues with a particular target
business, that it would be possible to uncover all material issues
through a customary amount of due diligence, or that factors
outside of the target business and outside of our control will not
later arise. As a result of these factors, we may be forced to
later write-down or write-off assets, restructure our operations,
or incur impairment or other charges that could result in our
reporting losses. Even if our due diligence successfully identifies
certain risks, unexpected risks may arise and previously known
risks may materialize in a manner not consistent with our
preliminary risk analysis. Even though these charges may be
non-cash items and not have an immediate impact on our liquidity,
the fact that we report charges of this nature could contribute to
negative market perceptions about us or our securities. In
addition, charges of this nature may cause us to violate net worth
or other covenants to which we may be subject as a result of
assuming pre-existing debt held by a target business or by virtue
of our obtaining post-combination debt financing. Accordingly, any
holders who choose to retain their securities following the
business combination could suffer a reduction in the value of their
securities. Such holders are unlikely to have a remedy for such
reduction in value.
If third parties bring claims against us, the proceeds held in the
trust account could be reduced and the per-share redemption amount
received by shareholders may be less than $10.00 per public
share.
Our placing of funds in the trust account may not protect those
funds from third-party claims against us. Although we will seek to
have all vendors, service providers (other than our independent
registered public accounting firm), prospective target businesses
and other entities with which we do business execute agreements
with us waiving any right, title, interest or claim of any kind in
or to any monies held in the trust account for the benefit of our
public shareholders, such parties may not execute such agreements,
or even if they execute such agreements, they may not be prevented
from bringing claims against the trust account, including, but not
limited to, fraudulent inducement, breach of fiduciary
responsibility or other similar claims, as well as claims
challenging the enforceability of the waiver, in each case in order
to gain advantage with respect to a claim against our assets,
including the funds held in the trust account. If any third-party
refuses to execute an agreement waiving such claims to the monies
held in the trust account, our management will perform an analysis
of the alternatives available to it and will only enter into an
agreement with a third-party that has not executed a waiver if
management believes that such third-party’s engagement would be
significantly more beneficial to us than any alternative. Making
such a request of potential target businesses may make our
acquisition proposal less attractive to them and, to the extent
prospective target businesses refuse to execute such a waiver, it
may limit the field of potential target businesses that we might
pursue.
Examples of possible instances where we may engage a third-party
that refuses to execute a waiver include the engagement of a
third-party consultant whose particular expertise or skills are
believed by management to be significantly superior to those of
other consultants that would agree to execute a waiver or in cases
where management is unable to find a service provider willing to
execute a waiver. In addition, there is no guarantee that such
entities will agree to waive any claims they may have in the future
as a result of, or arising out of, any negotiations, contracts or
agreements with us and will not seek recourse against the trust
account for any reason. Upon redemption of our public shares, if we
have not consummated an initial business combination within 24
months from the closing of the Initial Public Offering, or upon the
exercise of a redemption right in connection with our initial
business combination, we will be required to provide for payment of
claims of creditors that were not waived that may be brought
against us within the ten years following redemption. Accordingly,
the per-share redemption amount received by public shareholders
could be less than the $10.00 per public share initially held in
the trust account, due to claims of such creditors. Pursuant to the
letter agreement (the form of which is filed as an exhibit to this
Annual Report), our sponsor has agreed that it will be liable to us
if and to the extent any claims by (A) a third-party (other than
our independent registered public accounting firm) for services
rendered or products sold to us, or (B) a prospective target
business with which we have discussed entering into a transaction
agreement, reduce the amounts in the trust account to below the
lesser of (i) $10.00 per public share and (ii) the actual amount
per public share held in the trust account as of the date of the
liquidation of the trust account if less than $10.00 per public
share due to reductions in the value of the trust assets, in each
case net of the interest that may be withdrawn to pay our tax
obligations, provided that such liability will not apply to any
claims by a third-party or prospective target business that
executed a waiver of any and all rights to seek access to the trust
account nor will it apply to any claims under our indemnity of the
underwriters of the Initial Public Offering against certain
liabilities, including liabilities under the Securities Act.
Moreover, in the event that an executed waiver is deemed to be
unenforceable against a third-party, our sponsor will not be
responsible to the extent of any liability for such third-party
claims.
However, we have not asked our sponsor to reserve for such
indemnification obligations, nor have we independently verified
whether our sponsor has sufficient funds to satisfy its indemnity
obligations and we believe that our sponsor’s only assets are
securities of our company. Therefore, we cannot assure you that our
sponsor would be able to satisfy those obligations. As a result, if
any such claims were successfully made against the trust account,
the funds available for our initial business combination and
redemptions could be reduced to less than $10.00 per public share.
In such event, we may not be able to complete our initial business
combination, and you would receive such lesser amount per share in
connection with any redemption of your public shares. None of our
officers or directors will indemnify us for claims by third parties
including, without limitation, claims by vendors and prospective
target businesses.
Our independent directors may decide not to enforce the
indemnification obligations of our sponsor, resulting in a
reduction in the amount of funds in the trust account available for
distribution to our public shareholders.
In the event that the proceeds in the trust account are reduced
below the lesser of (i) $10.00 per public share and (ii) the actual
amount per public share held in the trust account as of the date of
the liquidation of the trust account if less than $10.00 per public
share due to reductions in the value of the trust assets, in each
case net of the interest that may be withdrawn to pay our tax
obligations, and our sponsor asserts that it is unable to satisfy
its obligations or that it has no indemnification obligations
related to a particular claim, our independent directors would
determine whether to take legal action against our sponsor to
enforce its indemnification obligations. While we currently expect
that our independent directors would take legal action on our
behalf against our sponsor to enforce its indemnification
obligations to us, it is possible that our independent directors in
exercising their business judgment and subject to their fiduciary
duties may choose not to do so in any particular instance. If our
independent directors choose not to enforce these indemnification
obligations, the amount of funds in the trust account available for
distribution to our public shareholders may be reduced below $10.00
per public share.
If, after we distribute the proceeds in the trust account to our
public shareholders, we file a bankruptcy or winding-up petition or
an involuntary bankruptcy or winding-up petition is filed against
us that is not dismissed, a bankruptcy or insolvency court may seek
to recover such proceeds, and the members of our board of directors
may be viewed as having breached their fiduciary duties to our
creditors, thereby exposing the members of our board of directors
and us to claims of punitive damages.
If, after we distribute the proceeds in the trust account to our
public shareholders, we file a bankruptcy or winding-up petition or
an involuntary bankruptcy or winding-up petition is filed against
us that is not dismissed, any distributions received by
shareholders could be viewed under applicable debtor/creditor
and/or bankruptcy or insolvency laws as either a “preferential
transfer” or a “fraudulent conveyance.” As a result, a bankruptcy
or insolvency court could seek to recover some or all amounts
received by our shareholders. In addition, our board of directors
may be viewed as having breached its fiduciary duty to our
creditors and/or having acted in bad faith, thereby exposing itself
and us to claims of punitive damages, by paying public shareholders
from the trust account prior to addressing the claims of
creditors.
If, before distributing the proceeds in the trust account to our
public shareholders, we file a bankruptcy or winding-up petition or
an involuntary bankruptcy or winding-up petition is filed against
us that is not dismissed, the claims of creditors in such
proceeding may have priority over the claims of our shareholders
and the per share amount that would otherwise be received by our
shareholders in connection with our liquidation may be
reduced.
If, before distributing the proceeds in the trust account to our
public shareholders, we file a bankruptcy or winding-up petition or
an involuntary bankruptcy or winding-up petition is filed against
us that is not dismissed, the proceeds held in the trust account
could be subject to applicable bankruptcy or insolvency law, and
may be included in our bankruptcy or insolvency estate and subject
to the claims of third parties with priority over the claims of our
shareholders. To the extent any bankruptcy or insolvency claims
deplete the trust account, the per-share amount that would
otherwise be received by our shareholders in connection with our
liquidation may be reduced.
If we are deemed to be an investment company under the Investment
Company Act, we may be required to institute burdensome compliance
requirements and our activities may be restricted, which may make
it difficult for us to complete our initial business
combination.
If we are deemed to be an investment company under the Investment
Company Act, our activities may be restricted,
including:
•restrictions
on the nature of our investments; and
•restrictions
on the issuance of securities,
each of which may make it difficult for us to complete our initial
business combination.
In addition, we may have imposed upon us burdensome requirements,
including:
•registration
as an investment company with the SEC;
•adoption
of a specific form of corporate structure; and
•reporting,
record keeping, voting, proxy and disclosure requirements and
compliance with other rules and regulations that we are currently
not subject to.
In order not to be regulated as an investment company under the
Investment Company Act, unless we can qualify for an exclusion, we
must ensure that we are engaged primarily in a business other than
investing, reinvesting or trading of securities and that our
activities do not include investing, reinvesting, owning, holding
or trading “investment securities” constituting more than 40% of
our total assets (exclusive of U.S. government securities and cash
items) on an unconsolidated basis. Our business will be to identify
and complete a business combination and thereafter to operate the
post-transaction business or assets for the long term. We do not
plan to buy businesses or assets with a view to resale or profit
from their resale. We do not plan to buy unrelated businesses or
assets or to be a passive investor.
We do not believe that our anticipated principal activities will
subject us to the Investment Company Act. To this end, the proceeds
held in the trust account may only be invested in United States
“government securities” within the meaning of Section 2(a)(16) of
the Investment Company Act having a maturity of 185 days or less or
in money market funds meeting certain conditions under Rule 2a-7
promulgated under the Investment Company Act which invest only in
direct U.S. government treasury obligations. Pursuant to the trust
agreement, the trustee is not permitted to invest in other
securities or assets. By restricting the investment of the proceeds
to these instruments, and by having a business plan targeted at
acquiring and growing businesses for the long term (rather than on
buying and selling businesses in the manner of a merchant bank or
private equity fund), we intend to avoid being deemed an
“investment company” within the meaning of the Investment Company
Act. The Initial Public Offering was not intended for persons who
are seeking a return on investments in government securities or
investment securities. The trust account is intended as a holding
place for funds pending the earliest to occur of either: (i) the
completion of our initial business combination; (ii) the redemption
of any public shares properly tendered in connection with a
shareholder vote to amend our amended and restated memorandum and
articles of association (A) to modify the substance or timing of
our obligation to provide holders of our Class A ordinary shares
the right to have their shares redeemed in connection with our
initial business combination or to redeem 100% of our public shares
if we do not complete our initial business combination within 24
months from the closing of the Initial Public Offering or (B) with
respect to any other provision relating to the rights of holders of
our Class A ordinary shares or pre-business combination activity;
or (iii) absent our completing an initial business combination
within 24 months from the closing of the Initial Public Offering,
our return of the funds held in the trust account to our public
shareholders as part of our redemption of the public shares. If we
do not invest the proceeds as discussed above, we may be deemed to
be subject to the Investment Company Act. If we were deemed to be
subject to the Investment Company Act, compliance with these
additional regulatory burdens would require additional expenses for
which we have not allotted funds and may hinder our ability to
complete a business combination. If we have not consummated our
initial
business combination within the required time period, our public
shareholders may receive only approximately $10.00 per public
share, or less in certain circumstances, on the liquidation of our
trust account and our warrants will expire worthless.
Changes in laws or regulations, or a failure to comply with any
laws and regulations, may adversely affect our business, including
our ability to negotiate and complete our initial business
combination, and results of operations.
We are subject to laws and regulations enacted by national,
regional and local governments. In particular, we will be required
to comply with certain SEC and other legal requirements. Compliance
with, and monitoring of, applicable laws and regulations may be
difficult, time consuming and costly. Those laws and regulations
and their interpretation and application may also change from time
to time and those changes could have a material adverse effect on
our business, investments and results of operations. In addition, a
failure to comply with applicable laws or regulations, as
interpreted and applied, could have a material adverse effect on
our business, including our ability to negotiate and complete our
initial business combination, and results of
operations.
Because we are neither limited to evaluating a target business in a
particular industry or sector nor have we selected any specific
target businesses with which to pursue our initial business
combination, you will be unable to ascertain the merits or risks of
any particular target business’s operations.
We may pursue business combination opportunities in any industry or
sector, except that we will not, under our amended and restated
memorandum and articles of association, be permitted to effectuate
our initial business combination solely with another blank check
company or similar company with nominal operations. Because we have
not selected any specific business combination target and we have
not, nor has anyone on our behalf, engaged in any substantive
discussions, directly or indirectly, with any business combination
target with respect to an initial business combination with us,
there is no basis to evaluate the possible merits or risks of any
particular target business’s operations, results of operations,
cash flows, liquidity, financial condition or prospects. To the
extent we complete our initial business combination, we may be
affected by numerous risks inherent in the business operations with
which we combine. For example, if we combine with a financially
unstable business or an entity lacking an established record of
sales or earnings, we may be affected by the risks inherent in the
business and operations of a financially unstable or a development
stage entity. Although our officers and directors will endeavor to
evaluate the risks inherent in a particular target business, we
cannot assure you that we will properly ascertain or assess all of
the significant risk factors or that we will have adequate time to
complete due diligence. Furthermore, some of these risks may be
outside of our control and leave us with no ability to control or
reduce the chances that those risks will adversely impact a target
business. We also cannot assure you that an investment in our Units
will ultimately prove to be more favorable to investors than a
direct investment, if such opportunity were available, in a
business combination target. Accordingly, any holders who choose to
retain their securities following the business combination could
suffer a reduction in the value of their securities. Such holders
are unlikely to have a remedy for such reduction in
value.
Although we have identified general criteria and guidelines that we
believe are important in evaluating prospective target businesses,
we may enter into our initial business combination with a target
that does not meet such criteria and guidelines and, as a result,
the target business with which we enter into our initial business
combination may not have attributes entirely consistent with our
general criteria and guidelines.
Although we have identified general criteria and guidelines for
evaluating prospective target businesses, it is possible that a
target business with which we enter into our initial business
combination will not have all of these positive attributes. If we
complete our initial business combination with a target that does
not meet some or all of these criteria and guidelines, such
combination may not be as successful as a combination with a
business that does meet all of our general criteria and guidelines.
In addition, if we announce a prospective business combination with
a target that does not meet our general criteria and guidelines, a
greater number of shareholders may exercise their redemption
rights, which may make it difficult for us to meet any closing
condition with a target business that requires us to have a minimum
net worth or a certain amount of cash. In addition, if shareholder
approval of the transaction is required by applicable law or stock
exchange listing requirements, or we decide to obtain shareholder
approval for business or other reasons, it may be more difficult
for us to attain shareholder approval of our initial business
combination if the target business does not meet our general
criteria and guidelines. If we have not consummated our initial
business combination within the required time period, our public
shareholders may receive only approximately $10.00 per public
share, or less in certain circumstances, on the liquidation of our
trust account and our warrants will expire worthless.
We may seek acquisition opportunities in industries or sectors
which may or may not be outside of our management’s area of
expertise.
We will consider a business combination outside of our management’s
area of expertise if a business combination target is presented to
us and we determine that such candidate offers an attractive
acquisition opportunity for our company. Although our management
will endeavor to evaluate the risks inherent in any particular
business combination target, we cannot assure you that we will
adequately ascertain or assess all of the significant risk factors.
We also cannot assure you that an investment in our Units will not
ultimately prove to be less favorable to investors in the Initial
Public Offering than a direct investment, if an opportunity were
available, in a business combination target. In the event we elect
to pursue an acquisition outside of the areas of our management’s
expertise, our management’s expertise may not be directly
applicable to its evaluation or operation, and the information
contained in this Annual Report regarding the areas of our
management’s expertise would not be relevant to an understanding of
the business that we elect to acquire. As a result, our management
may not be able to adequately ascertain or assess all of the
significant risk factors. Accordingly, any holders who choose to
retain their securities following the business combination could
suffer a reduction in the value of their securities. Such holders
are unlikely to have a remedy for such reduction in
value.
We are not required to obtain an opinion from an independent
accounting or investment banking firm and, consequently, you may
have no assurance from an independent source that the price we are
paying for the business is fair to our shareholders from a
financial point of view.
Unless we complete our initial business combination with an
affiliated entity, we are not required to obtain an opinion from an
independent investment banking firm or another independent entity
that commonly renders valuation opinions that the price we are
paying is fair to our shareholders from a financial point of view.
If no opinion is obtained, our shareholders will be relying on the
judgment of our board of directors, who will determine fair market
value based on standards generally accepted by the financial
community. Such standards used will be disclosed in our proxy
solicitation or tender offer materials, as applicable, related to
our initial business combination.
We may issue additional Class A ordinary shares or preference
shares to complete our initial business combination or under an
employee incentive plan after completion of our initial business
combination. We may also issue Class A ordinary shares upon the
conversion of the founder shares at a ratio greater than one-to-one
at the time of our initial business combination as a result of the
anti-dilution provisions contained in our amended and restated
memorandum and articles of association. Any such issuances would
dilute the interest of our shareholders and likely present other
risks.
Our amended and restated memorandum and articles of association
authorize the issuance of up to 500,000,000 Class A ordinary
shares, par value $0.0001 per share, 50,000,000 Class B ordinary
shares, par value $0.0001 per share, and 5,000,000 preference
shares, par value $0.0001 per share. There are 484,475,000 and
46,118,750 (assuming in each case that the underwriters have not
exercised their over-allotment option) authorized but unissued
Class A ordinary shares and Class B ordinary shares, respectively,
available for issuance which amount does not take into account
shares reserved for issuance upon exercise of outstanding warrants
or shares issuable upon conversion of the Class B ordinary shares,
if any. The Class B ordinary shares will automatically convert into
Class A ordinary shares (which such Class A ordinary shares
delivered upon conversion will not have any redemption rights or be
entitled to liquidating distributions from the trust account if we
fail to consummate an initial business combination) at the time of
our initial business combination or earlier at the option of the
holders thereof as described herein and in our amended and restated
memorandum and articles of association. There are no preference
shares issued and outstanding.
We may issue a substantial number of additional Class A ordinary
shares or preference shares to complete our initial business
combination or under an employee incentive plan after completion of
our initial business combination. We may also issue Class A
ordinary shares in connection with our redeeming the warrants or
upon conversion of the Class B ordinary shares at a ratio greater
than one-to-one at the time of our initial business combination as
a result of the anti-dilution provisions as set forth herein.
However, our amended and restated memorandum and articles of
association provide, among other things, that prior to or in
connection with our initial business combination, we may not issue
additional shares that would entitle the holders thereof to (i)
receive funds from the trust account or (ii) vote on any initial
business combination or on any other proposal presented to
shareholders prior to or in connection with the completion of an
initial business combination. These provisions of our amended and
restated memorandum and articles of association, like all
provisions of our amended and restated memorandum and articles of
association, may be amended with a shareholder vote. The issuance
of additional ordinary or preference shares:
•may
significantly dilute the equity interest of investors in the
Initial Public Offering, which dilution would increase if the
anti-dilution provisions in the Class B ordinary shares resulted in
the issuance of Class A ordinary shares on a greater than
one-to-one basis upon conversion of the Class B ordinary
shares;
•may
subordinate the rights of holders of Class A ordinary shares if
preference shares are issued with rights senior to those afforded
our Class A ordinary shares;
•could
cause a change in control if a substantial number of Class A
ordinary shares are issued, which may affect, among other things,
our ability to use our net operating loss carry forwards, if any,
and could result in the resignation or removal of our present
officers and directors;
•may
have the effect of delaying or preventing a change of control of us
by diluting the share ownership or voting rights of a person
seeking to obtain control of us;
•may
adversely affect prevailing market prices for our Units, Class A
ordinary shares and/or warrants; and
•may
not result in adjustment to the exercise price of our
warrants.
Resources could be wasted in researching acquisitions that are not
completed, which could materially adversely affect subsequent
attempts to locate and acquire or merge with another business. If
we have not consummated our initial business combination within the
required time period, our public shareholders may receive only
approximately $10.00 per public share, or less in certain
circumstances, on the liquidation of our trust account and our
warrants will expire worthless.
We anticipate that the investigation of each specific target
business and the negotiation, drafting and execution of relevant
agreements, disclosure documents and other instruments will require
substantial management time and attention and substantial costs for
accountants, attorneys and others. If we decide not to complete a
specific initial business combination, the costs incurred up to
that point for the proposed transaction likely would not be
recoverable. Furthermore, if we reach an agreement relating to a
specific target business, we may fail to complete our initial
business combination for any number of reasons including those
beyond our control. Any such event will result in a loss to us of
the related costs incurred which could materially adversely affect
subsequent attempts to locate and acquire or merge with another
business. If we have not consummated our initial business
combination within the required time period, our public
shareholders may receive only approximately $10.00 per public
share, or less in certain circumstances, on the liquidation of our
trust account and our warrants will expire worthless.
We may only be able to complete one business combination with the
proceeds of the Initial Public Offering and the sale of the private
placement warrants, which will cause us to be solely dependent on a
single business which may have a limited number of products or
services. This lack of diversification may negatively impact our
operations and profitability.
The net proceeds from the Initial Public Offering and the sale of
the private placement warrants will provide us with up to
$155,250,000 (after taking into account the $5,433,750 of deferred
underwriting commissions being held in the trust account and the
estimated expenses of the Initial Public Offering).
We may effectuate our initial business combination with a
single-target business or multiple-target businesses simultaneously
or within a short period of time. However, we may not be able to
effectuate our initial business combination with more than one
target business because of various factors, including the existence
of complex accounting issues and the requirement that we prepare
and file pro forma financial statements with the SEC that present
operating results and the financial condition of several target
businesses as if they had been operated on a combined basis. By
completing our initial business combination with only a single
entity, our lack of diversification may subject us to numerous
economic, competitive and regulatory developments. Further, we
would not be able to diversify our operations or benefit from the
possible spreading of risks or offsetting of losses, unlike other
entities which may have the resources to complete several business
combinations in different industries or different areas of a single
industry.
Accordingly, the prospects for our success may be:
•solely
dependent upon the performance of a single business, property or
asset; or
•dependent
upon the development or market acceptance of a single or limited
number of products, processes or services.
This lack of diversification may subject us to numerous economic,
competitive and regulatory risks, any or all of which may have a
substantial adverse impact upon the particular industry in which we
may operate subsequent to our initial business
combination.
We may attempt to simultaneously complete business combinations
with multiple prospective targets, which may hinder our ability to
complete our initial business combination and give rise to
increased costs and risks that could negatively impact our
operations and profitability.
If we determine to simultaneously acquire several businesses that
are owned by different sellers, we will need for each of such
sellers to agree that our purchase of its business is contingent on
the simultaneous closings of the other business combinations, which
may make it more difficult for us, and delay our ability, to
complete our initial business combination. With
multiple
business combinations, we could also face additional risks,
including additional burdens and costs with respect to possible
multiple negotiations and due diligence investigations (if there
are multiple sellers) and the additional risks associated with the
subsequent assimilation of the operations and services or products
of the acquired companies in a single operating business. If we are
unable to adequately address these risks, it could negatively
impact our profitability and results of operations.
We may attempt to complete our initial business combination with a
private company about which little information is available, which
may result in a business combination with a company that is not as
profitable as we suspected, if at all.
In pursuing our acquisition strategy, we may seek to effectuate our
initial business combination with a privately held company. Very
little public information generally exists about private companies,
and we could be required to make our decision on whether to pursue
a potential initial business combination on the basis of limited
information, which may result in a business combination with a
company that is not as profitable as we suspected, if at
all.
Our management may not be able to maintain control of a target
business after our initial business combination. Upon the loss of
control of a target business, new management may not possess the
skills, qualifications or abilities necessary to profitably operate
such business.
We may structure our initial business combination so that the
post-business combination company in which our public shareholders
own shares will own less than 100% of the equity interests or
assets of a target business, but we will only complete such
business combination if the post-business combination company owns
or acquires 50% or more of the outstanding voting securities of the
target or otherwise acquires a controlling interest in the target
business sufficient for us not to be required to register as an
investment company under the Investment Company Act. We will not
consider any transaction that does not meet such criteria. Even if
the post-business combination company owns 50% or more of the
voting securities of the target, our shareholders prior to our
initial business combination may collectively own a minority
interest in the post-business combination company, depending on
valuations ascribed to the target and us in the business
combination. For example, we could pursue a transaction in which we
issue a substantial number of new Class A ordinary shares in
exchange for all of the outstanding capital stock, shares or other
equity interests of a target. In this case, we would acquire a 100%
interest in the target. However, as a result of the issuance of a
substantial number of new Class A ordinary shares, our shareholders
immediately prior to such transaction could own less than a
majority of our outstanding Class A ordinary shares subsequent to
such transaction. In addition, other minority shareholders may
subsequently combine their holdings resulting in a single person or
group obtaining a larger share of the company’s shares than we
initially acquired. Accordingly, this may make it more likely that
our management will not be able to maintain control of the target
business.
The officers and directors of an acquisition candidate may resign
upon completion of our initial business combination. The loss of a
business combination target’s key personnel could negatively impact
the operations and profitability of our post-combination
business.
The role of an acquisition candidate’s key personnel upon the
completion of our initial business combination cannot be
ascertained at this time. Although we contemplate that certain
members of an acquisition candidate’s management team will remain
associated with the acquisition candidate following our initial
business combination, it is possible that members of the management
of an acquisition candidate will not wish to remain in
place.
We do not have a specified maximum redemption threshold. The
absence of such a redemption threshold may make it possible for us
to complete our initial business combination with which a
substantial majority of our shareholders do not agree.
Our amended and restated memorandum and articles of association do
not provide a specified maximum redemption threshold, except that
we will not redeem our public shares in an amount that would cause
our net tangible assets to be less than $5,000,001 (so that we do
not then become subject to the SEC’s “penny stock” rules) or any
greater net tangible asset or cash requirement that may be
contained in the agreement relating to our initial business
combination. As a result, we may be able to complete our initial
business combination even though a substantial majority of our
public shareholders do not agree with the transaction and have
redeemed their shares or, if we seek shareholder approval of our
initial business combination and do not conduct redemptions in
connection with our initial business combination pursuant to the
tender offer rules, have entered into privately negotiated
agreements to sell their shares to our sponsor, officers,
directors, advisors or their respective affiliates. In the event
the aggregate cash consideration we would be required to pay for
all Class A ordinary shares that are validly submitted for
redemption plus any amount required to satisfy cash conditions
pursuant to the terms of the proposed business combination exceed
the aggregate amount of cash available to us, we will not complete
the business combination or redeem any shares, all Class A ordinary
shares submitted for redemption will be returned to the holders
thereof, and we instead may search for an alternate business
combination.
In order to effectuate an initial business combination, blank check
companies have, in the recent past, amended various provisions of
their charters and other governing instruments, including their
warrant agreements. We cannot assure you that we will not seek to
amend our amended and restated memorandum and articles of
association or governing instruments, including our warrant
agreement, in a manner that will make it easier for us to complete
our initial business combination that holders of our securities may
not support.
In order to effectuate a business combination, blank check
companies have, in the recent past, amended various provisions of
their charters and governing instruments, including their warrant
agreements. For example, blank check companies have amended the
definition of business combination, increased redemption
thresholds, extended the time to consummate an initial business
combination and, with respect to their warrants, amended their
warrant agreements to require the warrants to be exchanged for cash
and/or other securities. Amending our amended and restated
memorandum and articles of association requires at least a special
resolution of our shareholders as a matter of Cayman Islands law,
meaning the approval of holders of at least two-thirds of our
ordinary shares who attend and vote at a general meeting of the
company, and amending our warrant agreement will require a vote of
holders of at least 50% of the public warrants and, solely with
respect to any amendment to the terms of the private placement
warrants or any provision of the warrant agreement with respect to
the private placement warrants, 50% of the number of the then
outstanding private placement warrants. In addition, our amended
and restated memorandum and articles of association require us to
provide our public shareholders with the opportunity to redeem
their public shares for cash if we propose an amendment to our
amended and restated memorandum and articles of association (A)
that would modify the substance or timing of our obligation to
provide holders of our Class A ordinary shares the right to have
their shares redeemed in connection with our initial business
combination or to redeem 100% of our public shares if we do not
complete our initial business combination within 24 months from the
closing of the Initial Public Offering or (B) with respect to any
other provision relating to the rights of holders of our Class A
ordinary shares. To the extent any of such amendments would be
deemed to fundamentally change the nature of any of the securities
offered through this registration statement, we would register, or
seek an exemption from registration for, the affected
securities.
We may be unable to obtain additional financing to complete our
initial business combination or to fund the operations and growth
of a target business, which could compel us to restructure or
abandon a particular business combination.
Although we believe that the net proceeds of the Initial Public
Offering and the sale of the private placement warrants will be
sufficient to allow us to complete our initial business
combination, because we have not yet selected any prospective
target business we cannot ascertain the capital requirements for
any particular transaction. If the net proceeds of the Initial
Public Offering and the sale of the private placement warrants
prove to be insufficient, either because of the size of our initial
business combination, the depletion of the available net proceeds
in search of a target business, the obligation to redeem for cash a
significant number of shares from shareholders who elect redemption
in connection with our initial business combination or the terms of
negotiated transactions to purchase shares in connection with our
initial business combination, we may be required to seek additional
financing or to abandon the proposed business combination. We
cannot assure you that such financing will be available on
acceptable terms, if at all. The current economic environment may
make it difficult for companies to obtain acquisition financing. To
the extent that additional financing proves to be unavailable when
needed to complete our initial business combination, we would be
compelled to either restructure the transaction or abandon that
particular business combination and seek an alternative target
business candidate. If we have not consummated our initial business
combination within the required time period, our public
shareholders may receive only approximately $10.00 per public
share, or less in certain circumstances, on the liquidation of our
trust account and our warrants will expire worthless. In addition,
even if we do not need additional financing to complete our initial
business combination, we may require such financing to fund the
operations or growth of the target business. The failure to secure
additional financing could have a material adverse effect on the
continued development or growth of the target business. None of our
officers, directors or shareholders is required to provide any
financing to us in connection with or after our initial business
combination. If we have not consummated our initial business
combination within the required time period, our public
shareholders may receive only approximately $10.00 per public
share, or less in certain circumstances, on the liquidation of our
trust account and our warrants will expire worthless.
We may not be able to consummate an initial business combination
within 24 months after the closing of the Initial Public Offering,
in which case we would cease all operations except for the purpose
of winding up and we would redeem our public shares and
liquidate.
We may not be able to find a suitable target business and
consummate an initial business combination within 24 months after
the closing of the Initial Public Offering. Our ability to complete
our initial business combination may be negatively impacted by
general market conditions, volatility in the capital and debt
markets and the other risks described herein. For example, the
outbreak of COVID-19 continues to grow both in the U.S. and
globally and, while the extent of the impact of the outbreak on us
will depend on future developments, it could limit our ability to
complete our initial business combination, including as a
result
of increased market volatility, decreased market liquidity and
third-party financing being unavailable on terms acceptable to us
or at all. Additionally, the outbreak of COVID-19 may negatively
impact businesses we may seek to acquire. Additionally, financial
markets may be adversely affected by current or anticipated
military conflict, including between Russia and Ukraine, terrorism,
sanctions or other geopolitical events globally. If we have not
consummated an initial business combination within such applicable
time period, we will: (i) cease all operations except for the
purpose of winding up; (ii) as promptly as reasonably possible but
not more than ten business days thereafter, redeem the public
shares, at a per-share price, payable in cash, equal to the
aggregate amount then on deposit in the trust account, including
interest earned on the funds held in the trust account and not
previously released to us to pay our taxes, if any (less up to
$100,000 of interest to pay dissolution expenses), divided by the
number of the then-outstanding public shares, which redemption will
completely extinguish public shareholders’ rights as shareholders
(including the right to receive further liquidation distributions,
if any); and (iii) as promptly as reasonably possible following
such redemption, subject to the approval of our remaining
shareholders and our board of directors, liquidate and dissolve,
subject in each case, to our obligations under Cayman Islands law
to provide for claims of creditors and the requirements of other
applicable law. Our amended and restated memorandum and articles of
association provide that, if we wind up for any other reason prior
to the consummation of our initial business combination, we will
follow the foregoing procedures with respect to the liquidation of
the trust account as promptly as reasonably possible but not more
than ten business days thereafter, subject to applicable Cayman
Islands law. In either such case, our public shareholders may
receive only $10.00 per public share, or less than $10.00 per
public share, on the redemption of their shares, and our warrants
will expire worthless.
Our search for a business combination, and any target business with
which we ultimately consummate a business combination, may be
materially adversely affected by the coronavirus (COVID-19)
outbreak and the status of debt and equity markets.
In December 2019, a novel strain of coronavirus was reported to
have surfaced, which has and is continuing to spread throughout the
world, including the United States. On January 30, 2020, the World
Health Organization declared the outbreak of the coronavirus
disease (COVID-19) a “Public Health Emergency of International
Concern.” On January 31, 2020, U.S. Health and Human Services
Secretary Alex M. Azar II declared a public health emergency for
the United States to aid the U.S. healthcare community in
responding to the COVID-19 outbreak, and on March 11, 2020 the
World Health Organization classified the outbreak as a “pandemic.”
The pandemic, together with resulting voluntary and U.S. federal
and state and non-U.S. governmental actions, including, without
limitation, mandatory business closures, public gathering
limitations, restrictions on travel and quarantines, has
meaningfully disrupted the global economy and markets. Although the
long-term economic fallout of the COVID-19 pandemic is difficult to
predict, it has and is expected to continue to have ongoing
material adverse effects across many, if not all, aspects of the
regional, national and global economy. The COVID-19 pandemic has
resulted, and a significant outbreak of other infectious diseases
could result, in a widespread health crisis that could adversely
affect the economies and financial markets worldwide, and the
business of any potential target business with which we consummate
a business combination could be materially and adversely affected.
Furthermore, we may be unable to complete a business combination if
continued concerns relating to the COVID-19 pandemic continues to
restrict travel, limit the ability to have meetings with potential
investors or the target company’s personnel, vendors and services
providers are unavailable to negotiate and consummate a transaction
in a timely manner. The extent to which the COVID-19 pandemic
impacts our search for a business combination will depend on future
developments, which are highly uncertain and cannot be predicted,
including new information which may emerge concerning the severity
of COVID-19 and the actions to contain COVID-19 or treat its
impact, among others. If the disruptions posed by the COVID-19
pandemic or other matters of global concern continue for an
extensive period of time, our ability to consummate a business
combination, or the operations of a target business with which we
ultimately consummate a business combination, may be materially
adversely affected.
In addition, our ability to consummate a transaction may be
dependent on the ability to raise equity and debt financing which
may be impacted by the COVID-19 pandemic and other events,
including as a result of increased market volatility, decreased
market liquidity and third-party financing being unavailable on
terms acceptable to us or at all.
We may seek business combination opportunities with a high degree
of complexity that require significant operational improvements,
which could delay or prevent us from achieving our desired
results.
We may seek business combination opportunities with large, highly
complex companies that we believe would benefit from operational
improvements. While we intend to implement such improvements, to
the extent that our efforts are delayed or we are unable to achieve
the desired improvements, the business combination may not be as
successful as we anticipate.
To the extent we complete our initial business combination with a
large complex business or entity with a complex operating
structure, we may also be affected by numerous risks inherent in
the operations of the business with which we combine, which could
delay or prevent us from implementing our strategy. Although our
management team will endeavor to evaluate the risks inherent in a
particular target business and its operations, we may not be able
to properly ascertain or assess all of the significant risk factors
until we complete our business combination. If we are not able to
achieve our desired operational improvements, or
the improvements take longer to implement than anticipated, we may
not achieve the gains that we anticipate. Furthermore, some of
these risks and complexities may be outside of our control and
leave us with no ability to control or reduce the chances that
those risks and complexities will adversely impact a target
business. Such combination may not be as successful as a
combination with a smaller, less complex organization.
Risks Relating to Our Securities
The NYSE may delist our securities from trading on its exchange,
which could limit investors’ ability to make transactions in our
securities and subject us to additional trading
restrictions.
Our Units, Class A ordinary shares and warrants are listed on the
NYSE. Although we currently meet, on a pro forma basis, the minimum
initial listing standards set forth in the NYSE listing standards,
our securities may not be listed on the NYSE in the future or prior
to our initial business combination. In order to continue listing
our securities on the NYSE prior to our initial business
combination, we must maintain certain financial, distribution and
share price levels, such as a minimum market capitalization
(generally $50,000,000) and a minimum number of holders of our
securities (generally 300 public holders) Additionally, our Units
will not be traded after completion of our initial business
combination and, in connection with our initial business
combination, we will be required to demonstrate compliance with the
NYSE initial listing requirements, which are more rigorous than the
NYSE continued listing requirements, in order to continue to
maintain the listing of our securities on the NYSE. For instance,
our share price would generally be required to be at least $4.00
per share, our total market capitalization would be required to be
at least $200.0 million, the aggregate market value of publicly
held shares would be required to be at least $100.0 million and we
would be required to have at least 400 round lot shareholders. We
may not be able to meet those listing requirements at that time,
especially if there are a significant number of redemptions in
connection with our initial business combination.
If the NYSE delists our securities from trading on its exchange and
we are not able to list our securities on another national
securities exchange, we expect our securities could be quoted on an
over-the-counter market. If this were to occur, we could face
significant material adverse consequences, including:
•a
limited availability of market quotations for our
securities;
•reduced
liquidity for our securities;
•a
determination that our Class A ordinary shares are a “penny stock”
which will require brokers trading in our Class A ordinary shares
to adhere to more stringent rules and possibly result in a reduced
level of trading activity in the secondary trading market for our
securities;
•a
limited amount of news and analyst coverage; and
•a
decreased ability to issue additional securities or obtain
additional financing in the future.
The National Securities Markets Improvement Act of 1996, as
amended, which is a federal statute, prevents or preempts the
states from regulating the sale of certain securities, which are
referred to as “covered securities.” Because we expect that our
Units and eventually our Class A ordinary shares and warrants will
be listed on the NYSE, our Units, Class A ordinary shares and
warrants will qualify as covered securities under the statute.
Although the states are preempted from regulating the sale of
covered securities, the federal statute does allow the states to
investigate companies if there is a suspicion of fraud and, if
there is a finding of fraudulent activity, then the states can
regulate or bar the sale of covered securities in a particular
case. While we are not aware of a state having used these powers to
prohibit or restrict the sale of securities issued by blank check
companies, other than the State of Idaho, certain state securities
regulators view blank check companies unfavorably and might use
these powers, or threaten to use these powers, to hinder the sale
of securities of blank check companies in their states. Further, if
we were no longer listed on the NYSE, our securities would not
qualify as covered securities under the statute and we would be
subject to regulation in each state in which we offer our
securities.
You will not be entitled to protections normally afforded to
investors of many other blank check companies.
Since the net proceeds of the Initial Public Offering and the sale
of the private placement warrants are intended to be used to
complete an initial business combination with a target business
that has not been selected, we may be deemed to be a “blank check”
company under the United States securities laws. However, because
we had net tangible assets in excess of $5,000,000 upon the
completion of the Initial Public Offering and the sale of the
private placement warrants and filed a Current Report on Form 8-K,
including an audited balance sheet demonstrating this fact, we are
exempt from rules promulgated by the SEC to protect investors in
blank check companies, such as Rule 419. Accordingly, investors are
not afforded the benefits or protections of those rules. Among
other things, this means we will have a longer period of time to
complete our initial business combination than do companies subject
to Rule 419.
If we seek shareholder approval of our initial business combination
and we do not conduct redemptions pursuant to the tender offer
rules and if you or a “group” of shareholders are deemed to hold in
excess of 15% of our Class A ordinary shares, you will lose the
ability to redeem all such shares in excess of 15% of our Class A
ordinary shares.
If we seek shareholder approval of our initial business combination
and we do not conduct redemptions in connection with our initial
business combination pursuant to the tender offer rules, our
amended and restated memorandum and articles of association provide
that a public shareholder, together with any affiliate of such
shareholder or any other person with whom such shareholder is
acting in concert or as a “group” (as defined under Section 13 of
the Exchange Act), will be restricted from redeeming its shares
with respect to more than an aggregate of 15% of the shares sold in
the Initial Public Offering, which we refer to as the “Excess
Shares,” without our prior consent. However, we would not be
restricting our shareholders’ ability to vote all of their shares
(including Excess Shares) for or against our initial business
combination. Your inability to redeem the Excess Shares will reduce
your influence over our ability to complete our initial business
combination and you could suffer a material loss on your investment
in us if you sell Excess Shares in open market transactions.
Additionally, you will not receive redemption distributions with
respect to the Excess Shares if we complete our initial business
combination. And as a result, you will continue to hold that number
of shares exceeding 15% and, in order to dispose of such shares,
would be required to sell your shares in open market transactions,
potentially at a loss.
Our shareholders may be held liable for claims by third parties
against us to the extent of distributions received by them upon
redemption of their shares.
If we are forced to enter into an insolvent liquidation, any
distributions received by shareholders could be viewed as an
unlawful payment if it was proved that immediately following the
date on which the distribution was made, we were unable to pay our
debts as they fall due in the ordinary course of business. As a
result, a liquidator could seek to recover some or all amounts
received by our shareholders. Furthermore, our directors may be
viewed as having breached their fiduciary duties to us or our
creditors and/or may have acted in bad faith, thereby exposing
themselves and our company to claims, by paying public shareholders
from the trust account prior to addressing the claims of creditors.
We cannot assure you that claims will not be brought against us for
these reasons. We and our directors and officers who knowingly and
willfully authorized or permitted any distribution to be paid out
of our share premium account while we were unable to pay our debts
as they fall due in the ordinary course of business would be guilty
of an offense and may be liable for a fine of $18,292.68 and
imprisonment for five years in the Cayman Islands.
We may not hold an annual general meeting until after the
consummation of our initial business combination.
In accordance with the NYSE corporate governance requirements, we
are not required to hold an annual general meeting until one year
after our first fiscal year end following our listing on the NYSE.
There is no requirement under the Companies Act for us to hold
annual or extraordinary general meetings to appoint directors.
Until we hold an annual general meeting, public shareholders may
not be afforded the opportunity to appoint directors and to discuss
company affairs with management. Our board of directors is divided
into three classes with only one class of directors being appointed
in each year and each class (except for those directors appointed
prior to our first annual general meeting) serving a three-year
term.
We are not registering the Class A ordinary shares issuable upon
exercise of the warrants under the Securities Act or any state
securities laws at this time, and such registration may not be in
place when an investor desires to exercise warrants, thus
precluding such investor from being able to exercise its warrants
except on a cashless basis and potentially causing such warrants to
expire worthless.
We are not registering the Class A ordinary shares issuable upon
exercise of the warrants under the Securities Act or any state
securities laws at this time. However, under the terms of the
warrant agreement, we have agreed that, as soon as practicable, but
in no event later than 20 business days after the closing of our
initial business combination, we will use our commercially
reasonable efforts to file with the SEC a registration statement
for the registration, under the Securities Act, of the Class A
ordinary shares and we will use our commercially reasonable efforts
to cause the same to become effective within 60 business days
following the closing of our initial business combination and to
maintain the effectiveness of such registration statement and a
current prospectus relating to those Class A ordinary shares until
the warrants expire or are redeemed. We cannot assure you that we
will be able to do so if, for example, any facts or events arise
which represent a fundamental change in the information set forth
in the registration statement or prospectus, the financial
statements contained or incorporated by reference therein are not
current, complete or correct or the SEC issues a stop order. If the
shares issuable upon exercise of the warrants are not registered
under the Securities Act in accordance with the above requirements,
we will be required to permit holders to exercise their warrants on
a cashless basis, in which case, the number of Class A ordinary
shares that you will receive upon cashless exercise will be based
on a formula subject to a maximum amount of shares equal to 0.361
Class A ordinary shares per warrant (subject to adjustment).
However, no warrant will be exercisable for cash or on a cashless
basis, and we will not be
obligated to issue any shares to holders seeking to exercise their
warrants, unless the issuance of the shares upon such exercise is
registered or qualified under the securities laws of the state of
the exercising holder, or an exemption from registration is
available. Notwithstanding the above, if our Class A ordinary
shares are at the time of any exercise of a public warrant not
listed on a national securities exchange such that they satisfy the
definition of a “covered security” under Section 18(b)(1) of the
Securities Act, we may, at our option, require holders of public
warrants who exercise their warrants to do so on a “cashless basis”
in accordance with Section 3(a)(9) of the Securities Act and, in
the event we so elect, we will not be required to file or maintain
in effect a registration statement for the registration, under the
Securities Act, of the Class A ordinary shares issuable upon
exercise of the warrants, but we will use our commercially
reasonable efforts to register or qualify for sale the shares under
applicable blue sky laws to the extent an exemption is not
available. Exercising the warrants on a cashless basis could have
the effect of reducing the potential “upside” of the holder’s
investment in our company because the warrant holder will hold a
smaller number of Class A ordinary shares upon a cashless exercise
of the warrants they hold. In no event will we be required to net
cash settle any warrant, or issue securities or other compensation
in exchange for the warrants in the event that we are unable to
register or qualify the shares underlying the warrants under
applicable state securities laws and no exemption is available. If
the issuance of the shares upon exercise of the warrants is not so
registered or qualified or exempt from registration or
qualification, the holder of such warrant shall not be entitled to
exercise such warrant and such warrant may have no value and expire
worthless. In such event, holders who acquired their warrants as
part of a purchase of Units will have paid the full Unit purchase
price solely for the Class A ordinary shares included in the Units.
There may be a circumstance where an exemption from registration
exists for holders of our private placement warrants to exercise
their warrants while a corresponding exemption does not exist for
holders of the public warrants included as part of Units sold in
the Initial Public Offering. In such an instance, our sponsor and
its permitted transferees (which may include our directors and
executive officers) would be able to exercise their warrants and
sell the ordinary shares underlying their warrants while holders of
our public warrants would not be able to exercise their warrants
and sell the underlying ordinary shares. If and when the warrants
become redeemable by us, we may exercise our redemption right even
if we are unable to register or qualify the underlying Class A
ordinary shares for sale under all applicable state securities
laws. As a result, we may redeem the warrants as set forth above
even if the holders are otherwise unable to exercise their
warrants.
The grant of registration rights to our initial shareholders and
holders of our private placement warrants and working capital
warrants and their respective permitted transferees may make it
more difficult to complete our initial business combination, and
the future exercise of such rights may adversely affect the market
price of our Class A ordinary shares.
Pursuant to an agreement to be entered into on or prior to the
closing of the Initial Public Offering, our initial shareholders
and holders of our private placement warrants and working capital
warrants and their respective permitted transferees can demand that
we register the resale of the Class A ordinary shares into which
founder shares are convertible, the private placement warrants and
the Class A ordinary shares issuable upon exercise of the private
placement warrants, and warrants that may be issued upon conversion
of working capital loans and the Class A ordinary shares issuable
upon conversion of such warrants. The registration and availability
of such a significant number of securities for trading in the
public market may have an adverse effect on the market price of our
Class A ordinary shares. In addition, the existence of the
registration rights may make our initial business combination more
costly or difficult to conclude. This is because the shareholders
of the target business may increase the equity stake they seek in
the combined entity or ask for more cash consideration to offset
the negative impact on the market price of our securities that is
expected when the securities owned by our initial shareholders,
holders of our private placement warrants or working capital
warrants or their respective permitted transferees are registered
for resale.
We may issue notes or other debt securities, or otherwise incur
substantial debt, to complete a business combination, which may
adversely affect our leverage and financial condition and thus
negatively impact the value of our shareholders’ investment in
us.
Although we have no commitments as of the date of this Annual
Report to issue any notes or other debt securities, or to otherwise
incur outstanding debt, we may choose to incur substantial debt to
complete our initial business combination. We and our officers have
agreed that we will not incur any indebtedness unless we have
obtained from the lender a waiver of any right, title, interest or
claim of any kind in or to the monies held in the trust account. As
such, no issuance of debt will affect the per-share amount
available for redemption from the trust account. Nevertheless, the
incurrence of debt could have a variety of negative effects,
including:
•default
and foreclosure on our assets if our operating revenues after an
initial business combination are insufficient to repay our debt
obligations;
•acceleration
of our obligations to repay the indebtedness even if we make all
principal and interest payments when due if we breach certain
covenants that require the maintenance of certain financial ratios
or reserves without a waiver or renegotiation of that
covenant;
•our
immediate payment of all principal and accrued interest, if any, if
the debt is payable on demand;
•our
inability to obtain necessary additional financing if the debt
contains covenants restricting our ability to obtain such financing
while the debt is outstanding;
•our
inability to pay dividends on our Class A ordinary
shares;
•using
a substantial portion of our cash flow to pay principal and
interest on our debt, which will reduce the funds available for
dividends on our Class A ordinary shares if declared, expenses,
capital expenditures, acquisitions and other general corporate
purposes;
•limitations
on our flexibility in planning for and reacting to changes in our
business and in the industry in which we operate;
•increased
vulnerability to adverse changes in general economic, industry and
competitive conditions and adverse changes in government
regulation; and
•limitations
on our ability to borrow additional amounts for expenses, capital
expenditures, acquisitions, debt service requirements, execution of
our strategy and other purposes and other disadvantages compared to
our competitors who have less debt.
Our initial shareholders paid $25,000, or approximately $0.007 per
founder share and, accordingly, you will experience immediate and
substantial dilution from the purchase of our Class A ordinary
shares.
The difference between the public offering price per share
(allocating all of the Unit purchase price to the Class A ordinary
share and none to the warrant included in the Unit) and the pro
forma net tangible book value per Class A ordinary share after the
Initial Public Offering constituted the dilution to investors in
our Initial Public Offering. Our initial shareholders acquired the
founder shares at a nominal price, significantly contributing to
this dilution. Upon closing of the Initial Public Offering, and
assuming no value is ascribed to the warrants included in the
Units, investors in our Initial Public Offering incurred an
immediate and substantial dilution of approximately
89.6%
(or $8.74 per share, assuming the underwriters do not exercise the
over-allotment option), the difference between the pro forma net
tangible book value per share of $1.04
and the initial offering price of $10.00 per Unit. This dilution
would increase to the extent that the anti-dilution provisions of
the Founder Shares result in the issuance of Class A ordinary
shares on a greater than one-to-one basis upon conversion of the
Founder Shares at the time of our initial business combination and
would become exacerbated to the extent that public shareholders
seek redemptions from the trust for their public shares. In
addition, because of the anti-dilution protection in the Founder
Shares, any equity or equity-linked securities or deemed issued in
connection with our initial business combination would be
disproportionately dilutive to our Class A ordinary
shares.
We may redeem your unexpired warrants prior to their exercise at a
time that is disadvantageous to you, thereby making your warrants
worthless.
We have the ability to redeem the outstanding public warrants at
any time after they become exercisable and prior to their
expiration, at a price of $0.01 per warrant, provided that the
closing price of our Class A ordinary shares equals or exceeds
$18.00 per share (as adjusted for adjustments to the number of
shares issuable upon exercise or the exercise price of a warrant)
for any 20 trading days within a 30 trading-day period ending on
the third trading day prior to proper notice of such redemption and
provided that certain other conditions are met. If and when the
warrants become redeemable by us, we may exercise our redemption
right even if we are unable to register or qualify the underlying
securities for sale under all applicable state securities laws. As
a result, we may redeem the warrants as set forth above even if the
holders are otherwise unable to exercise the warrants. Redemption
of the outstanding warrants could force you to (i) exercise your
warrants and pay the exercise price therefor at a time when it may
be disadvantageous for you to do so, (ii) sell your warrants at the
then-current market price when you might otherwise wish to hold
your warrants or (iii) accept the nominal redemption price which,
at the time the outstanding warrants are called for redemption, we
expect would be substantially less than the market value of your
warrants. None of the private placement warrants will be redeemable
by us so long as they are held by our sponsor or its permitted
transferees.
In addition, we have the ability to redeem the outstanding public
warrants at any time after they become exercisable and prior to
their expiration, at a price of $0.10 per warrant upon a minimum of
30 days’ prior written notice of redemption provided that the
closing price of our Class A ordinary shares equals or exceeds
$10.00 per share (as adjusted for adjustments to the number of
shares issuable upon exercise or the exercise price of a warrant)
for any 20 trading days within a 30 trading-day period ending on
the third trading day prior to proper notice of such redemption and
provided that certain other conditions are met, including that
holders will be able to exercise their warrants prior to redemption
for a number of Class A ordinary shares determined based on the
redemption date and the fair market value of our Class A ordinary
shares. The value received upon exercise of the warrants (1) may be
less than the value the holders would have received if they had
exercised their warrants at a later time where the underlying share
price is higher and (2) may not compensate the holders for the
value of the warrants, including because the number of ordinary
shares received is capped at 0.361 Class A ordinary shares per
warrant (subject to adjustment) irrespective of the remaining life
of the warrants. None of the private placement warrants will be
redeemable by us as so long as they are held by our sponsor or its
permitted transferees.
Our warrants may have an adverse effect on the market price of our
Class A ordinary shares and make it more difficult to effectuate
our initial business combination.
We issued warrants to purchase 3,875,000 of our Class A ordinary
shares as part of the Units offered in the Initial Public Offering
and, simultaneously with the closing of the Initial Public
Offering, we issued in a private placement an aggregate of
6,105,000 private placement warrants, each exercisable to purchase
one Class A ordinary share at $11.50 per share, subject to
adjustment. In addition, if the sponsor, its affiliates or a member
of our management team makes any working capital loans, it may
convert up to $2,000,000 of such loans into up to an additional
2,000,000 private placement warrants, at the price of $1.00 per
warrant. We may also issue Class A ordinary shares in connection
with our redemption of our warrants.
To the extent we issue ordinary shares for any reason, including to
effectuate a business combination, the potential for the issuance
of a substantial number of additional Class A ordinary shares upon
exercise of these warrants could make us a less attractive
acquisition vehicle to a target business. Such warrants, when
exercised, will increase the number of issued and outstanding Class
A ordinary shares and reduce the value of the Class A ordinary
shares issued to complete the business transaction. Therefore, our
warrants may make it more difficult to effectuate a business
transaction or increase the cost of acquiring the target
business.
Because we must furnish our shareholders with target business
financial statements, we may lose the ability to complete an
otherwise advantageous initial business combination with some
prospective target businesses.
The federal proxy rules require that a proxy statement with respect
to a vote on a business combination meeting certain financial
significance tests include historical and/or pro forma financial
statement disclosure in periodic reports. We will include the same
financial statement disclosure in connection with our tender offer
documents, whether or not they are required under the tender offer
rules. These financial statements may be required to be prepared in
accordance with, or be reconciled to, accounting principles
generally accepted in the United States of America, or GAAP, or
international financial reporting standards as issued by the
International Accounting Standards Board, or IFRS, depending on the
circumstances and the historical financial statements may be
required to be audited in accordance with the standards of the
Public Company Accounting Oversight Board (United States), or
PCAOB. These financial statement requirements may limit the pool of
potential target businesses we may acquire because some targets may
be unable to provide such statements in time for us to disclose
such statements in accordance with federal proxy rules and complete
our initial business combination within the prescribed time
frame.
Compliance obligations under the Sarbanes-Oxley Act may make it
more difficult for us to effectuate a business combination, require
substantial financial and management resources and increase the
time and costs of completing an acquisition.
Section 404 of the Sarbanes-Oxley Act requires that we evaluate and
report on our system of internal controls beginning with our Annual
Report on Form 10-K for the year ending December 31, 2022. Only in
the event we are deemed to be a large accelerated filer or an
accelerated filer and no longer qualify as an emerging growth
company, would we be required to comply with the independent
registered public accounting firm attestation requirement on our
internal control over financial reporting. The fact that we are a
blank check company makes compliance with the requirements of the
Sarbanes-Oxley Act particularly burdensome on us as compared to
other public companies because a target business with which we seek
to complete our initial business combination may not be in
compliance with the provisions of the Sarbanes-Oxley Act regarding
adequacy of its internal controls. The development of the internal
control of any such entity to achieve compliance with the
Sarbanes-Oxley Act may increase the time and costs necessary to
complete any such acquisition.
Provisions in our amended and restated memorandum and articles of
association may inhibit a takeover of us, which could limit the
price investors might be willing to pay in the future for our Class
A ordinary shares and could entrench management.
Our amended and restated memorandum and articles of association
contain provisions that may discourage unsolicited takeover
proposals that shareholders may consider to be in their best
interests. These provisions will include a staggered board of
directors, the ability of the board of directors to designate the
terms of and issue new series of preference shares, and the fact
that prior to the completion of our initial business combination
only holders of our Class B ordinary shares, which have been issued
to our initial shareholders, are entitled to vote on the
appointment of directors, which may make more difficult the removal
of management and may discourage transactions that otherwise could
involve payment of a premium over prevailing market prices for our
securities.
If we have not consummated an initial business combination within
24 months from the closing of the Initial Public Offering, our
public shareholders may be forced to wait beyond such 24 months
before redemption from our trust account.
If we have not consummated an initial business combination within
24 months from the closing of the Initial Public Offering, the
proceeds then on deposit in the trust account, including interest
earned on the funds held in the trust account and not previously
released to us to pay our taxes, if any (less up to $100,000 of
interest to pay dissolution expenses), will be used to fund the
redemption of our public shares, as further described herein. Any
redemption of public shareholders from the trust account will be
effected automatically by function of our amended and restated
memorandum and articles of association prior to any voluntary
winding up. If we are required to wind up, liquidate the trust
account and distribute such amount therein, pro rata, to our public
shareholders, as part of any liquidation process, such winding up,
liquidation and distribution must comply with the applicable
provisions of the Companies Act. In that case, investors may be
forced to wait beyond 24 months from the closing of the Initial
Public Offering before the redemption proceeds of our trust account
become available to them, and they receive the return of their pro
rata portion of the proceeds from our trust account. We have no
obligation to return funds to investors prior to the date of our
redemption or liquidation unless, prior thereto, we consummate our
initial business combination or amend certain provisions of our
amended and restated memorandum and articles of association, and
only then in cases where investors have sought to redeem their
Class A ordinary shares. Only upon our redemption or any
liquidation will public shareholders be entitled to distributions
if we do not complete our initial business combination and do not
amend certain provisions of our amended and restated memorandum and
articles of association. Our amended and restated memorandum and
articles of association provide that, if we wind up for any other
reason prior to the consummation of our initial business
combination, we will follow the foregoing procedures with respect
to the liquidation of the trust account as promptly as reasonably
possible but not more than ten business days thereafter, subject to
applicable Cayman Islands law.
Holders of Class A ordinary shares will not be entitled to vote on
any appointment or removal of directors and to continue our company
in a jurisdiction outside the Cayman Islands prior to our initial
business combination.
Prior to our initial business combination, only holders of our
founder shares will have the right to vote on the appointment of
directors and to continue our company in a jurisdiction outside the
Cayman Islands (including, but not limited to, the approval of the
organizational documents of our company in such other
jurisdiction). Holders of our public shares will not be entitled to
vote on the appointment of directors or to continue our company in
a jurisdiction outside the Cayman Islands during such time. In
addition, prior to our initial business combination, holders of a
majority of our founder shares may remove a member of the board of
directors for any reason. Accordingly, you will not have any say in
the management of our company prior to the consummation of an
initial business combination.
The warrants may become exercisable and redeemable for a security
other than the Class A ordinary shares, and you will not have any
information regarding such other security at this
time.
In certain situations, including if we are not the surviving entity
in our initial business combination, the warrants may become
exercisable for a security other than the Class A ordinary shares.
As a result, if the surviving company redeems your warrants for
securities pursuant to the warrant agreement, you may receive a
security in a company of which you do not have information at this
time. Pursuant to the warrant agreement, the surviving company will
be required to use commercially reasonable efforts to register the
issuance of the security underlying the warrants within twenty
business days of the closing of an initial business
combination.
Unlike some other similarly structured blank check companies, our
initial shareholders will receive additional Class A ordinary
shares if we issue shares to consummate an initial business
combination.
The founder shares will automatically convert into Class A ordinary
shares (which such Class A ordinary shares delivered upon
conversion will not have any redemption rights or be entitled to
liquidating distributions from the trust account if we fail to
consummate an initial business combination) at the time of our
initial business combination or earlier at the option of the
holders thereof at a ratio such that the number of Class A ordinary
shares issuable upon conversion of all founder shares will equal,
in the aggregate, on an as-converted basis, 20% of the sum of (i)
the total number of ordinary shares issued and outstanding upon
completion of the Initial Public Offering, plus (ii) the total
number of Class A ordinary shares issued or deemed issued or
issuable upon conversion or exercise of any equity-linked
securities or rights issued or deemed issued, by us in connection
with or in relation to the consummation of the initial business
combination, excluding any Class A ordinary shares or equity-linked
securities exercisable for or convertible into Class A ordinary
shares issued, deemed issued, or to be issued, to any seller of an
interest in the target to us in the initial business combination
and any private placement warrants issued to our sponsor, any of
its affiliates or any members of our management team upon
conversion of working capital loans. In no event will the Class B
ordinary shares convert into Class A ordinary shares at a rate of
less than one-to-one. This is
different than some other similarly structured blank check
companies in which the initial shareholders will only be issued an
aggregate of 20% of the total number of shares to be outstanding
prior to the initial business combination.
We may amend the terms of the warrants in a manner that may be
adverse to holders of public warrants with the approval by the
holders of at least 50% of the then-outstanding public warrants. As
a result, the exercise price of your warrants could be increased,
the exercise period could be shortened and the number of our Class
A ordinary shares purchasable upon exercise of a warrant could be
decreased, all without your approval.
Our warrants will be issued in registered form under a warrant
agreement between Continental Stock Transfer & Trust Company,
as warrant agent, and us. The warrant agreement provides that the
terms of the warrants may be amended without the consent of any
holder for the purpose of (i) curing any ambiguity or correct any
mistake, including to conform the provisions of the warrant
agreement to the description of the terms of the warrants and the
warrant agreement set forth in this Annual Report, or defective
provision (ii) amending the provisions relating to cash dividends
on ordinary shares as contemplated by and in accordance with the
warrant agreement or (iii) adding or changing any provisions with
respect to matters or questions arising under the warrant agreement
as the parties to the warrant agreement may deem necessary or
desirable and that the parties deem to not adversely affect the
rights of the registered holders of the warrants, provided that the
approval by the holders of at least 50% of the then-outstanding
public warrants is required to make any change that adversely
affects the interests of the registered holders of public warrants.
Accordingly, we may amend the terms of the public warrants in a
manner adverse to a holder if holders of at least 50% of the
then-outstanding public warrants approve of such amendment and,
solely with respect to any amendment to the terms of the private
placement warrants or any provision of the warrant agreement with
respect to the private placement warrants, 50% of the number of the
then outstanding private placement warrants. Although our ability
to amend the terms of the public warrants with the consent of at
least 50% of the then-outstanding public warrants is unlimited,
examples of such amendments could be amendments to, among other
things, increase the exercise price of the warrants, convert the
warrants into cash, shorten the exercise period or decrease the
number of Class A ordinary shares purchasable upon exercise of a
warrant.
Risks Relating to Our Management Team
Our executive officers and directors will allocate their time to
other businesses thereby causing conflicts of interest in their
determination as to how much time to devote to our affairs. This
conflict of interest could have a negative impact on our ability to
complete our initial business combination.
Our executive officers and directors are not required to, and will
not, commit their full time to our affairs, which may result in a
conflict of interest in allocating their time between our
operations and our search for a business combination and their
other businesses. We do not intend to have any full-time employees
prior to the completion of our initial business combination. Each
of our executive officers and directors is engaged in several other
business endeavors for which he or she may be entitled to
substantial compensation, and our executive officers and directors
are not obligated to contribute any specific number of hours per
week to our affairs. Our independent directors also serve as
officers and board members for other entities. If our executive
officers’ and directors’ other business affairs require them to
devote substantial amounts of time to such affairs in excess of
their current commitment levels, it could limit their ability to
devote time to our affairs which may have a negative impact on our
ability to complete our initial business combination. In addition,
senior management of HPS will spend a vast majority, if not
substantially all, of their business time on their other duties,
including to the investment management clients of HPS.
We are dependent upon our executive officers and directors and
their loss could adversely affect our ability to
operate.
Our operations are dependent upon a relatively small group of
individuals and, in particular, our executive officers and
directors. We believe that our success depends on the continued
service of our officers and directors, at least until we have
completed our initial business combination. In addition, our
executive officers and directors are not required to commit any
specified amount of time to our affairs and, accordingly, will have
conflicts of interest in allocating their time among various
business activities, including identifying potential business
combinations and monitoring the related due diligence. We do not
have an employment agreement with, or key-man insurance on the life
of, any of our directors or executive officers. The unexpected loss
of the services of one or more of our directors or executive
officers could have a detrimental effect on us.
Our ability to successfully effect our initial business combination
and to be successful thereafter will be dependent upon the efforts
of our key personnel, some of whom may join us following our
initial business combination. The loss of key personnel could
negatively impact the operations and profitability of our
post-combination business.
Our ability to successfully effect our initial business combination
is dependent upon the efforts of our key personnel. We believe that
our success depends on the continued service of our key personnel,
at least until we have consummated our initial
business combination. None of our officers are required to commit
any specified amount of time to our affairs and, accordingly, they
will have conflicts of interest in allocating management time among
various business activities, including identifying potential
business combinations and monitoring the related due diligence. If
our officers’ and directors’ other business affairs require them to
devote more substantial amounts of time to their other business
activities, it could limit their ability to devote time to our
affairs and could have a negative impact on our ability to
consummate our initial business combination. In addition, we do not
have employment agreements with, or key-man insurance on the life
of, any of our officers. The unexpected loss of the services of our
key personnel could have a detrimental effect on us.
The role of our key personnel after our initial business
combination, however, remains to be determined. Although some of
our key personnel serve in senior management or advisory positions
following our initial business combination, it is likely that most,
if not all, of the management of the target business will remain in
place. These individuals may be unfamiliar with the requirements of
operating a public company which could cause us to have to expend
time and resources helping them become familiar with such
requirements. This could be expensive and time-consuming and could
lead to various regulatory issues which may adversely affect our
operations.
Our key personnel may negotiate employment or consulting agreements
with a target business in connection with a particular business
combination, and a particular business combination may be
conditioned on the retention or resignation of such key personnel.
These agreements may provide for them to receive compensation
following our initial business combination and as a result, may
cause them to have conflicts of interest in determining whether a
particular business combination is the most
advantageous.
Our key personnel may be able to remain with our company after the
completion of our initial business combination only if they are
able to negotiate employment or consulting agreements in connection
with the business combination. Such negotiations would take place
simultaneously with the negotiation of the business combination and
could provide for such individuals to receive compensation in the
form of cash payments and/or our securities for services they would
render to us after the completion of the business combination. Such
negotiations also could make such key personnel’s retention or
resignation a condition to any such agreement. The personal and
financial interests of such individuals may influence their
motivation in identifying and selecting a target business. In
addition, pursuant to an agreement to be entered into on or prior
to the closing of the Initial Public Offering, our sponsor, upon
and following consummation of an initial business combination, will
be entitled to nominate three individuals for appointment to our
board of directors, as long as the sponsor holds any securities
covered by the registration and shareholder rights
agreement.
We may have a limited ability to assess the management of a
prospective target business and, as a result, may affect our
initial business combination with a target business whose
management may not have the skills, qualifications or abilities to
manage a public company.
When evaluating the desirability of effecting our initial business
combination with a prospective target business, our ability to
assess the target business’s management may be limited due to a
lack of time, resources or information. Our assessment of the
capabilities of the target business’s management, therefore, may
prove to be incorrect and such management may lack the skills,
qualifications or abilities we suspected. Should the target
business’s management not possess the skills, qualifications or
abilities necessary to manage a public company, the operations and
profitability of the post-combination business may be negatively
impacted. Accordingly, any holders who choose to retain their
securities following the business combination could suffer a
reduction in the value of their securities. Such holders are
unlikely to have a remedy for such reduction in value. The officers
and directors of an initial business combination candidate may
resign upon completion of our initial business combination. The
departure of a business combination target’s key personnel could
negatively impact the operations and profitability of our
post-combination business. The role of an initial business
combination candidate’s key personnel upon the completion of our
initial business combination cannot be ascertained at this time.
Although we contemplate that certain members of an acquisition
candidate’s management team will remain associated with the initial
business combination candidate following our initial business
combination, it is possible that members of the management of an
acquisition candidate will not wish to remain in place. As a
result, we may need to reconstitute the management team of the
post-transaction company in connection with our initial business
combination, which may adversely impact our ability to complete an
initial business combination in a timely manner or at
all.
Our officers and directors presently have, and any of them in the
future may have, additional, fiduciary or contractual obligations
to other entities, including another blank check company and,
accordingly, may have conflicts of interest in determining to which
entity a particular business opportunity should be
presented.
Following the completion of the Initial Public Offering and until
we consummate our initial business combination, we intend to engage
in the business of identifying and combining with one or more
businesses or entities. Each of our officers and
directors
presently has, and any of them in the future may have, additional
fiduciary or contractual obligations to other entities pursuant to
which such officer or director is or will be required to present a
business combination opportunity to such entity, subject to his or
her fiduciary duties under Cayman Islands law. Accordingly, they
may have conflicts of interest in determining to which entity a
particular business opportunity should be presented. These
conflicts may not be resolved in our favor and a potential target
business may be presented to another entity prior to its
presentation to us, subject to their fiduciary duties under Cayman
Islands law.
In addition, HPS and our sponsor, officers and directors are and
may in the future become affiliated with other blank check
companies that may have acquisition objectives that are similar to
ours. For example, HPS co-founded and co-sponsored Trine, and Mr.
Wasserman, our Chairman and Chief Executive Officer, was a director
of Trine since its initial public offering until its business
combination with Desktop Metal was completed in December 2020. In
addition, an affiliate of HPS founded and sponsored Altimar I, and
Mr. Wasserman, our Chairman and Chief Executive Officer, has been a
director of Altimar I since its formation until its business
combination with Blue Owl in May 2021. Furthermore, an affiliate of
HPS founded and sponsored Altimar II, and Mr. Wasserman, our
Chairman and Chief Executive Officer, has been a director of
Altimar II since its formation until its business combination with
Fathom in December 2021. Accordingly, they may have conflicts of
interest in determining to which entity a particular business
opportunity should be presented. These conflicts may not be
resolved in our favor and a potential target business may be
presented to such other blank check companies prior to its
presentation to us, subject to our officers’ and directors’
fiduciary duties under Cayman Islands law. Our amended and restated
memorandum and articles of association provide that, to the fullest
extent permitted by applicable law: (i) no individual serving as a
director or an officer shall have any duty, except to the extent
expressly assumed by contract, to refrain from engaging directly or
indirectly in the same or similar business activities or lines of
business as us; and (ii) we renounce any interest or expectancy in,
or in being offered an opportunity to participate in, any potential
transaction or matter which may be a corporate opportunity for any
director or officer, on the one hand, and us, on the
other.
Our executive officers, directors, security holders and their
respective affiliates may have competitive pecuniary interests that
conflict with our interests.
We have not adopted a policy that expressly prohibits our
directors, executive officers, security holders or affiliates from
having a direct or indirect pecuniary or financial interest in any
investment to be acquired or disposed of by us or in any
transaction to which we are a party or have an interest. In fact,
we may enter into a business combination with a target business
that is affiliated with our sponsor, our directors or executive
officers, although we do not intend to do so, or we may acquire a
target business through an Affiliated Joint Acquisition with one or
more funds or accounts advised by HPS and/or one or more investors
in funds managed by HPS. Nor do we have a policy that expressly
prohibits any such persons from engaging for their own account in
business activities of the types conducted by us. Accordingly, such
persons or entities may have a conflict between their interests and
ours.
The personal and financial interests of our directors and officers
may influence their motivation in timely identifying and selecting
a target business and completing a business combination.
Consequently, our directors’ and officers’ discretion in
identifying and selecting a suitable target business may result in
a conflict of interest when determining whether the terms,
conditions and timing of a particular business combination are
appropriate and in our shareholders’ best interest. If this were
the case, it would be a breach of their fiduciary duties to us as a
matter of Cayman Islands law and we or our shareholders might have
a claim against such individuals for infringing on our
shareholders’ rights. However, we might not ultimately be
successful in any claim we may make against them for such
reason.
We may engage in a business combination with one or more target
businesses that have relationships with entities that may be
affiliated with our sponsor, executive officers, directors or
initial shareholders which may raise potential conflicts of
interest.
In light of the involvement of our sponsor, executive officers and
directors with other entities, we may decide to acquire one or more
businesses affiliated with our sponsor, executive officers,
directors or initial shareholders. Our directors also serve as
officers and board members for other entities, including, without
limitation, Altimar I, Altimar II and those described under
“Management—Conflicts of Interest.” HPS and our sponsor, officers
and directors may sponsor, form or participate in other blank check
companies similar to ours during the period in which we are seeking
an initial business combination. In particular, Mr. Wasserman, an
affiliate of HPS and our officers and directors have sponsored and
are actively engaged in Altimar II, a SPAC that completed its
initial public offering in February 2021. Altimar II, like us, may
pursue initial business combination targets in any businesses or
industries with a focus on TMT, Healthcare, Financial Services/
Financial Technology and Consumer and has until 24 months after the
completion of its initial public offering to do so (absent an
extension in accordance with its memorandum and articles of
association). As a result, HPS and our sponsor, officers and
directors could have conflicts of interest in determining whether
to present business combination opportunities to us or to any other
blank check company
with which they may become involved, and such entities may compete
with us for business combination opportunities. HPS and its
affiliates manage a number of HPS Funds, which may compete with us
for acquisition opportunities. HPS and our sponsor, officers and
directors are not currently aware of any specific opportunities for
us to complete our initial business combination with any entities
with which they are affiliated, and there have been no substantive
discussions concerning a business combination with any such entity
or entities. Although we will not be specifically focusing on, or
targeting, any transaction with any affiliated entities, we would
pursue such a transaction if we determined that such affiliated
entity met our criteria and guidelines for a business combination
as set forth in “Proposed Business—Effecting Our Initial Business
Combination—Evaluation of a Target Business and Structuring of Our
Initial Business Combination” and such transaction was approved by
a majority of our independent and disinterested directors. Despite
our agreement to obtain an opinion from an independent investment
banking firm or another independent entity that commonly renders
valuation opinions regarding the fairness to our company from a
financial point of view of a business combination with one or more
domestic or international businesses affiliated with our sponsor,
executive officers, directors or initial shareholders, potential
conflicts of interest still may exist and, as a result, the terms
of the business combination may not be as advantageous to our
public shareholders as they would be absent any conflicts of
interest.
Moreover, we may, at our option, pursue an Affiliated Joint
Acquisition opportunity with an entity affiliated with HPS and/or
one or more investors in funds managed by HPS. Any such parties may
co-invest with us in the target business at the time of our initial
business combination, or we could raise additional proceeds to
complete the acquisition by making a specified future issuance to
any such parties.
Since our initial shareholders will lose their entire investment in
us if our initial business combination is not completed (other than
with respect to public shares they may have acquired in connection
with or acquired after our Initial Public Offering), a conflict of
interest may arise in determining whether a particular business
combination target is appropriate for our initial business
combination.
On January 15, 2021, our sponsor paid $25,000, or approximately
$0.007 per share, to cover certain of our offering and formation
costs in consideration of 3,593,750 Class B ordinary shares, par
value $0.0001. On January 28, 2021, our sponsor transferred 10,000
founder shares to each of our director nominees, resulting in our
sponsor holding 3,533,750 founder shares. Prior to the initial
investment in the company of $25,000 by the sponsor, the company
had no assets, tangible or intangible. The per share price of the
founder shares was determined by dividing the amount contributed to
the company by the number of founder shares issued. The founder
shares will be worthless if we do not complete an initial business
combination. In addition, our sponsor purchased an aggregate of
6,105,000 private placement warrants, each exercisable to purchase
one Class A ordinary share at $11.50 per share, subject to
adjustment, at a price of $1.00 per warrant ($6,105,000 in the
aggregate), in a private placement that closed simultaneously with
the closing of the Initial Public Offering. If we do not consummate
an initial business within 24 months from the closing of the
Initial Public Offering, the private placement warrants will expire
worthless. The personal and financial interests of our executive
officers and directors may influence their motivation in
identifying and selecting a target business combination, completing
an initial business combination and influencing the operation of
the business following the initial business combination. This risk
may become more acute as the 24-month anniversary of the closing of
the Initial Public Offering nears, which is the deadline for our
consummation of an initial business combination.
We may not have sufficient funds to satisfy indemnification claims
of our directors and executive officers.
We have agreed to indemnify our officers and directors to the
fullest extent permitted by law. However, our officers and
directors have agreed to waive any right, title, interest or claim
of any kind in or to any monies in the trust account and to not
seek recourse against the trust account for any reason whatsoever
(except to the extent they are entitled to funds from the trust
account due to their ownership of public shares). Accordingly, any
indemnification provided will be able to be satisfied by us only if
(i) we have sufficient funds outside of the trust account or (ii)
we consummate an initial business combination. Our obligation to
indemnify our officers and directors may discourage shareholders
from bringing a lawsuit against our officers or directors for
breach of their fiduciary duty. These provisions also may have the
effect of reducing the likelihood of derivative litigation against
our officers and directors, even though such an action, if
successful, might otherwise benefit us and our shareholders.
Furthermore, a shareholder’s investment may be adversely affected
to the extent we pay the costs of settlement and damage awards
against our officers and directors pursuant to these
indemnification provisions.
Involvement of members of our management and companies with which
they are affiliated in civil disputes and litigation, governmental
investigations or negative publicity unrelated to our business
affairs could materially impact our ability to consummate an
initial business combination.
Members of our management team and companies with which they are
affiliated have been, and in the future will continue to be,
involved in a wide variety of business affairs, including
transactions, such as sales and purchases of businesses, and
ongoing
operations. As a result of such involvement, members of our
management and companies with which they are affiliated in have
been, and may in the future be, involved in civil disputes,
litigation, governmental investigations and negative publicity
relating to their business affairs. Any such claims,
investigations, lawsuits or negative publicity may be detrimental
to our reputation and could negatively affect our ability to
identify and complete an initial business combination in a material
manner and may have an adverse effect on the price of our
securities.
After our initial business combination, it is possible that a
majority of our directors and officers will live outside the United
States and all of our assets will be located outside the United
States and, therefore, investors may not be able to enforce federal
securities laws or their other legal rights.
It is possible that after our initial business combination, a
majority of our directors and officers will reside outside of the
United States, and all of our assets will be located outside of the
United States. As a result, it may be difficult, or in some cases
not possible, for investors in the United States to enforce their
legal rights, to effect service of process upon all of our
directors or officers or to enforce judgments of United States
courts predicated upon civil liabilities and criminal penalties on
our directors and officers under United States laws.
Changes in the market for directors and officers liability
insurance could make it more difficult and more expensive for us to
negotiate and complete an initial business
combination.
In recent months, the market for directors and officers liability
insurance for special purpose acquisition companies has changed in
ways adverse to us and our management team. Fewer insurance
companies are offering quotes for directors and officers liability
coverage, the premiums charged for such policies have generally
increased and the terms of such policies have generally become less
favorable. These trends may continue into the future.
The increased cost and decreased availability of directors and
officers liability insurance could make it more difficult and more
expensive for us to negotiate an initial business combination. In
order to obtain directors and officers liability insurance or
modify its coverage as a result of becoming a public company, the
post-business combination entity might need to incur greater
expense, accept less favorable terms or both. However, any failure
to obtain adequate directors and officers liability insurance could
have an adverse impact on the post-business combination’s ability
to attract and retain qualified officers and
directors.
In addition, even after we were to complete an initial business
combination, our directors and officers could still be subject to
potential liability from claims arising from conduct alleged to
have occurred prior to the initial business combination. As a
result, in order to protect our directors and officers, the
post-business combination entity may need to purchase additional
insurance with respect to any such claims (“run-off insurance”).
The need for run-off insurance would be an added expense for the
post-business combination entity, and could interfere with or
frustrate our ability to consummate an initial business combination
on terms favorable to our investors.
Risks Associated with Acquiring and Operating a Business in Foreign
Countries
If we pursue a target company with operations or opportunities
outside of the United States for our initial business combination,
we may face additional burdens in connection with investigating,
agreeing to and completing such initial business combination, and
if we effect such initial business combination, we would be subject
to a variety of additional risks that may negatively impact our
operations.
If we pursue a target a company with operations or opportunities
outside of the United States for our initial business combination,
we would be subject to risks associated with cross-border business
combinations, including in connection with investigating, agreeing
to and completing our initial business combination, conducting due
diligence in a foreign jurisdiction, having such transaction
approved by any local governments, regulators or agencies and
changes in the purchase price based on fluctuations in foreign
exchange rates.
If we effect our initial business combination with such a company,
we would be subject to any special considerations or risks
associated with companies operating in an international setting,
including any of the following:
•costs
and difficulties inherent in managing cross-border business
operations;
•rules
and regulations regarding currency redemption;
•complex
corporate withholding taxes on individuals;
•laws
governing the manner in which future business combinations may be
effected;
•exchange
listing and/or delisting requirements;
•tariffs
and trade barriers;
•regulations
related to customs and import/export matters;
•local
or regional economic policies and market conditions;
•unexpected
changes in regulatory requirements;
•longer
payment cycles;
•tax
issues, such as tax law changes and variations in tax laws as
compared to the United States;
•currency
fluctuations and exchange controls;
•rates
of inflation;
•challenges
in collecting accounts receivable;
•cultural
and language differences;
•employment
regulations;
•underdeveloped
or unpredictable legal or regulatory systems;
•corruption;
•protection
of intellectual property;
•social
unrest, crime, strikes, riots and civil disturbances;
•regime
changes and political upheaval;
•terrorist
attacks, natural disasters and wars,
including the conflict in Ukraine and the surrounding region;
and
•deterioration
of political relations with the United States.
We may not be able to adequately address these additional risks. If
we were unable to do so, we may be unable to complete such initial
business combination or, if we complete such combination, our
operations might suffer, either of which may adversely impact our
business, financial condition and results of
operations.
If our management following our initial business combination is
unfamiliar with United States securities laws, they may have to
expend time and resources becoming familiar with such laws, which
could lead to various regulatory issues.
Following our initial business combination, our management may
resign from their positions as officers or directors of the company
and the management of the target business at the time of the
business combination will remain in place. Management of the target
business may not be familiar with United States securities laws. If
new management is unfamiliar with United States securities laws,
they may have to expend time and resources becoming familiar with
such laws. This could be expensive and time-consuming and could
lead to various regulatory issues which may adversely affect our
operations.
After our initial business combination, substantially all of our
assets may be located in a foreign country and substantially all of
our revenue may be derived from our operations in any such country.
Accordingly, our results of operations and prospects will be
subject, to a significant extent, to the economic, political and
social conditions and government policies, developments and
conditions in the country in which we operate.
The economic, political and social conditions, as well as
government policies, of the country in which our operations are
located could affect our business. Economic growth could be uneven,
both geographically and among various sectors of the economy and
such growth may not be sustained in the future. If in the future
such country’s economy experiences a downturn or grows at a slower
rate than expected, there may be less demand for spending in
certain industries. A decrease in demand for spending in certain
industries could materially and adversely affect our ability to
find an attractive target business with which to consummate our
initial business combination and if we effect our initial business
combination, the ability of that target business to become
profitable.
Exchange rate fluctuations and currency policies may cause a target
business’ ability to succeed in the international markets to be
diminished.
In the event we acquire a non-U.S. target, all revenues and income
would likely be received in a foreign currency, and the dollar
equivalent of our net assets and distributions, if any, could be
adversely affected by reductions in the value of the local
currency. The value of the currencies in our target regions
fluctuate and are affected by, among other things, changes in
political and economic conditions. Any change in the relative value
of such currency against our reporting currency may affect the
attractiveness of any target business or, following consummation of
our initial business combination, our financial condition and
results of operations. Additionally, if a currency appreciates in
value against the dollar prior to the consummation of our initial
business combination, the cost of a target business as measured in
dollars will increase, which may make it less likely that we are
able to consummate such transaction.
General Risk Factors
We are a recently incorporated company with no operating history
and no revenues, and you have no basis on which to evaluate our
ability to achieve our business objective.
We are a blank check company incorporated under the laws of the
Cayman Islands with no operating results, and we did not commence
operations until obtaining funding through the Initial Public
Offering. Because we have a limited operating history, you have
little basis upon which to evaluate our ability to achieve our
business objective of completing our initial business combination
with one or more target businesses. We have not selected any
specific business combination target and we have not, nor has
anyone on our behalf, engaged in any substantive discussions,
directly or indirectly, with any business combination target with
respect to an initial business combination with us and may be
unable to complete our initial business combination. If we fail to
complete our initial business combination, we will never generate
any operating revenues.
Past performance by HPS, our management team or either of their
respective affiliates may not be indicative of future performance
of an investment in us.
Information regarding performance is presented for informational
purposes only. Any past experience or performance, including
related to blank check companies sponsored by HPS or its affiliates
and the associated business combinations is not a guarantee of
either (i) our ability to successfully identify and execute a
transaction or (ii) success with respect to any business
combination that we may consummate. You should not rely on the
historical record of HPS, our management team or either of their
respective affiliates as indicative of the future performance of an
investment in us or the returns we will, or are likely to, generate
going forward. In addition, HPS advises funds and accounts which
have investment mandates that overlap with ours and therefore may
compete for investment opportunities with us, and HPS will not be
obligated to present any investment opportunities to us over the
funds and accounts it manages.
Certain agreements related to the Initial Public Offering may be
amended without shareholder approval.
Certain agreements, including the underwriting agreement relating
to the Initial Public Offering, the letter agreement among us and
our sponsor, officers and directors, and the registration rights
agreement among us and our initial shareholders, may be amended
without shareholder approval. These agreements contain various
provisions that our public shareholders might deem to be material.
While we do not expect our board to approve any amendment to any of
these agreements prior to our initial business combination, it may
be possible that our board, in exercising its business judgment and
subject to its fiduciary duties, chooses to approve one or more
amendments to any such agreement in connection with the
consummation of our initial business combination. Any such
amendments would not require approval from our shareholders, may
result in the completion of our initial business combination that
may not otherwise have been possible, and may have an adverse
effect on the value of an investment in our
securities.
We are an emerging growth company and a smaller reporting company
within the meaning of the Securities Act, and if we take advantage
of certain exemptions from disclosure requirements available to
“emerging growth companies” or “smaller reporting companies,” this
could make our securities less attractive to investors and may make
it more difficult to compare our performance with other public
companies.
We are an “emerging growth company” within the meaning of the
Securities Act, as modified by the JOBS Act, and we may take
advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not
“emerging growth companies” including, but not limited to, not
being required to comply with the auditor attestation requirements
of Section 404 of the Sarbanes-Oxley Act, reduced disclosure
obligations regarding executive compensation in our periodic
reports and proxy statements, and exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and
shareholder approval of any golden parachute payments not
previously approved. As a result, our shareholders may not have
access to certain information they may deem important. We could be
an emerging growth company for up to five years, although
circumstances could cause us to lose that status earlier, including
if the market value of our Class A ordinary shares held by
non-affiliates exceeds $700 million as of any June 30 before that
time, in which case we would no longer be an emerging growth
company as of the following December 31. We cannot predict whether
investors will find our securities less attractive because we will
rely on these exemptions. If some investors find our securities
less attractive as a result of our reliance on these exemptions,
the trading prices of our securities may be lower than they
otherwise would be, there may be a less active trading market for
our securities and the trading prices of our securities may be more
volatile.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth
companies from being required to comply with new or revised
financial accounting standards until private companies (that is,
those that have not had a Securities Act registration statement
declared effective or do not have a class of securities registered
under the Exchange Act) are required to comply with
the new or revised financial accounting standards. The JOBS Act
provides that a company can elect to opt out of the extended
transition period and comply with the requirements that apply to
non-emerging growth companies but any such election to opt out is
irrevocable. We have elected not to opt out of such extended
transition period which means that when a standard is issued or
revised and it has different application dates for public or
private companies, we, as an emerging growth company, can adopt the
new or revised standard at the time private companies adopt the new
or revised standard. This may make comparison of our financial
statements with another public company which is neither an emerging
growth company nor an emerging growth company which has opted out
of using the extended transition period difficult or impossible
because of the potential differences in accounting standards
used.
Additionally, we are a “smaller reporting company” as defined in
Item 10(f)(1) of Regulation S-K. Smaller reporting companies may
take advantage of certain reduced disclosure obligations,
including, among other things, providing only two years of audited
financial statements. We will remain a smaller reporting company
until the last day of the fiscal year in which (1) the market value
of our ordinary shares held by non-affiliates exceeds $250 million
as of the prior June 30, or (2) our annual revenues exceeded $100
million during such completed fiscal year and the market value of
our ordinary shares held by non-affiliates exceeds $700 million as
of the prior June 30. To the extent we take advantage of such
reduced disclosure obligations, it may also make comparison of our
financial statements with other public companies difficult or
impossible.
We may be a passive foreign investment company, or “PFIC,” which
could result in adverse U.S. federal income tax consequences to
U.S. investors.
If we are a PFIC for any taxable year (or portion thereof) that is
included in the holding period of a U.S. Holder (as defined in
“Taxation—United States Federal Income Tax Considerations—Passive
Foreign Investment Company Rules”) of our Class A ordinary shares
or warrants, the U.S. Holder may be subject to adverse U.S. federal
income tax consequences and may be subject to additional reporting
requirements. Our PFIC status for our current and subsequent
taxable years may depend on whether we qualify for the PFIC
start-up exception. Depending on the particular circumstances the
application of the start-up exception may be subject to
uncertainty, and there cannot be any assurance that we will qualify
for the start-up exception. Additionally, even if we qualify for
the start-up exception with respect to a given taxable year, there
cannot be any assurance that we would not be a PFIC in other
taxable years. Accordingly, there can be no assurances with respect
to our status as a PFIC for our current taxable year or any
subsequent taxable year. Our actual PFIC status for any taxable
year will not be determinable until after the end of such taxable
year. Moreover, if we determine we are a PFIC for any taxable year,
upon written request, we will endeavor to provide to a U.S. Holder
such information as the Internal Revenue Service (the “IRS”) may
require, including a PFIC Annual Information Statement, in order to
enable the U.S. Holder to make and maintain a “qualified electing
fund” election with respect to their Class A ordinary shares, but
there can be no assurance that we will timely provide such required
information, and such election would be unavailable with respect to
our warrants in all cases. We urge U.S. investors to consult their
tax advisors regarding the possible application of the PFIC
rules.
We may reincorporate in another jurisdiction in connection with our
initial business combination and such reincorporation may result in
taxes imposed on shareholders or warrant holders.
We may, in connection with our initial business combination and
subject to requisite shareholder approval under the Companies Act,
reincorporate in the jurisdiction in which the target company or
business is located or in another jurisdiction. The transaction may
require a shareholder or warrant holder to recognize taxable income
in the jurisdiction in which the shareholder or warrant holder is a
tax resident or in which its members are resident if it is a tax
transparent entity. We do not intend to make any cash distributions
to shareholders or warrant holders to pay such taxes. Shareholders
or warrant holders may be subject to withholding taxes or other
taxes with respect to their ownership of us after the
reincorporation.
The provisions of our amended and restated memorandum and articles
of association that relate to the rights of holders of our Class A
ordinary shares (and corresponding provisions of the agreement
governing the release of funds from our trust account) may be
amended with the approval of a special resolution which requires
the approval of the holders of at least two-thirds of our ordinary
shares who attend and vote at a general meeting of the company,
which is a lower amendment threshold than that of some other blank
check companies. It may be easier for us, therefore, to amend our
amended and restated memorandum and articles of association to
facilitate the completion of an initial business combination that
some of our shareholders may not support.
Some other blank check companies have a provision in their charter
which prohibits the amendment of certain of its provisions,
including those which relate to the rights of a company’s
shareholders, without approval by a certain percentage of the
company’s shareholders. In those companies, amendment of these
provisions typically requires approval by between 90% and 100% of
the company’s shareholders. Our amended and restated memorandum and
articles of association provide that any of its provisions related
to the rights of holders of our Class A ordinary shares (including
the requirement to deposit proceeds of the
Initial Public Offering and the private placement of warrants into
the trust account and not release such amounts except in specified
circumstances, and to provide redemption rights to public
shareholders as described herein) may be amended if approved by
special resolution, meaning holders of at least two-thirds of our
ordinary shares who attend and vote at a general meeting of the
company, and corresponding provisions of the trust agreement
governing the release of funds from our trust account may be
amended if approved by holders of at least 65% of our ordinary
shares; provided that the provisions of our amended and restated
memorandum and articles of association governing the appointment or
removal of directors prior to our initial business combination may
only be amended by a special resolution passed by not less than
two-thirds of our ordinary shares who attend and vote at our
general meeting which shall include the affirmative vote of a
simple majority of our Class B ordinary shares. Our initial
shareholders and their respective permitted transferees, if any,
who collectively beneficially owned, on an as-converted basis, 20%
of our Class A ordinary shares upon the closing of the Initial
Public Offering (assuming they do not purchase any Units in the
Initial Public Offering), will participate in any vote to amend our
amended and restated memorandum and articles of association and/or
trust agreement and will have the discretion to vote in any manner
they choose. As a result, we may be able to amend the provisions of
our amended and restated memorandum and articles of association
which govern our pre-business combination behavior more easily than
some other blank check companies, and this may increase our ability
to complete a business combination with which you do not agree. Our
shareholders may pursue remedies against us for any breach of our
amended and restated memorandum and articles of
association.
Our sponsor, executive officers, directors and director nominees
have agreed, pursuant to agreements with us, that they will not
propose any amendment to our amended and restated memorandum and
articles of association (A) that would modify the substance or
timing of our obligation to provide holders of our Class A ordinary
shares the right to have their shares redeemed in connection with
our initial business combination or to redeem 100% of our public
shares if we do not complete our initial business combination
within 24 months from the closing of the Initial Public Offering or
(B) with respect to any other provision relating to the rights of
holders of our Class A ordinary shares, unless we provide our
public shareholders with the opportunity to redeem their Class A
ordinary shares upon approval of any such amendment at a per-share
price, payable in cash, equal to the aggregate amount then on
deposit in the trust account, including interest earned on the
funds held in the trust account and not previously released to us
to pay our taxes, if any, divided by the number of the
then-outstanding public shares. Our shareholders are not parties
to, or third-party beneficiaries of, these agreements and, as a
result, will not have the ability to pursue remedies against our
sponsor, executive officers, directors or director nominees for any
breach of these agreements. As a result, in the event of a breach,
our shareholders would need to pursue a shareholder derivative
action, subject to applicable law.
Our initial shareholders control a substantial interest in us and
thus may exert a substantial influence on actions requiring a
shareholder vote, potentially in a manner that you do not
support.
Upon closing of the Initial Public Offering, our initial
shareholders owned, on an as-converted basis, 20% of our issued and
outstanding ordinary shares. Accordingly, they may exert a
substantial influence on actions requiring a shareholder vote,
potentially in a manner that you do not support, including
amendments to our amended and restated memorandum and articles of
association. If our initial shareholders purchase any additional
Class A ordinary shares in the aftermarket or in privately
negotiated transactions, this would increase their control. Neither
our initial shareholders nor, to our knowledge, any of our officers
or directors, have any current intention to purchase additional
securities. Factors that would be considered in making such
additional purchases would include consideration of the current
trading price of our Class A ordinary shares. In addition, our
board of directors, whose members were appointed by our sponsor, is
and will be divided into three classes, each of which will
generally serve for a term of three years with only one class of
directors being appointed in each year. We may not hold an annual
general meeting to appoint new directors prior to the completion of
our initial business combination, in which case all of the current
directors will continue in office until at least the completion of
the business combination. If there is an annual general meeting, as
a consequence of our “staggered” board of directors, only a
minority of the board of directors will be considered for
appointment and our initial shareholders, because of their
ownership position, will control the outcome, as only holders of
our Class B ordinary shares will have the right to vote on the
appointment and removal of directors and to continue our company in
a jurisdiction outside the Cayman Islands (including, but not
limited to, the approval of the organizational documents of our
company in such other jurisdiction) prior to our initial business
combination. Accordingly, our initial shareholders will continue to
exert control at least until the completion of our initial business
combination. In addition, we have agreed not to enter into a
definitive agreement regarding an initial business combination
without the prior consent of our initial shareholders.
Our warrant agreement will designate the courts of the State of New
York or the United States District Court for the Southern District
of New York as the sole and exclusive forum for certain types of
actions and proceedings that may be initiated by holders of our
warrants, which could limit the ability of warrant holders to
obtain a favorable judicial forum for disputes with our
company.
Our warrant agreement will provide that, subject to applicable law,
(i) any action, proceeding or claim against us arising out of or
relating in any way to the warrant agreement, including under the
Securities Act, will be brought and enforced in the courts of the
State of New York or the United States District Court for the
Southern District of New York, and (ii) that we irrevocably submit
to such jurisdiction, which jurisdiction shall be the exclusive
forum for any such action, proceeding or claim. We will waive any
objection to such exclusive jurisdiction and that such courts
represent an inconvenient forum.
Notwithstanding the foregoing, these provisions of the warrant
agreement will not apply to suits brought to enforce any liability
or duty created by the Exchange Act or any other claim for which
the federal district courts of the United States of America are the
sole and exclusive forum. Any person or entity purchasing or
otherwise acquiring any interest in any of our warrants shall be
deemed to have notice of and to have consented to the forum
provisions in our warrant agreement. If any action, the subject
matter of which is within the scope the forum provisions of the
warrant agreement, is filed in a court other than a court of the
State of New York or the United States District Court for the
Southern District of New York (a “foreign action”) in the name of
any holder of our warrants, such holder shall be deemed to have
consented to (x) the personal jurisdiction of the state and federal
courts located in the State of New York in connection with any
action brought in any such court to enforce the forum provisions
(an “enforcement action”), and (y) having service of process made
upon such warrant holder in any such enforcement action by service
upon such warrant holder’s counsel in the foreign action as agent
for such warrant holder.
This choice-of-forum provision may limit a warrant holder’s ability
to bring a claim in a judicial forum that it finds favorable for
disputes with our company, which may discourage such lawsuits.
Alternatively, if a court were to find this provision of our
warrant agreement inapplicable or unenforceable with respect to one
or more of the specified types of actions or proceedings, we may
incur additional costs associated with resolving such matters in
other jurisdictions, which could materially and adversely affect
our business, financial condition and results of operations and
result in a diversion of the time and resources of our management
and board of directors.
Because each Unit contains one-fourth of one redeemable warrant and
only a whole warrant may be exercised, the Units may be worth less
than Units of other blank check companies.
Each Unit contains one-fourth of one redeemable warrant. Pursuant
to the warrant agreement, no fractional warrants will be issued
upon separation of the Units, and only whole Units will trade. If,
upon exercise of the warrants, a holder would be entitled to
receive a fractional interest in a share, we will, upon exercise,
round down to the nearest whole number the number of Class A
ordinary shares to be issued to the warrant holder. This is
different from other offerings similar to ours whose Units include
one ordinary share and one whole warrant to purchase one whole
share. We have established the components of the Units in this way
in order to reduce the dilutive effect of the warrants upon
completion of a business combination since the warrants will be
exercisable in the aggregate for one-fourth of the number of shares
compared to Units that each contain a whole warrant to purchase one
whole share, thus making us, we believe, a more attractive merger
partner for target businesses. Nevertheless, this Unit structure
may cause our Units to be worth less than if a Unit included a
warrant to purchase one whole share.
A provision of our warrant agreement may make it more difficult for
us to consummate an initial business combination.
Unlike most blank check companies, if (i) we issue additional Class
A ordinary shares or equity-linked securities for capital raising
purposes in connection with the closing of our initial business
combination at a Newly Issued Price of less than $9.20 per ordinary
share, (ii) the aggregate gross proceeds from such issuances
represent more than 60% of the total equity proceeds, and interest
thereon, available for the funding of our initial business
combination on the date of the consummation of our initial business
combination (net of redemptions), and (iii) the Market Value is
below $9.20 per share, then the exercise price of the warrants will
be adjusted to be equal to 115% of the higher of the Market Value
and the Newly Issued Price, and the $18.00 per share redemption
trigger prices will be adjusted (to the nearest cent) to be equal
to 180% of the higher of the Market Value and the Newly Issued
Price, and the $10.00 per share redemption trigger price will be
adjusted (to the nearest cent) to be equal to the higher of the
Market Value and the Newly Issued Price. This may make it more
difficult for us to consummate an initial business combination with
a target business.
Because we are incorporated under the laws of the Cayman Islands,
you may face difficulties in protecting your interests, and your
ability to protect your rights through the U.S. federal courts may
be limited.
We are an exempted company incorporated under the laws of the
Cayman Islands. As a result, it may be difficult for investors to
effect service of process within the United States upon our
directors or executive officers, or enforce judgments obtained in
the United States courts against our directors or
officers.
Our corporate affairs will be governed by our amended and restated
memorandum and articles of association, the Companies Act (as the
same may be supplemented or amended from time to time) and the
common law of the Cayman Islands. We will also be subject to the
federal securities laws of the United States. The rights of
shareholders to take action against the directors, actions by
minority shareholders and the fiduciary responsibilities of our
directors to us under Cayman Islands law are to a large extent
governed by the common law of the Cayman Islands. The common law of
the Cayman Islands is derived in part from comparatively limited
judicial precedent in the Cayman Islands as well as from English
common law, the decisions of whose courts are of persuasive
authority, but are not binding on a court in the Cayman Islands.
The rights of our shareholders and the fiduciary responsibilities
of our directors under Cayman Islands law are different from what
they would be under statutes or judicial precedent in some
jurisdictions in the United States. In particular, the Cayman
Islands has a different body of securities laws as compared to the
United States, and certain states, such as Delaware, may have more
fully developed and judicially interpreted bodies of corporate law.
In addition, Cayman Islands companies may not have standing to
initiate a shareholders derivative action in a Federal court of the
United States.
We have been advised by Maples and Calder (Cayman), LLP, our Cayman
Islands legal counsel, that the courts of the Cayman Islands are
unlikely (i) to recognize or enforce against us judgments of courts
of the United States predicated upon the civil liability provisions
of the federal securities laws of the United States or any state
and (ii) in original actions brought in the Cayman Islands, to
impose liabilities against us predicated upon the civil liability
provisions of the federal securities laws of the United States or
any state, so far as the liabilities imposed by those provisions
are penal in nature. In those circumstances, although there is no
statutory enforcement in the Cayman Islands of judgments obtained
in the United States, the courts of the Cayman Islands will
recognize and enforce a foreign money judgment of a foreign court
of competent jurisdiction without retrial on the merits based on
the principle that a judgment of a competent foreign court imposes
upon the judgment debtor an obligation to pay the sum for which
judgment has been given provided certain conditions are met. For a
foreign judgment to be enforced in the Cayman Islands, such
judgment must be final and conclusive and for a liquidated sum, and
must not be in respect of taxes or a fine or penalty, inconsistent
with a Cayman Islands judgment in respect of the same matter,
impeachable on the grounds of fraud or obtained in a manner, or be
of a kind the enforcement of which is, contrary to natural justice
or the public policy of the Cayman Islands (awards of punitive or
multiple damages may well be held to be contrary to public policy).
A Cayman Islands Court may stay enforcement proceedings if
concurrent proceedings are being brought elsewhere.
As a result of all of the above, public shareholders may have more
difficulty in protecting their interests in the face of actions
taken by management, members of the board of directors or
controlling shareholders than they would as public shareholders of
a United States company.
An investment in this Company may result in uncertain or adverse
U.S. federal income tax consequences.
An investment in this Company may result in uncertain U.S. federal
income tax consequences. For instance, because there are no
authorities that directly address instruments similar to the Units
we are issuing, the allocation an investor makes with respect to
the purchase price of a Unit between the Class A ordinary shares
and the one-fourth of a warrant to purchase one Class A ordinary
share included in each Unit could be challenged by the IRS or
courts. Furthermore, the U.S. federal income tax consequences of a
cashless exercise of warrants included in the Units we are issuing
are unclear under current law. Finally, it is unclear whether the
redemption rights with respect to our ordinary shares suspend the
running of a U.S. Holder’s (as defined below in “Taxation—United
States Federal Income Tax Considerations—General”) holding period
for purposes of determining whether any gain or loss realized by
such holder on the sale or exchange of Class A ordinary shares is
long-term capital gain or loss and for determining whether any
dividend we pay would be considered “qualified dividends” for U.S.
federal income tax purposes. Prospective investors are urged to
consult their tax advisors with respect to these and other tax
consequences when purchasing, holding or disposing of our
securities.
Cyber incidents or attacks directed at us could result in
information theft, data corruption, operational disruption and/or
financial loss.
We depend on digital technologies, including information systems,
infrastructure and cloud applications and services, including those
of HPS and third parties with which we may deal. Sophisticated and
deliberate attacks on, or security breaches in, our systems or
infrastructure, or the systems or infrastructure of third parties
or the cloud, could lead to corruption or misappropriation of our
assets, proprietary information and sensitive or confidential data.
As an early-stage company without significant investments in data
security protection, we may not be sufficiently protected against
such occurrences. We may not have sufficient resources to
adequately protect against, or to investigate and remediate any
vulnerability to, cyber incidents. It is possible that any of these
occurrences, or a combination of them, could have adverse
consequences on our business and lead to financial
loss.
Since only holders of our founder shares will have the right to
vote on the appointment of directors, upon the listing of our
shares on the NYSE, the NYSE may consider us to be a “controlled
company” within the meaning of the NYSE rules and, as a result, we
may qualify for exemptions from certain corporate governance
requirements.
Only holders of our founder shares will have the right to vote on
the appointment of directors. As a result, the NYSE may consider us
to be a “controlled company” within the meaning of the NYSE
corporate governance standards. Under the NYSE corporate governance
standards, a company of which more than 50% of the voting power is
held by an individual, group or another company is a “controlled
company” and may elect not to comply with certain corporate
governance requirements, including the requirements
that:
•we
have a board that includes a majority of “independent directors,”
as defined under the rules of the NYSE;
•we
have a compensation committee of our board that is comprised
entirely of independent directors with a written charter addressing
the committee’s purpose and responsibilities; and
•we
have a nominating and corporate governance committee of our board
that is comprised entirely of independent directors with a written
charter addressing the committee’s purpose and
responsibilities.
We do not intend to utilize these exemptions and intend to comply
with the corporate governance requirements of the NYSE, subject to
applicable phase-in rules. However, if we determine in the future
to utilize some or all of these exemptions, you will not have the
same protections afforded to shareholders of companies that are
subject to all of the NYSE corporate governance
requirements.
We may reincorporate in another jurisdiction in connection with our
initial business combination, and the laws of such jurisdiction may
govern some or all of our future material agreements and we may not
be able to enforce our legal rights.
In connection with our initial business combination, we may
relocate the home jurisdiction of our business from the Cayman
Islands to another jurisdiction. If we determine to do this, the
laws of such jurisdiction may govern some or all of our future
material agreements. The system of laws and the enforcement of
existing laws in such jurisdiction may not be as certain in
implementation and interpretation as in the United States. The
inability to enforce or obtain a remedy under any of our future
agreements could result in a significant loss of business, business
opportunities or capital.
We are subject to changing law and regulations regarding regulatory
matters, corporate governance and public disclosure that have
increased both our costs and the risk of
non-compliance.
We are subject to rules and regulations by various governing
bodies, including, for example, the SEC, which are charged with the
protection of investors and the oversight of companies whose
securities are publicly traded, and to new and evolving regulatory
measures under applicable law. Our efforts to comply with new and
changing laws and regulations have resulted in and are likely to
continue to result in, increased general and administrative
expenses and a diversion of management time and attention from
seeking a business combination target.
Moreover, because these laws, regulations and standards are subject
to varying interpretations, their application in practice may
evolve over time as new guidance becomes available. This evolution
may result in continuing uncertainty regarding compliance matters
and additional costs necessitated by ongoing revisions to our
disclosure and governance practices. If we fail to address and
comply with these regulations and any subsequent changes, we may be
subject to penalty and our business may be harmed.
As the number of special purpose acquisition companies evaluating
targets increases, attractive targets may become scarcer and there
may be more competition for attractive targets. This could increase
the cost of our initial business combination and could even result
in our inability to find a target or to consummate an initial
business combination.
In recent years, the number of special purpose acquisition
companies that have been formed has increased substantially. Many
potential targets for special purpose acquisition companies have
already entered into an initial business combination, and there are
still many special purpose acquisition companies seeking targets
for their initial business combination, as well as many such
companies currently in registration. As a result, at times, fewer
attractive targets may be available, and it may require more time,
more effort and more resources to identify a suitable target and to
consummate an initial business combination.
In addition, because there are more special purpose acquisition
companies seeking to enter into an initial business combination
with available targets, the competition for available targets with
attractive fundamentals or business models may increase, which
could cause target companies to demand improved financial terms.
Attractive deals could also become scarcer for other reasons, such
as economic or industry sector downturns, geopolitical tensions, or
increases in the cost of additional capital needed to close
business combinations or operate targets post-business combination.
This could increase the cost of, delay or
otherwise complicate or frustrate our ability to find and
consummate an initial business combination, and may result in our
inability to consummate an initial business combination on terms
favorable to our investors altogether.
In connection with the Restatements, as defined herein, our
management has concluded that our disclosure controls and
procedures were not effective as of December 31, 2021 due to a
material weakness in internal control over financial reporting
related to the classification of a portion of our Class A Ordinary
Shares as permanent equity. If we are unable to maintain an
effective system of internal control over financial reporting, we
may not be able to accurately report our financial results in a
timely manner, which may adversely affect investor confidence in us
and materially and adversely affect our business and results of
operations.
As described elsewhere in this Annual Report, subsequent to the
original issuance of the Company’s unaudited interim condensed
financial statements as of and for the three and nine months ended
September 30, 2021, the Company identified an error in its
previously issued financial statements for the Affected Periods:
that a portion of its Class A Ordinary Shares were incorrectly
classified as permanent equity to maintain shareholders’ equity
greater than $5,000,000 on the basis that the Company will
consummate its initial Business Combination only if the Company has
net tangible assets of at least $5,000,001. Previously, the Company
did not consider redeemable shares classified as temporary equity
as part of net tangible assets. The Company revised this
interpretation to include temporary equity in net tangible
assets.
Therefore, management re-evaluated the Company’s application of ASC
480-10-99 to its accounting classification of its Class A Ordinary
Shares and upon such re-evaluation, management determined that the
Class A Ordinary Shares include certain provisions that require
classification of a portion of the Class A Ordinary Shares as
temporary equity.
A material weakness is a deficiency, or a combination of
deficiencies, in internal control over financial reporting such
that there is a reasonable possibility that a material misstatement
of our annual or interim financial statements will not be
prevented, or detected and corrected on a timely basis. Effective
internal control over financial reporting is necessary for us to
provide reliable financial reports and prevent fraud. We expect to
take steps to remediate the material weakness, but there is no
assurance that any remediation efforts will ultimately have the
intended effects.
If we identify any new material weaknesses in the future, any such
newly identified material weakness could limit our ability to
prevent or detect a misstatement of our accounts or disclosures
that could result in a material misstatement of our annual or
interim financial statements. In such case, we may be unable to
maintain compliance with securities law requirements and applicable
stock exchange listing requirements, and investors may lose
confidence in our financial reporting and our stock price may
decline as a result. We cannot assure you that the measures we have
taken to date, or any measures that we may take in the future, will
be sufficient to avoid potential future material
weaknesses.
Item 1B. Unresolved Staff Comments
None.
Item 2. Properties
We currently maintain our executive offices at 40 West 57th Street,
33rd Floor, New York, NY 10019. The cost for our use of this space
is included in the $10,000 per month fee we will pay to an
affiliate of our Sponsor for office space, administration and
support services. We consider our current office space adequate for
our current operations.
Item 3. Legal Proceedings.
We are not currently subject to any material legal proceedings,
nor, to our knowledge, is any material legal proceeding threatened
against us or any of our officers or directors in their corporate
capacity.
Item 4. Mine Safety Disclosures.
Not applicable.
PART II
Item 5. Market for Registrant’s Common Equity, Related Shareholder
Matters and Issuer Purchases of Equity Securities
Market Information.
Our Units, Class A ordinary shares and warrants are traded on the
NYSE under the symbols “ATAQ.U,” “ATAQ” and “ATAQ-W,”
respectively.
Holders
Although there are a larger number of beneficial owners, at
December 31, 2021, there was one holder of record of our
Units, one holder of record of our separately traded Class A
ordinary shares and two holders of record of our separately traded
warrants.
Dividends
We have not paid any cash dividends on our ordinary shares to date
and do not intend to pay cash dividends. The payment of cash
dividends in the future will be dependent upon our revenues and
earnings, if any, capital requirements and general financial
condition. The payment of any cash dividends will be within the
discretion of our board of directors. In addition, our board of
directors is not currently contemplating and does not anticipate
declaring any cash dividends in the foreseeable future. Further, if
we incur any future indebtedness, our ability to declare dividends
may be limited by restrictive covenants we may agree to in
connection therewith.
Securities Authorized for Issuance Under Equity Compensation
Plans
None.
Recent Sales of Unregistered Securities; Use of Proceeds from
Registered Offerings
On March 8, 2021, we consummated our Initial Public Offering
of 15,525,000 Units. The Units sold in the Initial Public Offering
and the full exercise of the Over-allotment Option generated total
gross proceeds of $155,250,000. Goldman Sachs & Co. LLC and
J.P. Morgan acted as the joint book-running managers. The
securities sold in the Initial Public Offering were registered
under the Securities Act on a Registration Statement on Form S-1
(No. 333-252570). The Registration Statement was declared effective
by the SEC on March 3, 2021.
Simultaneously with the consummation of the Initial Public
Offering, we consummated a private placement of 6,105,000 Placement
Warrants to our Sponsor at a price of $1.00 per Private Placement
Warrant, generating total proceeds of $6,105,000. Such securities
were issued pursuant to the exemption from registration contained
in Section 4(a)(2) of the Securities Act.
The Private Placement Warrants are identical to the public warrants
underlying the Units sold in the Initial Public Offering, except
that the Private Placement Warrants are not transferable,
assignable or salable until 30 days after the completion of an
initial business combination, subject to certain limited
exceptions.
Of the gross proceeds received from the Initial Public Offering,
and the sale of the Private Placement Warrants, $155,250,000 was
placed in the Trust Account.
We paid a total of $3,105,000 in underwriting discounts and
commissions and $444,676 for other offering costs related to the
Initial Public Offering. In addition, the underwriters agreed to
defer $5,433,750 in underwriting discounts and
commissions.
Item 6. [Reserved].
Item 7. Management’s Discussion and Analysis of Financial
Condition and Results of Operations.
The following discussion and analysis of the Company’s financial
condition and results of operations should be read in conjunction
with our audited financial statements and the notes related thereto
which are included in “Item 8. Financial Statements and
Supplementary Data” of this Annual Report on Form 10-K. Certain
information contained in the discussion and analysis set forth
below includes forward-looking statements. Our actual results may
differ materially from those anticipated in these forward-looking
statements as a result of many factors, including those set forth
under “Special Note Regarding Forward-Looking Statements,” “Item
1A. Risk Factors” and elsewhere in this Annual Report on Form
10-K.
Overview
We are a blank check company incorporated in the Cayman Islands on
January 11, 2021 formed for the purpose of effecting a merger,
share exchange, asset acquisition, share purchase, reorganization
or similar business combination with one or more businesses or
entities. We intend to effectuate our Business Combination using
cash derived from the proceeds of the Initial Public Offering and
the sale of the Private Placement Warrants, our share capital, debt
or a combination of cash, share capital and debt.
We expect to continue to incur significant costs in the pursuit of
a Business Combination. We cannot assure you that our plans to
complete a Business Combination will be successful.
Results of Operations
We have neither engaged in any operations nor generated any
revenues through December 31, 2021. All activity for the
period from January 11, 2021 (inception) through
December 31, 2021 were organizational activities, those
necessary to prepare for the Initial Public Offering as described
below and, subsequent to the closing of the Initial Public
Offering, identifying a target company for a Business Combination.
We do not expect to generate any operating revenues until after the
completion of our Business Combination. We generate non-operating
income in the form of interest income on investments held in the
Trust Account. We incur expenses as a result of being a public
company (for legal, financial reporting, accounting and auditing
compliance), as well as for due diligence expenses.
For the period from January 11, 2021 (inception) through
December 31, 2021, we had a net loss of $1,598,299, which
consists of operating costs of $945,070, transaction costs
allocated to the Warrants of $208,936 and an increase in the fair
value of warrant liability of $452,317, offset by interest income
on investments held in the Trust Account of $8,024.
Liquidity and Capital Resources
On March 8, 2021, we consummated the Initial Public Offering
of 15,525,000 Units at $10.00 per Unit, generating gross proceeds
of $155,250,000. Simultaneously with the closing of the Initial
Public Offering, we consummated the sale of 6,105,000 Private
Placement Warrants at a price of $1.00 per Private Placement
Warrant in a private placement transaction to the Sponsor,
generating gross proceeds of $6,105,000.
Following the Initial Public Offering, the full exercise of the
over-allotment option and the sale of the Private Placement
Warrants, a total of $155,250,000 was placed in the Trust Account.
We incurred $8,983,426 in costs related to the Initial Public
Offering, consisting of $3,105,000 of underwriting fees, $5,433,750
of deferred underwriting fees and $444,676 of other offering
costs.
For the period from January 11, 2021 (inception) through
December 31, 2021, cash used in operating activities was
$1,428,037. Net loss of $1,598,299 was affected by formation costs
paid by the Sponsor in exchange for issuance of the Founder Shares
of $5,000, an increase in the fair value of warrant liability of
$452,317, transaction costs allocated to the Warrants of $208,936
and interest earned on investments held in the Trust Account of
$8,024. Changes in operating assets and liabilities used $487,967
of cash for operating activities.
As of December 31, 2021, we had investments held in the Trust
Account of $155,258,024 (including $8,024 of interest income)
consisting of money market funds, which are invested primarily in
U.S. Treasury Bills with a maturity of 185 days or less. We may
withdraw interest from the Trust Account to pay taxes, if any. We
intend to use substantially all of the funds held in the Trust
Account, including any amounts representing interest earned on the
Trust Account (less income taxes payable), to complete our Business
Combination. To the extent that our share capital or debt is used,
in whole or in part, as consideration to
complete our Business Combination, the remaining proceeds held in
the Trust Account will be used as working capital to finance the
operations of the target business or businesses, make other
acquisitions and pursue our growth strategies.
As of December 31, 2021, we had cash of $1,147,287 held
outside of the Trust Account. We intend to use the funds held
outside the Trust Account primarily to identify and evaluate target
businesses, perform business due diligence on prospective target
businesses, travel to and from the offices, plants or similar
locations of prospective target businesses or their representatives
or owners, review corporate documents and material agreements of
prospective target businesses and structure, negotiate and complete
a Business Combination.
In order to fund working capital deficiencies or finance
transaction costs in connection with a Business Combination, the
Sponsor, or an affiliate of the Sponsor, or certain of the
Company’s executive officers and directors may, but are not
obligated to, loan the Company funds as may be required. If we
complete a Business Combination, we would repay such Working
Capital Loans. In the event that a Business Combination does not
close, we may use a portion of the working capital held outside the
Trust Account to repay such Working Capital Loans but no proceeds
from the Trust Account would be used for such repayment. Up to
$2,000,000 of such Working Capital Loans may be convertible into
warrants at a price of $1.00 per warrant, at the option of the
lender. The warrants would be identical to the Private Placement
Warrant.
We do not believe we will need to raise additional funds in order
to meet the expenditures required for operating our business.
However, if our estimate of the costs of identifying a target
business, undertaking in-depth due diligence and negotiating a
Business Combination is less than the actual amount necessary to do
so, we may have insufficient funds available to operate our
business prior to our Business Combination. Moreover, we may need
to obtain additional financing either to complete our Business
Combination or because we become obligated to redeem a significant
number of the Public Shares upon consummation of our Business
Combination, in which case we may issue additional securities or
incur debt in connection with such Business
Combination.
Off-Balance Sheet Arrangements
We have no obligations, assets or liabilities, which would be
considered off-balance sheet arrangements as of December 31,
2021. We do not participate in transactions that create
relationships with unconsolidated entities or financial
partnerships, often referred to as variable interest entities,
which would have been established for the purpose of facilitating
off-balance sheet arrangements. We have not entered into any
off-balance sheet financing arrangements, established any special
purpose entities, guaranteed any debt or commitments of other
entities or purchased any non-financial assets.
Contractual Obligations
We do not have any long-term debt, capital lease obligations,
operating lease obligations or long-term liabilities, other than an
agreement to pay an affiliate of the Sponsor a sum of $10,000 per
month for office space and secretarial and administrative services.
We began incurring these fees on March 3, 2021 and will
continue to incur these fees monthly until the earlier of the
completion of the Business Combination and our
liquidation.
The underwriters are entitled to a deferred underwriting fee of
$0.35 per Unit, or $5,433,750 in the aggregate. The deferred
underwriting fee will become payable to the underwriters from the
amounts held in the Trust Account solely in the event that the
Company completes a Business Combination, subject to the terms of
the underwriting agreement.
Critical Accounting Policies
The preparation of condensed financial statements and related
disclosures in conformity with GAAP requires our management to make
estimates and assumptions that affect the reported amounts of
assets and liabilities, disclosure of contingent assets and
liabilities at the date of the condensed financial statements, and
income and expenses during the periods reported. Actual results
could materially differ from those estimates. We have identified
the critical accounting policies set forth below.
Warrant Liability
We account for the Warrants as either equity-classified or
liability-classified instruments based on an assessment of the
Warrants’ specific terms and applicable authoritative guidance in
the FASB ASC Topic 480, “Distinguishing
Liabilities from Equity,”
and ASC Topic 815, “Derivatives
and Hedging.”
The assessment considers whether the Warrants are freestanding
financial instruments pursuant to ASC Topic 480, whether Warrants
meet the definition of a liability pursuant to ASC Topic 480 and
whether the Warrants meet all of the requirements for equity
classification under ASC Topic 815, including whether the Warrants
are indexed to the Class A Ordinary Shares, among other
conditions for equity classification. This assessment,
which requires the use of professional judgment, is conducted at
the time of issuance of the Warrants and as of each subsequent
quarterly period end date while the Warrants are
outstanding.
For issued or modified Warrants that meet all of the criteria for
equity classification, the Warrants are required to be recorded as
a component of additional paid-in capital at the time of issuance.
For issued or modified Warrants that do not meet all the criteria
for equity classification, the Warrants are required to be recorded
at their initial fair value on the date of issuance and each
balance sheet date thereafter. Changes in the estimated fair value
of the warrants are recognized as a non-cash gain or loss on the
statements of operations. The fair value of the Public Warrants was
determined using the closing price of the Public Warrants, and the
fair value of the Private Placement Warrants was estimated using a
Monte Carlo simulation approach.
Class A Ordinary Shares Subject to Possible
Redemption
We account for the Class A Ordinary Shares subject to possible
redemption in accordance with the guidance in ASC Topic 480,
“Distinguishing
Liabilities from Equity.”
Class A Ordinary Shares subject to mandatory redemption are
classified as a liability instrument and are measured at fair
value. Conditionally redeemable Class A Ordinary Shares
(including Class A Ordinary Shares that feature redemption
rights that are either within the control of the holder or subject
to redemption upon the occurrence of uncertain events not solely
within the Company’s control) are classified as temporary equity.
At all other times, Class A Ordinary Shares are classified as
shareholders’ equity. The Class A Ordinary Shares feature
certain redemption rights that are considered to be outside of the
Company’s control and subject to occurrence of uncertain future
events. Accordingly, the Class A Ordinary Shares subject to
possible redemption are presented at redemption value as temporary
equity, outside of the shareholders’ equity section of our
condensed balance sheet.
Net Loss Per Ordinary Share
The Company has two classes of ordinary shares, which are referred
to as Class A Ordinary Shares and Class B Ordinary Shares. Income
and losses are shared pro rata between the two classes of ordinary
shares. Net loss per ordinary share is computed by dividing net
loss by the weighted average number of ordinary shares outstanding
for the period. The calculation of diluted loss per share does not
consider the effect of the Public Warrants issued in
connection with the Initial Public Offering and the sale of the
Private Placement Warrants, because the exercise of the warrants is
contingent upon the occurrence of future events.
Recent Accounting Standards
In August 2020, the FASB issued Accounting Standards Update No.
2020-06, “Debt—Debt
with Conversion and Other Options (Subtopic
470-20)”
and “Derivatives
and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40):
Accounting for Convertible Instruments and Contracts in an Entity’s
Own Equity,”
which simplifies accounting for convertible instruments by removing
major separation models required under current GAAP. ASU 2020-06
removes certain settlement conditions that are required for equity
contracts to qualify for the derivative scope exception and it also
simplifies the diluted earnings per share calculation in certain
areas. ASU 2020-06 is effective for fiscal years beginning
after December 15, 2023, including interim periods within
those fiscal years, with early adoption permitted. We adopted ASU
2020-06 effective as of January 1, 2021. The adoption of ASU
2020-06 did not have an impact on our condensed financial
statements.
Our management does not believe that any other recently issued, but
not yet effective, accounting standards, if currently adopted,
would have a material effect on our condensed financial
statements.
Item 7A. Quantitative and Qualitative Disclosures About Market
Risk.
Not required for smaller reporting companies.
Item 8. Financial Statements and Supplementary Data
ALTIMAR ACQUISITION CORP. III
INDEX TO FINANCIAL STATEMENTS
Report of Independent Registered Public Accounting
Firm
To the Shareholders and the Board of Directors of
Altimar Acquisition Corp. III
Opinion on the Financial Statements
We have audited the accompanying balance sheet of Altimar
Acquisition Corp. III (the “Company”) as of December 31, 2021, the
related statements of operations, changes in shareholders’
(deficit) equity and cash flows for the period from January 11,
2021 (inception) through December 31, 2021, and the related notes
(collectively referred to as the “financial statements”). In our
opinion, the financial statements present fairly, in all material
respects, the financial position of the Company as of December 31,
2021, and the results of its operations and its cash flows for the
period from January 11, 2021 (inception) through December 31, 2021,
in conformity with accounting principles generally accepted in the
United States of America.
Basis for Opinion
These financial statements are the responsibility of the Company’s
management. Our responsibility is to express an opinion on the
Company's financial statements based on our audit. We are a public
accounting firm registered with the Public Company Accounting
Oversight Board (United States) (“PCAOB”) and are required to be
independent with respect to the Company in accordance with the U.S.
federal securities laws and the applicable rules and regulations of
the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the
PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the financial
statements are free of material misstatement, whether due to error
or fraud. The Company is not required to have, nor were we engaged
to perform, an audit of its internal control over financial
reporting. As part of our audit we are required to obtain an
understanding of internal control over financial reporting but not
for the purpose of expressing an opinion on the effectiveness of
the Company's internal control over financial reporting.
Accordingly, we express no such opinion.
Our audit included performing procedures to assess the risks of
material misstatement of the financial statements, whether due to
error or fraud, and performing procedures that respond to those
risks. Such procedures included examining, on a test basis,
evidence regarding the amounts and disclosures in the financial
statements. Our audit also included evaluating the accounting
principles used and significant estimates made by management, as
well as evaluating the overall presentation of the financial
statements. We believe that our audit provides a reasonable basis
for our opinion.
/s/ WithumSmith+Brown, PC
We have served as the Company's auditor since 2021.
New York, New York
March 8, 2022
PCAOB ID 100
ALTIMAR ACQUISITION CORP. III
BALANCE SHEET
|
|
|
|
|
|
|
December 31, 2021 |
ASSETS |
|
Current assets |
|
Cash |
$ |
1,147,287 |
|
Prepaid expenses |
660,875 |
|
Total current assets |
1,808,162 |
|
Investments held in the Trust Account |
155,258,024 |
|
TOTAL ASSETS |
$ |
157,066,186 |
|
LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
Current liabilities—accrued expenses |
$ |
172,908 |
|
Warrant liability |
9,871,069 |
|
Deferred underwriting fee payable |
5,433,750 |
|
Total liabilities |
15,477,727 |
|
Commitments and Contingencies |
|
Class A Ordinary Shares subject to possible redemption,
$0.0001 par value; 15,525,000 shares issued and outstanding at
$10.00 per share redemption value
|
155,250,000 |
|
Shareholders’ Equity (Deficit) |
|
Preference shares, $0.0001 par value; 5,000,000 shares authorized;
none issued or outstanding
|
— |
|
Class A Ordinary Shares, $0.0001 par value; 500,000,000 shares
authorized; none issued and outstanding (excluding 15,525,000
shares subject to redemption)
|
— |
|
Class B Ordinary Shares, $0.0001 par value; 50,000,000 shares
authorized; 3,881,250 shares issued and outstanding
|
388 |
|
Additional paid-in capital |
— |
|
Accumulated deficit |
(13,661,929) |
|
Total shareholders’ equity (deficit) |
(13,661,541) |
|
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT) |
$ |
157,066,186 |
|
The accompanying notes are an integral part of the financial
statements.
ALTIMAR ACQUISITION CORP. III
STATEMENTS OF OPERATIONS
FOR THE PERIOD FROM JANUARY 11, 2021 (INCEPTION) THROUGH
DECEMBER 31, 2021
|
|
|
|
|
|
|
For the Period from January 11, 2021 (inception) through
December 31, 2021 |
Operating and formation costs |
$ |
945,070 |
|
Loss from operations |
(945,070) |
|
Other income (expense) |
|
Interest earned on investments held in the Trust
Account |
8,024 |
|
Transaction costs allocated to the Warrants |
(208,936) |
|
Change in fair value of warrant liability |
(452,317) |
|
Other income (expense), net |
(653,229) |
|
Net loss |
$ |
(1,598,299) |
|
Weighted average shares outstanding, redeemable Class A
Ordinary Shares |
13,075,986 |
|
Basic and diluted net loss per share, redeemable Class A
Ordinary Shares |
$ |
(0.09) |
|
Weighted average shares outstanding, Class B Ordinary
Shares |
3,801,391 |
|
Basic and diluted net loss per share, Class B Ordinary
Shares |
$ |
(0.09) |
|
The accompanying notes are an integral part of the financial
statements.
ALTIMAR ACQUISITION CORP. III
STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
(DEFICIT)
FOR THE PERIOD FROM JANUARY 11, 2021 (INCEPTION)
THROUGH
DECEMBER 31, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class A
Ordinary Shares |
|
Class B
Ordinary Shares |
|
Additional
Paid-In
Capital |
|
Accumulated
Surplus (Deficit) |
|
Total
Shareholders’
Equity (Deficit) |
|
Shares |
|
Amount |
|
Shares |
|
Amount |
Balance—January 11, 2021 |
— |
|
|
$ |
— |
|
|
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
Issuance of the Class B Ordinary Shares to the
Sponsor |
— |
|
|
— |
|
|
3,881,250 |
|
|
388 |
|
|
24,612 |
|
|
— |
|
|
25,000 |
|
Accretion of Class A Ordinary Shares to redemption
amount |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(24,612) |
|
|
(12,063,630) |
|
|
(12,088,242) |
|
Net loss |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(1,598,299) |
|
|
(1,598,299) |
|
Balance—December 31, 2021 |
— |
|
|
$ |
— |
|
|
3,881,250 |
|
|
$ |
388 |
|
|
$ |
— |
|
|
$ |
(13,661,929) |
|
|
$ |
(13,661,541) |
|
The accompanying notes are an integral part of the financial
statements.
ALTIMAR ACQUISITION CORP. III
STATEMENT OF CASH FLOWS
FOR THE PERIOD FROM JANUARY 11, 2021 (INCEPTION)
THROUGH
DECEMBER 31, 2021
|
|
|
|
|
|
|
For the Period from January 11, 2021 (inception) through
December 31, 2021 |
Cash flows from operating activities |
|
Net loss |
$ |
(1,598,299) |
|
Adjustments to reconcile net loss to net cash used in operating
activities |
|
Formation cost paid by the Sponsor in exchange for issuance of the
Founder Shares |
5,000 |
|
Interest income on investments held in the Trust
Account |
(8,024) |
|
Transaction costs allocated to the Warrants |
208,936 |
|
Change in fair value of warrant liability |
452,317 |
|
Changes in operating assets and liabilities |
|
Prepaid expenses |
(660,875) |
|
Accrued expenses |
172,908 |
|
Net cash used in operating activities |
(1,428,037) |
|
Cash flows from investing activities |
|
Investment of cash in the Trust Account |
(155,250,000) |
|
Net cash used in investing activities |
(155,250,000) |
|
Cash flows from financing activities |
|
Proceeds from sale of the Units, net of underwriting discounts
paid |
152,145,000 |
|
Proceeds from sale of the Private Placement Warrants |
6,105,000 |
|
Repayment of the Promissory Note—related party |
(43,101) |
|
Payment of offering costs |
(381,575) |
|
Net cash provided by financing activities |
157,825,324 |
|
Net change in cash |
1,147,287 |
|
Cash—beginning of period |
— |
|
Cash—end of period |
$ |
1,147,287 |
|
Non-cash investing and financing activities |
|
Offering costs paid by the Sponsor in exchange for issuance of the
Founder Shares |
$ |
20,000 |
|
Offering costs paid through the Promissory Note |
$ |
43,101 |
|
Deferred underwriting fee payable |
$ |
5,433,750 |
|
The accompanying notes are an integral part of the financial
statements.
ALTIMAR ACQUISITION CORP. III
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2021
NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS
OPERATIONS
Altimar Acquisition Corp. III (the “Company”)
is a blank check company incorporated as a Cayman Islands exempted
company on January 11, 2021. The Company was incorporated for
the purpose of effecting a merger, share exchange, asset
acquisition, share purchase, reorganization or similar business
combination with one or more businesses or entities (a
“Business
Combination”).
The Company is not limited to a particular industry or sector for
purposes of consummating a Business Combination. The Company is an
early stage and emerging growth company and, as such, the Company
is subject to all of the risks associated with early stage and
emerging growth companies.
As of December 31, 2021, the Company had not commenced any
operations. All activity for the period from January 11, 2021
(inception) through December 31, 2021 relates to the Company’s
formation, the Company’s initial public offering (the
“Initial
Public Offering”)
which is described below and, subsequent to the completion of the
Initial Public Offering, identifying a target company for a
Business Combination. The Company will not generate any operating
revenues until after the completion of a Business Combination, at
the earliest. The Company generates non-operating income in the
form of interest income from the proceeds derived from the Initial
Public Offering. The Company has selected December 31 as its
fiscal year end.
The Registration Statement on Form S-1 (File
No. 333-252570) (the “Registration
Statement”)
for the Initial Public Offering was declared effective on
March 3, 2021. On March 8, 2021, the Company consummated
the Initial Public Offering of 15,525,000 Units (the
“Units”
and, with respect to the Class A Ordinary Shares and the
warrants included in the Units, the “Public
Shares”
and the “Public
Warrants,”
respectively), which includes the full exercise by the underwriters
of their over-allotment option in the amount of 2,025,000 Units, at
$10.00 per Unit, generating gross proceeds of $155,250,000, as
described in Note 3.
Simultaneously with the closing of the Initial Public Offering, the
Company consummated the sale of 6,105,000 warrants (the
“Private
Placement Warrants”
and, together with the Public Warrants, the “Warrants”)
at a price of $1.00 per Private Placement Warrant in a private
placement to Altimar Sponsor III, LLC (the “Sponsor”),
generating gross proceeds of $6,105,000, as described in Note
4.
Transaction costs amounted to $8,983,426, consisting of $3,105,000
of underwriting fees, $5,433,750 of deferred underwriting fees (see
Note 6) and $444,676 of other offering costs.
Following the closing of the Initial Public Offering on
March 8, 2021, an amount of $155,250,000 ($10.00 per Unit)
from the net proceeds of the sale of the Units in the Initial
Public Offering and the sale of the Private Placement Warrants was
placed in a trust account (the “Trust
Account”)
and will be invested in U.S. government securities, within the
meaning set forth in Section 2(a)(16) of the Investment
Company Act of 1940, as amended (the “Investment
Company Act”),
with a maturity of 185 days or less, or in any open-ended
investment company that holds itself out as a money market fund
investing solely in U.S. Treasuries and meeting certain conditions
under Rule 2a-7 of the Investment Company Act, as determined by the
Company, until the earlier of (i) the completion of a Business
Combination and (ii) the distribution of the funds in the
Trust Account to the Company’s shareholders, as described
below.
The Company’s management has broad discretion with respect to the
specific application of the net proceeds of the Initial Public
Offering and the sale of the Private Placement Warrants, although
substantially all of the net proceeds are intended to be applied
generally toward consummating a Business Combination. The New York
Stock Exchange listing rules require that the Business Combination
must be with one or more operating businesses or assets with a fair
market value equal to at least 80% of the assets held in the Trust
Account (excluding the amount of deferred underwriting commissions
and taxes payable on the income earned on the Trust Account) at the
time of the signing a definitive agreement in connection with the
initial Business Combination. The Company will only complete a
Business Combination if the post-Business Combination company owns
or acquires 50% or more of the issued and outstanding voting
securities of the target or otherwise acquires a controlling
interest in the target business sufficient for it not to be
required to register as an investment company under the Investment
Company Act. There is no assurance that the Company will be able to
complete a Business Combination successfully.
ALTIMAR ACQUISITION CORP. III
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2021
The Company will provide the holders of the Public Shares (the
“Public
Shareholders”)
with the opportunity to redeem all or a portion of their Public
Shares either (i) in connection with a general meeting called
to approve the Business Combination or (ii) by means of a
tender offer. The decision as to whether the Company will seek
shareholder approval of a Business Combination or conduct a tender
offer will be made by the Company, solely in its discretion. The
Public Shareholders will be entitled to redeem their Public Shares,
equal to the aggregate amount then on deposit in the Trust Account,
calculated as of two business days prior to the consummation of the
Business Combination (initially anticipated to be $10.00 per Public
Share), including interest (which interest shall be net of taxes
payable), divided by the number of the then issued and outstanding
Public Shares, subject to certain limitations as described in the
Registration Statement. The per-Public Share amount to be
distributed to the Public Shareholders who properly redeem their
Public Shares will not be reduced by the deferred underwriting
commissions the Company will pay to the underwriters in the Initial
Public Offering (as discussed in Note 6). There will be no
redemption rights in connection with a Business Combination with
respect to the Warrants.
The Company will not redeem Public Shares in an amount that would
cause its net tangible assets to be less than $5,000,001 (so that
it does not then become subject to the U.S. Securities and Exchange
Commission’s (the “SEC”)
“penny stock” rules) or any greater net tangible asset or cash
requirement that may be contained in the agreement relating to the
Business Combination. If the Company seeks shareholder approval of
the Business Combination, the Company will proceed with a Business
Combination only if the Company receives an ordinary resolution
under Cayman Islands law approving a Business Combination, which
requires the affirmative vote of a majority of the ordinary shares
represented in person or by proxy and entitled to vote thereon and
who vote at a general meeting, or such other vote as required by
applicable law or stock exchange rules. If a shareholder vote is
not required and the Company does not decide to hold a shareholder
vote for business or other legal reasons, the Company will,
pursuant to the Company’s amended and restated memorandum and
articles of association (the “Amended
and Restated Memorandum and Articles of
Association”),
conduct the redemptions pursuant to the tender offer rules of the
SEC and file tender offer documents containing substantially the
same information as would be included in a proxy statement with the
SEC prior to completing a Business Combination. If the Company
seeks shareholder approval in connection with a Business
Combination, the Sponsor has agreed to vote the Founder Shares (as
defined below) and any Public Shares purchased during or after the
Initial Public Offering in favor of approving a Business
Combination. Additionally, the Public Shareholders may elect to
redeem their Public Shares without voting and, if they do vote,
irrespective of whether they vote for or against a proposed
Business Combination.
Notwithstanding the foregoing, if the Company seeks shareholder
approval of the Business Combination and the Company does not
conduct redemptions pursuant to the tender offer rules, a Public
Shareholder, together with any affiliate of such Public Shareholder
or any other person with whom such Public Shareholder is acting in
concert or as a “group” (as defined under Section 13 of the
Securities Exchange Act of 1934, as amended (the
“Exchange
Act”)),
will be restricted from redeeming its Public Shares with respect to
more than an aggregate of 15% of the Public Shares without the
Company’s prior written consent.
Each of the Sponsor and the Company’s executive officers and
directors have agreed (a) to waive its redemption rights with
respect to any Founder Shares and Public Shares held by it in
connection with a Business Combination and (b) not to propose
an amendment to the Amended and Restated Memorandum and Articles of
Association (i) to modify the substance or timing of the
Company’s obligation to allow redemption in connection with an
initial Business Combination or to redeem 100% of the Public Shares
if the Company does not complete a Business Combination prior to
March 8, 2023 (the “Combination
Period”)
or (ii) with respect to any other provision relating to
shareholders’ rights or pre-initial business combination activity,
unless the Company provides the Public Shareholders with the
opportunity to redeem their Public Shares upon approval of any such
amendment at a per-Public Share price, payable in cash, equal to
the aggregate amount then on deposit in the Trust Account,
including interest earned on the amount on deposit in the Trust
Account and not previously released to pay taxes, divided by the
number of then issued and outstanding Public Shares.
The Company will have until March 8, 2023 to consummate a
Business Combination. However, if the Company has not completed a
Business Combination within the Combination Period, the Company
will (i) cease all operations except for the purpose of
winding up, (ii) as promptly as reasonably possible but not
more than ten business days thereafter, redeem 100% of the Public
Shares, at a per-share price, payable in cash, equal to the
aggregate amount then on deposit in the Trust Account, including
interest earned and not previously released to the Company to pay
taxes, if any (less up to $100,000 of interest to pay dissolution
expenses), divided by the number of the then issued and outstanding
Public Shares, which redemption will completely extinguish the
rights of the Public Shareholders as shareholders (including the
right to receive further liquidating istributions, if any), and
(iii) as promptly as reasonably possible following such
redemption, subject to the approval of the Company’s remaining
Public Shareholders and its board of directors, liquidate and
dissolve, subject, in each case, to the
ALTIMAR ACQUISITION CORP. III
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2021
Company’s obligations under Cayman Islands law to provide for
claims of creditors and the requirements of other
applicable
law. There will be no redemption rights or liquidating
distributions with respect to the Warrants, which will expire
worthless if the Company fails to complete a Business Combination
within the Combination Period.
The Sponsor has agreed to waive its rights to liquidating
distributions from the Trust Account with respect to the Founder
Shares held by the Sponsor if the Company fails to complete a
Business Combination within the Combination Period. However, if the
Sponsor or any of its affiliates acquires Public Shares, such
Public Shares will be entitled to liquidating distributions from
the Trust Account if the Company fails to complete a Business
Combination within the Combination Period. The underwriters have
agreed to waive their rights to their deferred underwriting
commission (see Note 6) held in the Trust Account in the event the
Company fails to complete a Business Combination within the
Combination Period and, in such event, such amounts will be
included with the other funds held in the Trust Account that will
be available to fund the redemption of the Public Shares. In the
event of such distribution, it is possible that the per share value
of the assets remaining available for distribution will be less
than the offering price per Unit ($10.00).
In order to protect the amounts held in the Trust Account, the
Sponsor has agreed that it will be liable to the Company if and to
the extent any claims by a third party (other than the Company’s
independent registered public accounting firm) for services
rendered or products sold to the Company, or a prospective target
business with which the Company has discussed entering into a
transaction agreement, reduce the amount of funds in the Trust
Account to below the lesser of (1) $10.00 per Public Share and (2)
the actual amount per Public Share held in the Trust Account as of
the date of the liquidation of the Trust Account, if less than
$10.00 per Public Share, due to reductions in the value of trust
assets, in each case, net of the interest that may be withdrawn to
pay taxes. This liability will not apply to any claims by a third
party that executed a waiver of any and all rights to seek access
to the Trust Account and as to any claims under the Company’s
indemnity of the underwriters in the Initial Public Offering
against certain liabilities, including liabilities under the
Securities Act of 1933, as amended (the “Securities
Act”).
In the event that an executed waiver is deemed to be unenforceable
against a third party, the Sponsor will not be responsible to the
extent of any liability for such third-party claims. The Company
will seek to reduce the possibility that the Sponsor will have to
indemnify the Trust Account due to claims of creditors by
endeavoring to have all vendors, service providers (other than the
Company’s independent registered public accounting firm),
prospective target businesses or other entities with which the
Company does business, execute agreements with the Company waiving
any right, title, interest or claim of any kind in or to monies
held in the Trust Account.
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying financial statements have been prepared in
accordance with accounting principles generally accepted in the
United States of America (“GAAP”)
and pursuant to the accounting and disclosure rules and regulations
of the SEC.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in
Section 2(a) of the Securities Act, as modified by the
Jumpstart Our Business Startups Act of 2012, as amended (the
“JOBS
Act”),
and may take advantage of certain exemptions from various reporting
requirements that are applicable to other public companies that are
not emerging growth companies, including, among others, not being
required to comply with the independent registered public
accounting firm attestation requirements of Section 404 of the
Sarbanes-Oxley Act of 2002, as amended, reduced disclosure
obligations regarding executive compensation in its periodic
reports and proxy statements and exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and
shareholder approval of any golden parachute payments not
previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging
growth companies from being required to comply with new or revised
financial accounting standards until private companies (that is,
those that have not had a registration statement under the
Securities Act declared effective or do not have a class of
securities registered under the Exchange Act) are required to
comply with the new or revised financial accounting standards. The
JOBS Act provides that a company can elect to opt out of the
extended transition period and comply with the requirements that
apply to non-emerging growth companies but any such election to opt
out is irrevocable. The Company has elected not to opt out of such
extended transition period which means that, when a standard is
issued or revised and it has different application dates for public
or private companies, the Company, as an
ALTIMAR ACQUISITION CORP. III
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2021
emerging growth company, can adopt the new or revised standard at
the time private companies adopt the new or revised standard. This
may make comparison of the Company’s financial statement with
another public company which is neither an emerging growth company
nor an emerging growth company which has opted out of using the
extended transition period difficult or impossible because of the
potential differences in accounting standards used.
Use of Estimates
The preparation of the financial statements in conformity with GAAP
requires the Company’s management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the
condensed financial statements and the reported amounts of revenues
and expenses during the reporting period.
Making estimates requires the Company’s management to exercise
significant judgment. It is at least reasonably possible that the
estimate of the effect of a condition, situation or set of
circumstances that existed at the date of the financial statements,
which the Company’s management considered in formulating its
estimate, could change in the near term due to one or more future
confirming events. Accordingly, the actual results could differ
significantly from those estimates.
One of the more significant accounting estimates included in these
financial statements is the determination of the fair value of the
warrant liability. Such estimates may be subject to change as more
current information becomes available and accordingly the actual
results could differ significantly from those
estimates.
Cash and Cash Equivalents
The Company considers all short-term investments with an original
maturity of three months or less when purchased to be cash
equivalents. As of December 31, 2021, the Company held
$155,258,024 in a money market fund in the Trust
Account.
Offering Costs
Offering costs consist of legal, accounting and underwriting fees
and other costs incurred through the balance sheet date that are
directly related to the Initial Public Offering. Offering costs
amounted to $8,983,426, of which $8,774,490 were charged to Class A
Ordinary Shares subject to possible redemption upon the completion
of the Initial Public Offering and $208,936 were expensed on the
statements of operations.
Class A Ordinary Shares Subject to Possible
Redemption
The Company accounts for the Class A Ordinary Shares subject
to possible redemption in accordance with the guidance in
Accounting Standards Codification (“ASC”)
Topic 480, “Distinguishing
Liabilities from Equity.”
Class A Ordinary Shares subject to mandatory redemption are
classified as a liability instrument and are measured at fair
value. Conditionally redeemable Class A Ordinary Shares
(including Class A Ordinary Shares that feature redemption
rights that are either within the control of the holder or subject
to redemption upon the occurrence of uncertain events not solely
within the Company’s control) are classified as temporary equity.
At all other times, Class A Ordinary Shares are classified as
shareholders’ equity. The Class A Ordinary Shares feature
certain redemption rights that are considered to be outside of the
Company’s control and subject to occurrence of uncertain future
events. Accordingly, as of December 31, 2021, 15,525,000
Class A Ordinary Shares subject to possible redemption are
presented at redemption value as temporary equity, outside of the
shareholders’ equity section of the Company’s balance
sheet.
The Company recognizes changes in redemption value immediately as
they occur and adjusts carrying value of the redeemable Class A
Ordinary Shares to equal the redemption value at the end of each
reporting period. Immediately upon the closing of the Initial
Public Offering, the Company recognized the accretion from initial
book value to redemption amount value. The change in the carrying
value of the redeemable Class A Ordinary Shares resulted in charges
against additional paid-in capital and accumulated
deficit.
At December 31, 2021, the Class A Ordinary Shares reflected in
the balance sheet are reconciled in the following
table:
ALTIMAR ACQUISITION CORP. III
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2021
|
|
|
|
|
|
Gross proceeds |
$ |
155,250,000 |
|
Plus / (less) adjustments to carrying value: |
|
Proceeds allocated to the Public Warrants |
(3,326,894) |
|
Class A Ordinary Shares issuance costs |
(8,774,490) |
|
Proceeds allocated to the Private Placement Warrants |
13,142 |
|
Plus: |
|
Accretion of carrying value to redemption value |
12,088,242 |
|
Class A Ordinary Shares subject to possible redemption |
$ |
155,250,000 |
|
Warrant Liability
The Company accounts for the Warrants as either equity-classified
or liability-classified instruments based on an assessment of the
Warrants’ specific terms and applicable authoritative guidance in
the Financial Accounting Standards Board (the “FASB”)
ASC Topic 480, “Distinguishing
Liabilities from Equity,”
and ASC Topic 815, “Derivatives
and Hedging.”
The assessment considers whether the Warrants are freestanding
financial instruments pursuant to ASC Topic 480, whether Warrants
meet the definition of a liability pursuant to ASC Topic 480 and
whether the Warrants meet all of the requirements for equity
classification under ASC Topic 815, including whether the Warrants
are indexed to the Class A Ordinary Shares, among other
conditions for equity classification. This assessment, which
requires the use of professional judgment, is conducted at the time
of issuance of the Warrants and as of each subsequent quarterly
period end date while the Warrants are outstanding.
For issued or modified Warrants that meet all of the criteria for
equity classification, the Warrants are required to be recorded as
a component of additional paid-in capital at the time of issuance.
For issued or modified Warrants that do not meet all the criteria
for equity classification, the Warrants are required to be recorded
at their fair value on the date of issuance and each balance sheet
date thereafter. Changes in the estimated fair value of the
warrants are recognized as a non-cash gain or loss on the
statements of operations. The fair value of the Public Warrants was
determined using the closing price of the Public Warrants, and the
fair value of the Private Placement Warrants was estimated using a
Monte Carlo simulation approach (see Note 9).
Income Taxes
The Company accounts for income taxes under ASC Topic 740,
“Income
Taxes,”
which prescribes a recognition threshold and a measurement
attribute for the financial statement recognition and measurement
of tax positions taken or expected to be taken in a tax return. For
those benefits to be recognized, a tax position must be more likely
than not to be sustained upon examination by taxing authorities.
The Company’s management determined that the Cayman Islands is the
Company’s major tax jurisdiction. The Company recognizes accrued
interest and penalties related to unrecognized tax benefits as
income tax expense. As of December 31, 2021, there were no
unrecognized tax benefits and no amounts accrued for interest and
penalties. The Company is currently not aware of any issues under
review that could result in significant payments, accruals or
material deviation from its position.
The Company is considered to be an exempted Cayman Islands company
with no connection to any other taxable jurisdiction and is
presently not subject to income taxes or income tax filing
requirements in the Cayman Islands or the United States. As such,
the Company’s tax provision was zero for the period
presented.
Net Loss per Ordinary Share
The Company complies with accounting and disclosure requirements of
ASC Topic 260, “Earnings
Per Share.”
The Company has two classes of ordinary shares, which are referred
to as Class A Ordinary Shares and Class B Ordinary Shares. Income
and losses are shared pro rata between the two classes of ordinary
shares.
Net loss per ordinary share is computed by dividing net loss by the
weighted average number of ordinary shares outstanding for the
period. The calculation of diluted loss per share does not consider
the effect of the Public Warrants issued in connection with the
Initial Public Offering and the sale of the Private Placement
Warrants, because the exercise of the Warrants is
ALTIMAR ACQUISITION CORP. III
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2021
contingent upon the occurrence of future events. Accretion
associated with the redeemable shares of Class A Ordinary Shares is
excluded from earnings per share as the redemption value
approximates fair value.
The following table reflects the calculation of basic and diluted
net loss per ordinary share (in dollars, except per share
amounts):
|
|
|
|
|
|
|
For the Period from January 11, 2021 (inception) through
December 31, 2021 |
Redeemable Class A Ordinary Shares |
|
Numerator: |
|
Allocation of net loss |
$ |
(1,238,305) |
|
Denominator: |
|
Basic and diluted weighted average shares outstanding |
13,075,986 |
|
Basic and diluted net loss per share |
$ |
(0.09) |
|
|
|
Class B Ordinary Shares |
|
Numerator: |
|
Allocation of net loss |
$ |
(359,994) |
|
Denominator: |
|
Basic and diluted weighted average shares outstanding |
3,801,391 |
|
Basic and diluted net loss per share |
$ |
(0.09) |
|
For the period from January 11, 2021 (inception) through
December 31, 2021, basic and diluted shares are the same as
there are no non-redeemable securities that are dilutive to the
Company’s shareholders.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to
concentrations of credit risk consist of cash accounts in a
financial institution, which at times may exceed the Federal
Depository Insurance Corporation coverage limit of $250,000. The
Company has not experienced losses on these accounts and the
Company’s management believes the Company is not exposed to
significant risks on such account.
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which
qualify as financial instruments under ASC Topic 820,
“Fair
Value Measurement,”
approximates the carrying amounts represented in the accompanying
condensed balance sheet, primarily due to their short-term nature,
except for the warrant liability (see Note 9).
Recent Accounting Standards
In August 2020, the FASB issued Accounting Standards Update No.
2020-06, ”Debt—Debt with Conversion and Other Options
(Subtopic 470-20)” and “Derivatives
and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40):
Accounting for Convertible Instruments and Contracts in an Entity’s
Own Equity”
(“ASU
2020-06”),
which simplifies accounting for convertible instruments by removing
major separation models required under current GAAP. ASU 2020-06
removes certain settlement conditions that are required for equity
contracts to qualify for the derivative scope exception and it also
simplifies the diluted earnings per share calculation in certain
areas. ASU 2020-06 is effective for fiscal years beginning
after December 15, 2023, including interim periods within
those fiscal years, with early adoption permitted. The Company
adopted ASU 2020-06 at inception. The adoption of ASU 2020-06 did
not have an impact on the Company’s financial statements as the
Company did not hold convertible instruments at
inception.
ALTIMAR ACQUISITION CORP. III
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2021
The Company’s management does not believe that any other recently
issued, but not yet effective, accounting standards, if currently
adopted, would have a material effect on the Company’s financial
statements.
NOTE 3. INITIAL PUBLIC OFFERING
The Company sold 15,525,000 Units in the Initial Public
Offering, which includes a full exercise by the underwriters of
their over-allotment option in the amount of 2,025,000 Units at a
purchase price of $10.00 per Unit. Each Unit consists of one
Class A Ordinary Share and one-fourth of one redeemable Public
Warrant. Each whole Public Warrant entitles the holder to purchase
one Class A Ordinary Share at an exercise price of $11.50 per
Class A Ordinary Share (see Note 8).
NOTE 4. PRIVATE PLACEMENT
Simultaneously with the closing of the Initial Public Offering and
the underwriters’ full exercise of their over-allotment option, the
Sponsor purchased an aggregate of 6,105,000 Private Placement
Warrants at a price of $1.00 per Private Placement Warrant, for an
aggregate purchase price of $6,105,000 in a private placement
transaction. Each Private Placement Warrant is exercisable to
purchase one Class A Ordinary Share at a price of $11.50 per
Class A Ordinary Share, subject to adjustment (see Note 8). A
portion of the proceeds from the sale of the Private Placement
Warrants was added to the proceeds from the Initial Public Offering
held in the Trust Account. If the Company does not complete a
Business Combination within the Combination Period, the proceeds
from the sale of the Private Placement Warrants will be used to
fund the redemption of the Public Shares, subject to the
requirements of applicable law, and the Private Placement Warrants
will expire worthless.
NOTE 5. RELATED PARTY TRANSACTIONS
Founder Shares
On January 15, 2021, the Sponsor paid $25,000 to cover certain
offering and formation costs of the Company in consideration for
3,593,750 Founder Shares. On January 28, 2021, the Sponsor
transferred 10,000 Founder Shares to certain of the Company’s
directors, resulting in the Sponsor holding 3,533,750 Founder
Shares. On March 3, 2021, the Company effected a share
capitalization and issued an additional 287,500 Founder Shares,
resulting in the Sponsor and the Company’s directors collectively
holding 3,881,250 Founder Shares. Each of the Company’s directors
has waived any right to receive additional Founder Shares in
connection with such stock dividend. The Founder Shares included an
aggregate of up to 506,250 Founder Shares that were subject to
forfeiture depending on the extent to which the
underwriters’ over-allotment option was exercised, so that the
number of the Founder Shares would equal, on an as-converted basis,
approximately 20% of the Company’s issued and outstanding ordinary
shares after the Initial Public Offering. As a result of the
underwriters’ election to fully exercise their over-allotment
option on March 8, 2021, the 506,250 Founder Shares are no
longer subject to forfeiture.
The Sponsor has agreed, subject to limited exceptions, not to
transfer, assign or sell any of the Founder Shares until the
earlier of (A) one year after the completion of a Business
Combination and (B) subsequent to a Business Combination,
(x) if the closing price of the Class A Ordinary Shares
equals or exceeds $12.00 per share (as adjusted for share
sub-divisions, share dividends, rights issuances, reorganizations,
recapitalizations and the like) for any 20 trading days within any
30-trading day period commencing at least 150 days after a Business
Combination, or (y) the date on which the Company completes a
liquidation, merger, share exchange or other similar transaction
that results in all of the Public Shareholders having the right to
exchange their Class A Ordinary Shares for cash, securities or
other property.
Administrative Services Agreement
The Company entered into an agreement, commencing on March 3,
2021, through the earlier of the Company’s consummation of a
Business Combination and its liquidation, to pay an affiliate of
the Sponsor a sum of $10,000 per month for office space and
secretarial and administrative services. For the period from
January 11, 2021 (inception) through December 31, 2021,
the Company incurred $100,000 in fees for these services, of which
$10,000 is included in current liabilities — accrued expenses in
the accompanying condensed balance sheet.
ALTIMAR ACQUISITION CORP. III
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2021
Promissory Note—Related Party
On January 15, 2021, the Company issued an unsecured promissory
note (the “Promissory
Note”)
to the Sponsor, pursuant to which the Company may borrow up to an
aggregate principal amount of $300,000. The Promissory Note was
non-interest bearing and payable on the earlier of (i) December 31,
2021 and (ii) the completion of the Initial Public Offering. The
outstanding balance under the Promissory Note of $43,101 was repaid
at the closing of the Initial Public Offering on March 8, 2021, at
which point the Promissory Note was no longer available to the
Company.
Related Party Loans
In order to finance transaction costs in connection with a Business
Combination, the Sponsor or an affiliate of the Sponsor, or certain
of the Company’s executive officers and directors may, but are not
obligated to, loan the Company funds as may be required (the
“Working
Capital Loans”).
If the Company completes a Business Combination, the Company would
repay the Working Capital Loans out of the proceeds of the Trust
Account released to the Company. Otherwise, the Working Capital
Loans would be repaid only out of funds held outside the Trust
Account. In the event that a Business Combination does not close,
the Company may use a portion of proceeds held outside the Trust
Account to repay the Working Capital Loans, but no proceeds held in
the Trust Account would be used to repay the Working Capital Loans.
Except for the foregoing, the terms of the Working Capital Loans,
if any, have not been determined and no written agreements exist
with respect to the Working Capital Loans. The Working Capital
Loans would either be repaid upon consummation of a Business
Combination, without interest, or, at the lender’s discretion, up
to $2,000,000 of the Working Capital Loans may be convertible into
warrants of the post-Business Combination entity at a price of
$1.00 per warrant. The warrants would be identical to the Private
Placement Warrants. As of December 31, 2021, there were no
amounts outstanding under the Working Capital Loans.
NOTE 6. COMMITMENTS AND CONTINGENCIES
Risks and Uncertainties
Management continues to evaluate the impact of the COVID-19
pandemic and has concluded that, while it is reasonably possible
that the COVID-19 pandemic could have a negative effect on the
Company’s financial position, results of its operations and/or
search for a target company, the specific impact is not readily
determinable as of the date of these financial statements. The
financial statements do not include any adjustments that might
result from the outcome of this uncertainty.
Registration and Shareholder Rights
Pursuant to a registration and shareholder rights agreement entered
into on March 3, 2021, the holders of the Founder Shares, the
Private Placement Warrants and any warrants that may be issued upon
conversion of the Working Capital Loans (and any Class A
Ordinary Shares issuable upon the exercise of the Private Placement
Warrants and warrants that may be issued upon conversion of the
Working Capital Loans) will be entitled to registration rights
pursuant to a registration and shareholder rights agreement. The
holders of these securities are entitled to make up to three
demands, excluding short form demands, that the Company register
such securities. In addition, the holders have certain “piggy-back”
registration rights with respect to registration statements filed
subsequent to the completion of a Business Combination. However,
the registration and shareholder rights agreement provides that the
Company will not permit any registration statement filed under the
Securities Act to become effective until termination of the
applicable lockup period. The registration rights agreement does
not contain liquidating damages or other cash settlement provisions
resulting from delays in registering the Company’s securities. The
Company will bear the expenses incurred in connection with the
filing of any such registration statements.
Underwriting Agreement
The underwriters are entitled to a deferred underwriting fee of
$0.35 per Unit, or $5,433,750 in the aggregate. The deferred
underwriting fee will become payable to the underwriters from the
amounts held in the Trust Account solely in the event that the
Company completes a Business Combination, subject to the terms of
the underwriting agreement.
ALTIMAR ACQUISITION CORP. III
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2021
NOTE 7. SHAREHOLDERS’ EQUITY
Preference Shares—The
Company is authorized to issue 5,000,000 preference shares, with a
par value of $0.0001 per share, with such designations, voting and
other rights and preferences as may be determined from time to time
by the Company’s board of directors. As of December 31, 2021,
there were no preference shares issued or outstanding.
Class A Ordinary Shares—The
Company is authorized to issue 500,000,000 Class A Ordinary
Shares, with a par value of $0.0001 per share. Holders of the
Class A Ordinary Shares are entitled to one vote for each
Class A Ordinary Share. As of December 31, 2021, there
were none issued and outstanding, excluding 15,525,000 Class A
Ordinary Shares subject to possible redemption.
Class B
Ordinary Shares—The
Company is authorized to issue 50,000,000 Class B Ordinary
Shares, with a par value of $0.0001 per share. Holders of the
Class B Ordinary Shares are entitled to one vote for each
Class B Ordinary Shares. As of December 31, 2021, there
were 3,881,250 Class B Ordinary Shares issued and
outstanding.
Only holders of the Class B Ordinary Shares will have the
right to vote on the election of directors prior to the Business
Combination. Holders of the Class A Ordinary Shares and the
Class B Ordinary Shares will vote together as a single class
on all other matters submitted to a vote of shareholders, except as
required by law. In connection with a Business Combination, the
Company may enter into a shareholders agreement or other
arrangements with the shareholders of the target or other investors
to provide for voting or other governance arrangements that differ
from those in effect upon completion of the Initial Public
Offering.
The Class B Ordinary Shares will automatically convert into
the Class A Ordinary Shares at the time of a Business
Combination, or earlier at the option of the holders thereof, at a
ratio such that the number of the Class A Ordinary Shares
issuable upon conversion of all of the Founder Shares will equal,
in the aggregate, on an as-converted basis, 20% of the sum of
(i) the total number of ordinary shares issued and outstanding
upon completion of the Initial Public Offering, plus (ii) the
total number of the Class A Ordinary Shares issued or deemed
issued or issuable upon conversion or exercise of any equity-linked
securities or rights issued or deemed issued, by the Company in
connection with or in relation to the consummation of a Business
Combination, excluding the Class A Ordinary Shares or
equity-linked securities exercisable for or convertible into the
Class A Ordinary Shares issued, deemed issued or to be issued
to any seller of an interest in the target to the Company in a
Business Combination and any Private Placement Warrants issued to
the Sponsor, its affiliates or any member of the Company’s
management team upon conversion of the Working Capital Loans. In no
event will the Class B Ordinary Shares convert into the
Class A Ordinary Shares at a rate of less than
one-to-one.
NOTE 8. WARRANT LIABILITY
As of December 31, 2021, there were 3,881,250 Public Warrants
outstanding. Public Warrants may only be exercised for a whole
number of shares. No fractional shares will be issued upon exercise
of the Public Warrants. The Public Warrants will become exercisable
on the later of (i) 30 days after the completion of a Business
Combination and (ii) one year from the closing of the Initial
Public Offering. The Public Warrants will expire five years from
the completion of a Business Combination or earlier upon redemption
or liquidation.
The Company will not be obligated to deliver any Class A
Ordinary Shares pursuant to the exercise of a Public Warrant and
will have no obligation to settle such exercise unless a
registration statement under the Securities Act with respect to the
Class A Ordinary Shares underlying the Public Warrant is then
effective and a prospectus relating thereto is current, subject to
the Company satisfying its obligations with respect to
registration, or a valid exemption from registration is available.
No Public Warrant will be exercisable and the Company will not be
obligated to issue a Class A Ordinary Share upon exercise of a
Public Warrant unless the Class A Ordinary Share issuable upon
such exercise has been registered, qualified or deemed to be exempt
under the securities laws of the state of residence of the
registered holder of the Public Warrant.
The Company has agreed that as soon as practicable, but in no event
later than 20 business days, after the closing of a Business
Combination, it will use its commercially reasonable efforts to
file with the SEC a registration statement for the registration,
under the Securities Act, of the Class A Ordinary Shares
issuable upon exercise of the Public Warrants, and the Company will
use its commercially reasonable efforts to cause the same to become
effective within 60 business days following the closing of a
Business Combination, and to maintain the effectiveness of such
registration statement and a current prospectus relating
to
ALTIMAR ACQUISITION CORP. III
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2021
those Class A Ordinary Shares until the Public Warrants expire
or are redeemed, as specified in the warrant agreement;
provided,
however,
that, if the Class A Ordinary Shares are at the time of any
exercise of a Public Warrant not listed on a national securities
exchange such that they satisfy the definition of a “covered
security” under Section 18(b)(1) of the Securities Act, the
Company may, at its option, require holders of Public Warrants who
exercise their Public Warrants to do so on a “cashless basis” in
accordance with Section 3(a)(9) of the Securities Act and, in
the event the Company so elects, the Company will not be required
to file or maintain in effect a registration statement for the
registration, under the Securities Act, of the Class A
Ordinary Shares issuable upon exercise of the Public Warrants, but
the Company will use its commercially reasonable efforts to
register or qualify for sale the Class A Ordinary Shares under
applicable blue sky laws to the extent an exemption is not
available. If a registration statement covering the Class A
Ordinary Shares issuable upon exercise of the Public Warrants is
not effective by the 60th day after the closing of a Business
Combination, holders of Public Warrants may, until such time as
there is an effective registration statement and during any period
when the Company will have failed to maintain an effective
registration statement, exercise Public Warrants on a “cashless
basis” in accordance with Section 3(a)(9) of the Securities
Act or another exemption, but the Company will use its commercially
reasonable efforts to register or qualify the Class A Ordinary
Shares under applicable blue sky laws to the extent an exemption is
not available.
Redemption of the Warrants when the price per Class A Ordinary
Share equals or exceeds $18.00
Once the Warrants become exercisable, the Company may redeem the
outstanding Warrants (except as described with respect to the
Private Placement Warrants):
•in
whole and not in part;
•at
a price of $0.01 per Warrant;
•upon
a minimum of 30 days’ prior written notice of redemption to each
holder of the Warrant; and
•if,
and only if, the closing price of the Class A Ordinary Shares
equals or exceeds $18.00 per share (as adjusted) for any 20 trading
days within a 30-trading day period ending
three trading days before the Company sends the notice of
redemption to the holders of the Warrants.
If and when the Warrants become redeemable by the Company, the
Company may exercise its redemption right even if it is unable to
register or qualify the underlying securities for sale under all
applicable state securities laws.
Redemption of the Warrants when the price per Class A Ordinary
Share equals or exceeds $10.00.
Once the Warrants become exercisable, the Company may redeem the
outstanding Warrants:
•in
whole and not in part;
•at
a price of $0.10 per Warrant upon a minimum of 30 days’ prior
written notice of redemption;
provided,
however,
that holders will be able to exercise their Warrants on a cashless
basis prior to redemption and receive that number of shares
determined based on the redemption date and the fair market value
of the Class A Ordinary Shares; and
•if,
and only if, the closing price of the Class A Ordinary Shares
equal or exceeds $10.00 per Class A Ordinary Share (as
adjusted) for any 20 trading days within the 30-trading day period
ending
three trading days before the Company sends the notice of
redemption of the holders of the Warrants.
If the Company calls the Public Warrants for redemption, as
described above, the Company’s management will have the option to
require any holder that wishes to exercise the Public Warrants to
do so on a “cashless basis,” as described in the warrant agreement.
The exercise price and number of the Class A Ordinary Shares
issuable upon exercise of the Public Warrants may be adjusted in
certain circumstances including in the event of a share dividend,
extraordinary dividend or recapitalization, reorganization, merger
or consolidation. However, except as described below, the Public
Warrants will not be adjusted for issuances of the Class A
Ordinary Shares at a price below its exercise price. Additionally,
in no event will the Company be required to net cash settle the
Public Warrants. If the Company is unable to complete a Business
Combination within the Combination Period and the Company
liquidates the funds held in the Trust Account, holders of the
Public Warrants will not receive any of such funds with respect to
their Public Warrants, nor will they receive any distribution from
the Company’s assets held outside of the Trust Account with respect
to their Public Warrants. Accordingly, the Public Warrants may
expire worthless.
ALTIMAR ACQUISITION CORP. III
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2021
In addition, if (x) the Company issues additional Class A
Ordinary Shares or equity-linked securities for capital raising
purposes in connection with the closing of a Business Combination
at an issue price or effective issue price of less than $9.20 per
Class A Ordinary Share (with such issue price or effective
issue price to be determined in good faith by the Company’s board
of directors and, in the case of any such issuance to the Sponsor
or holders of the Class B Ordinary Shares or their respective
affiliates, without taking into account any Founder Shares held by
the Sponsor, holders of the Class B Ordinary Shares or such
affiliates, as applicable, prior to such issuance) (the
“Newly
Issued Price”),
(y) the aggregate gross proceeds from such issuances represent
more than 60% of the total equity proceeds, and interest thereon,
available for the funding of a Business Combination on the date of
the consummation of a Business Combination (net of redemptions),
and (z) the volume weighted average trading price of its
Class A Ordinary Shares during the 20 trading day period
starting on the trading day after the day on which the Company
consummates its Business Combination (such price, the
“Market
Value”)
is below $9.20 per share, the exercise price of the warrants will
be adjusted (to the nearest cent) to be equal to 115% of the higher
of the Market Value and the Newly Issued Price, and the $18.00 per
share redemption trigger price will be adjusted (to the nearest
cent) to be equal to 180% of the higher of the Market Value and the
Newly Issued Price, and the $10.00 per share redemption trigger
price will be adjusted (to the nearest cent) to be equal to the
higher of the Market Value and the Newly Issued Price.
As of December 31, 2021, there were 6,105,000 Private
Placement Warrants outstanding. The Private Placement Warrants are
identical to the Public Warrants underlying the Units sold in the
Initial Public Offering, except that the Private Placement Warrants
and the Class A Ordinary Shares issuable upon the exercise of
the Private Placement Warrants will not be transferable, assignable
or salable until 30 days after the completion of a Business
Combination, subject to certain limited exceptions. Additionally,
the Private Placement Warrants will be exercisable on a cashless
basis and be non-redeemable, except as described above, so long as
they are held by the initial purchasers or their permitted
transferees. If the Private Placement Warrants are held by someone
other than the initial purchasers or their permitted transferees,
the Private Placement Warrants will be redeemable by the Company
and exercisable by such holders on the same basis as the Public
Warrants.
NOTE 9. FAIR VALUE MEASUREMENTS
The fair value of the Company’s financial assets and liabilities
reflects the Company’s management’s estimate of amounts that the
Company would have received in connection with the sale of the
assets or paid in connection with the transfer of the liabilities
in an orderly transaction between market participants at the
measurement date. In connection with measuring the fair value of
its assets and liabilities, the Company seeks to maximize the use
of observable inputs (market data obtained from independent
sources) and to minimize the use of unobservable inputs (internal
assumptions about how market participants would price assets and
liabilities). The following fair value hierarchy is used to
classify assets and liabilities based on the observable inputs and
unobservable inputs used in order to value the assets and
liabilities:
•Level
1—Quoted prices in active markets for identical assets or
liabilities. An active market for an asset or liability is a market
in which transactions for the asset or liability occur with
sufficient frequency and volume to provide pricing information on
an ongoing basis.
•Level 2—Observable
inputs other than Level 1 inputs. Examples of Level 2
inputs include quoted prices in active markets for similar assets
or liabilities and quoted prices for identical assets or
liabilities in markets that are not active.
•Level 3—Unobservable
inputs based on our assessment of the assumptions that market
participants would use in pricing the asset or
liability.
As of December 31, 2021, assets held in the Trust Account were
comprised of $155,258,024 in money market funds, which are invested
primarily in U.S. Treasury securities.
ALTIMAR ACQUISITION CORP. III
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2021
The following table presents information about the Company’s assets
and liabilities that are measured at fair value on a recurring
basis as of December 31, 2021 and indicates the fair value
hierarchy of the valuation inputs the Company utilized to determine
such fair value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Description |
|
Level |
|
December 31, 2021 |
Assets: |
|
|
|
|
Investments held in the Trust Account |
|
1 |
|
|
$ |
155,258,024 |
|
Liabilities: |
|
|
|
|
Warrant liability—Public Warrants |
|
1 |
|
|
$ |
3,482,017 |
|
Warrant liability—Private Placement Warrants |
|
3 |
|
|
$ |
6,389,052 |
|
The Warrants were accounted for as liabilities in accordance with
ASC 815-40 and are presented within warrant liability in the
accompanying balance sheet. The warrant liabilities are measured at
fair value at inception and on a recurring basis, with changes in
fair value presented within change in fair value of warrant
liabilities in the statements of operations.
The Warrants were initially valued using a Monte Carlo simulation
model, which is considered to be a Level 3 fair value
measurement for which there are uncertainties involved. If factors
or assumptions change, the estimated fair values could be
materially different. The Monte Carlo simulation model’s primary
unobservable input utilized in determining the fair value of the
Warrants is the expected volatility of the ordinary shares. The
expected volatility as of the closing date of the Initial Public
Offering was derived from observable public warrant pricing on
comparable ‘blank-check’ companies without an identified target.
The expected volatility as of subsequent valuation dates was
implied from the Company’s own public warrant pricing. A Monte
Carlo simulation methodology was used in estimating the fair value
of the Public Warrants for periods where no observable traded price
was available, using the same expected volatility as was used in
measuring the fair value of the Private Warrants. The Public
Warrants have detached from the Units and the Public Warrants were
moved from Level 3 to Level 1. For periods subsequent to the
detachment, the closing price of the Public Warrants will be used
as the fair value as of each relevant date.
The following table provides quantitative information regarding
Level 3 fair value measurements:
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2021 |
Stock price |
|
$ |
9.32 |
Strike price |
|
$ |
11.50 |
Term (in years) |
|
5.0 |
Volatility |
|
40.00 |
% |
Risk-free rate |
|
1.31 |
% |
Dividend yield |
|
0.00 |
% |
The following table presents the changes in the fair value of
Level 3 warrant liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private
Placement Warrants |
|
Public Warrants |
|
Warrant Liabilities |
Fair value as of March 8, 2021 |
$ |
6,091,858 |
|
|
$ |
3,326,894 |
|
|
$ |
9,418,752 |
|
Change in valuation inputs or other assumptions |
297,194 |
|
|
962,175 |
|
|
1,259,369 |
|
Fair value of Warrants transferred out of Level 3 |
— |
|
|
(4,289,069) |
|
|
(4,289,069) |
|
Fair value of Level 3 warrant liabilities as of December 31,
2021 |
$ |
6,389,052 |
|
|
$ |
— |
|
|
$ |
6,389,052 |
|
ALTIMAR ACQUISITION CORP. III
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2021
NOTE 10. SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions that
occurred after the balance sheet date up to the date that the
financial statements were issued. Based upon this review, the
Company did not identify any subsequent events that would have
required adjustment or disclosure in the financial
statements.
Item 9. Changes in and Disagreements With Accountants on Accounting
and Financial Disclosure
None.
Item 9A. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Disclosure controls are procedures that are designed with the
objective of ensuring that information required to be disclosed in
our reports filed under the Exchange Act, is recorded, processed,
summarized, and reported within the time period specified in the
SEC’s rules and forms. Disclosure controls are also designed with
the objective of ensuring that such information is accumulated and
communicated to our management, including the chief executive
officer and chief financial officer, as appropriate to allow timely
decisions regarding required disclosures.
Under the supervision and with the participation of our management,
including our principal executive officer and principal financial
and accounting officer, we conducted an evaluation of the
effectiveness of our disclosure controls and procedures as of the
end of December 31, 2021, as such term is defined in Rules
13a-15(e) and 15d-15(e) promulgated under the Exchange Act. Based
on this evaluation, the Company’s principal executive officer and
principal financial officer have concluded that, due to the events
that led to the Company’s restatements of its Post-Initial Public
Offering Balance Sheet and its unaudited interim financial
statements for the quarters ended March 31, 2021, June 30, 2021 and
September 30, 2021 (collectively, the “Restatements”) to properly
account for the Class A Ordinary Shares subject to possible
redemption, a material weakness existed and the Company’s
disclosure controls and procedures were not effective.
Management’s Report on Internal Controls Over Financial
Reporting
This Annual Report on Form 10-K does not include a report of
management’s assessment regarding internal control over financial
reporting or an attestation report of our independent registered
public accounting firm due to a transition period established by
rules of the SEC for newly public companies.
Changes in Internal Control over Financial Reporting
There were changes in our internal control over financial
reporting
(as such term is defined in Rules 13a-15(f) and 15d-15(f) of the
Exchange Act)
that occurred during the three months ended December 31, 2021
covered by this Annual Report that has materially affected, or is
reasonably likely to materially affect, our internal control over
financial reporting. In light of the material weakness identified
and the related Restatements described above, we have enhanced our
processes to identify and appropriately apply applicable accounting
requirements to better evaluate and understand the nuances of the
complex accounting standards that apply to our financial
statements. The enhancements include providing enhanced access to
accounting literature, research materials and documents and
increased communication among personnel and third-party
professionals with whom we consult regarding complex accounting
applications. The elements of our remediation plan can only be
accomplished over time, and we can offer no assurance that these
initiatives will ultimately have the intended effects.
Item 9B. Other Information.
None.
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent
Inspections
None.
PART III
Item 10. Directors, Executive Officers and Corporate
Governance
Our officers and directors are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name |
|
Age |
|
Position |
Tom Wasserman |
|
47 |
|
Chief Executive Officer and Chairman of the Board of
Directors |
Wendy Lai |
|
46 |
|
Chief Financial Officer |
Payne D. Brown |
|
59 |
|
Director |
Richard M. Jelinek |
|
56 |
|
Director |
Roma Khanna |
|
52 |
|
Director |
Michael Rubenstein |
|
48 |
|
Director |
Vijay K. Sondhi |
|
57 |
|
Director |
Michael Vorhaus |
|
64 |
|
Director |
Tom Wasserman—Chairman and Chief Executive
Officer.
Tom Wasserman serves as our Chairman and Chief Executive Officer.
Mr. Wasserman also currently serves as a Managing Director at HPS,
where he heads the Growth Equity group. Mr. Wasserman has served as
a member of the board of directors of Trine since its initial
public offering in March 2019 until its business combination with
Desktop Metal in December 2020. Mr. Wasserman has worked within TMT
(including prior to his transition to HPS) since 1999. Mr.
Wasserman’s current board roles include serving as a director of BT
One Phone Limited, OnePhone Holding AB and Revolt Media and TV
Holdings, LLC. Mr. Wasserman served as Chairman of Hibernia
Networks (sold to GTT Communications). Mr. Wasserman began his
career at Donaldson, Lufkin and Jenrette in the investment banking
division. He has a BA in Business Administration from the
University of Michigan where he graduated with distinction. We
believe Mr. Wasserman is well qualified to serve as a member of our
board of directors due to his significant investment and industry
experience and vast network of relationships.
Wendy Lai—Chief Financial Officer.
Wendy Lai serves as our Chief Financial Officer. Ms. Lai is a
Managing Director at HPS where she leads the corporate finance,
regulatory capital compliance and technology transformation of
financial systems. Prior to joining HPS in 2016, Ms. Lai was a
Senior Vice President at Blackstone, where she oversaw accounting
of registered investment advisors, corporate consolidation, and
financial reporting functions. Ms. Lai worked for
PricewaterhouseCoopers as the Senior Manager, where she managed the
audit engagements of hedge funds and Fortune 500 insurance
companies. She holds MBA in Finance from Columbia University and a
BA in Economics from Tufts University.
Payne D. Brown—Director.
Mr. Brown serves as a member of our board of directors. Mr. Brown
currently serves as Managing Director HPS Investment Partners.
Prior to becoming Managing Director, he was President of THINK450,
the for-profit innovation engine of the National Basketball Players
Association. Before this he served as the Managing Partner of
Econet Media Partners. And prior to that, Mr. Brown was Managing
Director at Highbridge Principal Strategies (“Highbridge”), an
alternative investment management organization, where he focused on
media opportunities in the private equity group. Mr. Brown also
served as the Chief of Staff to the interim owner of the Los
Angeles Clippers, Mr. Dick Parsons in 2014. Prior to joining
Highbridge in 2012, Mr. Brown was Vice President of Strategic
Initiatives and a corporate officer at Comcast Corporation and also
served as a strategic advisor to Comcast senior leadership, crisis
manager and negotiations expert during Comcast Corporation’s
acquisition of NBCUniversal from 2009 to 2011. Prior to joining
Comcast Corporation in 1998, Mr. Brown spent three years practicing
law at Helmke, Beams, and Boyer. He also served as an assistant
prosecutor for the State of Indiana, and as the Director of Public
Safety for the city of Fort Wayne, Indiana. He served on the Fort
Wayne Community Schools school board for eight years, presiding as
President of the board for two years.
He currently serves on REVOLT TV’S board of directors and chairs
the compensation committee. Mr. Brown has previously served on a
number of other boards, including the Philadelphia Urban League,
Project Home, and on the Board of Advisors for the Philadelphia
Chapter of the National Association for Multi- Ethnicity in
Communications (NAMIC). He has served as an advisor to The
HistoryMakers, TV One, the American Black Film Festival and the
Black Filmmaker Foundation. Mr. Brown has also served as a retained
strategic advisor to Comcast Corporation. Mr. Brown received a J.D.
from George Washington University and a B.S. in Management from
Purdue University.
Richard M. Jelinek—Director.
Mr. Jelinek serves as a member of our board of directors. Mr.
Jelinek is Managing Director at Czech One Capital Partners and an
active healthcare investor and executive. Previously, Mr. Jelinek
was executive vice president, enterprise modernization and
integration at CVS Health. He led the integration efforts related
to the CVS Health and Aetna merger as well as the broad scale
infrastructure modernization activities. Mr. Jelinek has held
senior leadership roles within payor, provider and private equity
organizations, including working as an operating partner at Advent
International over his 25-year career. Previously, Mr. Jelinek
served as executive vice president of enterprise strategy and head
of Aetna’s local markets and national accounts operations. For 19
years of his career, Mr. Jelinek served in a variety of executive
leadership roles at UnitedHealth Group and a predecessor company,
including CEO of OptumHealth and CEO of the company’s Medicaid,
Medicare Advantage and Emerging Businesses Group.
Mr. Jelinek is a member of the Young Presidents’ Organization and a
founding advisory board member for the Griffith Leadership Center
at the University of Michigan School of Public Health. He currently
is a member of the boards of directors of HealthEdge, RxBenefits
and In Health MD Alliance and previously served on the boards of
directors of Cotiviti, Sutter Health, Redbrick Health, the
Minnesota Children’s Museum and The Long Term Care
Group.
Mr. Jelinek holds a master’s degree in health services
administration and an MBA from the University of Michigan, as well
as a bachelor’s degree in business administration from the
University of Southern California.
Roma Khanna—Director.
Ms. Khanna serves as a member of our board of directors. Ms. Khanna
is a content innovator, executive and entrepreneur. From 2017 to
2020, Ms. Khanna was the chief executive officer at REVOLT Media
and TV, responsible for leading strategy and operations of the
real-time, multi-platform brand and network, reporting directly to
the Chairman, Sean Combs, and the board of directors. She remained
on as advisor to the board of directors after she chose to step
down as chief executive officer.
From 2011 through 2015, Ms. Khanna was President of MGM Television
Group and Digital where she oversaw creative development and
production as well as worldwide TV and digital distribution for
branded channels. Under Ms. Khanna’s leadership, MGM Television
developed and delivered several critically acclaimed award-winning
series, including “The Handmaid’s Tale” to Hulu, “Fargo” to FX,
“Vikings” to HISTORY. Prior to joining MGM, Ms. Khanna served as
President, Universal Networks International & Digital
Initiatives, with NBC Universal. While at NBC Universal, Roma
oversaw and grew NBC Universal’s portfolio of international
television channels, including the Syfy Channel, 13th Street,
Universal Channel, Hallmark Channel, Divatv and Movies24 brands, as
well as the Digital Initiatives division. Ms. Khanna has also
served as Senior Vice President, Content and Co-Head of Television
for CHUM Limited in Canada. Ms. Khanna began her career in digital
media with Snap Media in Canada and in music at Sony Music
Canada.
Ms. Khanna serves as a board member of the Canadian Film Centre and
as a member of the Board of Governors for OCAD U, as well as on the
West Coast Advisory Board for the Peabody Awards. Since November
2020, Ms. Khanna has also served as the Executive Chairman of
HiddenLight Productions Limited. Ms. Khanna has received The Euro
50 award from Eurodata and was the first recipient of Reed MIDEM’s
“MIPCube Media Architect of the Future Award” for her pioneering
work in the use of new digital platforms. Ms. Khanna earned a
bachelor of science from the University of Toronto, a J.D. from the
University of Detroit, a bachelor of law from the University of
Windsor and an MBA from York University-Schulich School of
Business.
Michael Rubenstein—Director.
Mr. Rubenstein serves as a member of our board of directors. He is
an entrepreneur and executive who currently serves as Co-Founder
and President of OpenStore, an e-commerce company. Previously, he
played a key role in building AppNexus, which was acquired by
AT&T in 2018, and DoubleClick, which was acquired by Google in
2008. Mr. Rubenstein specializes in marketplace strategy, win-win
partnerships, developing talent, and building high-performing
go-to-market organizations that create global impact.
In his capacity of Co-Founder and President of OpenStore, he
oversees all day-to-day operations of the company. At AT&T, he
served as President of AppNexus (re-branded Xandr), where he
oversaw go-to-market for the company’s digital ad platform. Prior
to AT&T, Mr. Rubenstein spent nearly a decade as President and
Board member at AppNexus, and was a chief architect of the
company’s growth from startup to a leader in programmatic
advertising. Prior to joining AppNexus, Mr. Rubenstein founded and
served as General Manager of DoubleClick Ad Exchange, a leading
marketplace for programmatic advertising, after joining DoubleClick
through the acquisition of Toronto-based smartech startup
FloNetwork, later re-branded DARTmail.
Mr. Rubenstein also serves on the board of directors for Estrella
Broadcasting, Inc. Mr. Rubenstein has also served on non-profit
Boards, including the Interactive Advertising Bureau and Global
Cities (a Bloomberg Philanthropy). Mr. Rubenstein regularly speaks
at business conferences and schools, and actively advises and
invests in the next generation of entrepreneurial ventures. He
holds a bachelor’s degree from McGill University and an MBA from
Columbia Business School.
Vijay K. Sondhi—Director.
Mr. Sondhi serves as a member of our board of directors. Mr. Sondhi
is the CEO of NMI. He is an accomplished fintech executive and
investor. Mr. Sondhi ran Visa’s CyberSource and Authorize.net
businesses, was head of Visa’s corporate strategy and launched
Visa’s flagship One-Market Innovation Center. He served as chief
financial officer for three private equity and venture-backed
companies spanning a wide variety of fintech solutions, including
ERP accounting, point-of-sale systems, hospitality reservations and
billing, plus financial document management, where he raised
private capital, executed merger and acquisition transactions and
oversaw an initial public offering. Mr. Sondhi’s executive career
includes senior roles with Oracle-Micros, OpenText-IXOS and SAP. He
serves on the board of Tangem. Mr. Sondhi earned an MBA in finance
from Columbia University and a Bachelor of Science degree in
computer science from The University of British
Columbia.
Michael Vorhaus—Director.
Mr. Vorhaus serves as a member of our board of directors. Mr.
Vorhaus currently serves as a member of the board of directors of
Perion Network (Nasdaq: PERI) and Rewardify. Starting December
2018, Mr. Vorhaus founded Vorhaus Advisors and is CEO of the firm.
From 1994 to November 2018, he was in a variety of positions at
Frank N. Magid Associates, Inc., a research-based strategic
consulting firm. From 1994 to 2008, Mr. Vorhaus served as its
Senior Vice President and Managing Director and from 2008 to 2018
he served as the President of Magid Advisor, a unit of Magid
Associates. From 2013 to 2014, Mr. Vorhaus served as a director of
Grow Mobile. In 1987, he founded Vorhaus Investments. Mr. Vorhaus
holds a B.A. in Psychology from Wesleyan University and completed
the Management Development Program at the University of California,
Berkeley’s Haas School of Business.
Number and Terms of Office of Officers and Directors
Our board of directors is divided into three classes, with only one
class of directors being appointed in each year, and with each
class (except for those directors appointed prior to our first
annual general meeting) serving a three-year term. In accordance
with the NYSE corporate governance requirements, we are not
required to hold an annual general meeting until one year after our
first fiscal year end following our listing on the NYSE. The term
of office of the first class of directors, consisting of Mr. Brown
and Mr. Jelinek, will expire at our first annual general meeting.
The term of office of the second class of directors, consisting of
Ms. Khanna, and Mr. Rubenstein, will expire at our second annual
general meeting. The term of office of the third class of
directors, consisting of Mr. Sondhi, Mr. Vorhaus and Mr. Wasserman,
will expire at our third annual general meeting.
Prior to the completion of an initial business combination, any
vacancy on the board of directors may be filled by a nominee chosen
by holders of a majority of our founder shares. In addition, prior
to the completion of an initial business combination, holders of a
majority of our founder shares may remove a member of the board of
directors for any reason.
Our Sponsor, upon and following consummation of an initial business
combination, will be entitled to nominate three individuals for
appointment to our board of directors, as long as the Sponsor holds
any securities covered by the registration and shareholder rights
agreement.
Our officers are appointed by the board of directors and serve at
the discretion of the board of directors, rather than for specific
terms of office. Our board of directors is authorized to appoint
persons to the offices set forth in our amended and restated
memorandum and articles of association as it deems appropriate. Our
amended and restated memorandum and articles of association provide
that our officers may consist of one or more chairman of the board,
chief executive officer, president, chief financial officer, vice
presidents, secretary, treasurer and such other offices as may be
determined by the board of directors.
Director Independence
The NYSE listing standards require that a majority of our board of
directors be independent. Our board of directors has determined
that each of Mr. Jelinek, Ms. Khanna, Mr. Rubenstein, Mr. Sondhi
and Mr. Vorhaus are “independent directors” as defined in the NYSE
listing standards. Our independent directors will have regularly
scheduled meetings at which only independent directors are
present.
Executive Officer and Director Compensation
None of our executive officers or directors have received any cash
compensation for services rendered to us. Commencing on the date
that our securities are first listed on the NYSE through the
earlier of consummation of our initial business combination and our
liquidation, we will reimburse an affiliate of our Sponsor for
office space, secretarial and administrative services provided to
us in the amount of $10,000 per month. In addition, our Sponsor,
executive officers and directors, or their respective affiliates
will be reimbursed for any out-of-pocket expenses incurred in
connection with activities on our behalf such as identifying
potential target businesses and performing due diligence on
suitable business combinations. Our audit committee will review on
a quarterly basis all payments that were made by us to our Sponsor,
executive officers or directors, or their affiliates. Any such
payments prior to an initial business combination will be made
using funds held outside the Trust Account. Other than quarterly
audit committee review of such reimbursements, we do not expect to
have any additional controls in place governing our reimbursement
payments to our directors and executive officers for their
out-of-pocket expenses incurred in connection with our activities
on our behalf in connection with identifying and consummating an
initial business combination. Other than these payments and
reimbursements, no compensation of any kind, including finder’s and
consulting fees, will be paid by the Company to our Sponsor,
executive officers and directors, or their respective affiliates,
prior to completion of our initial business
combination.
After the completion of our initial business combination, directors
or members of our management team who remain with us may be paid
consulting or management fees from the combined company. All of
these fees will be fully disclosed to
shareholders, to the extent then known, in the definitive Proxy
Statement furnished to our shareholders in connection with a
proposed initial business combination. We have not established any
limit on the amount of such fees that may be paid by the combined
company to our directors or members of management. It is unlikely
the amount of such compensation will be known at the time of the
proposed initial business combination, because the directors of the
post-combination business will be responsible for determining
executive officer and director compensation. Any compensation to be
paid to our executive officers will be determined, or recommended
to the board of directors for determination, either by a
compensation committee constituted solely by independent directors
or by a majority of the independent directors on our board of
directors.
We do not intend to take any action to ensure that members of our
management team maintain their positions with us after the
consummation of our initial business combination, although it is
possible that some or all of our executive officers and directors
may negotiate employment or consulting arrangements to remain with
us after our initial business combination. The existence or terms
of any such employment or consulting arrangements to retain their
positions with us may influence our management’s motivation in
identifying or selecting a target business but we do not believe
that the ability of our management to remain with us after the
consummation of our initial business combination will be a
determining factor in our decision to proceed with any potential
business combination. We are not party to any agreements with our
executive officers and directors that provide for benefits upon
termination of employment.
Committees of the Board of Directors
Our board of directors has three standing committees: an audit
committee, a nominating committee and a compensation committee.
Subject to phase-in rules and a limited exception, the rules of the
NYSE and Rule 10A-3 of the Exchange Act require that the audit
committee of a listed company be comprised solely of independent
directors. Subject to phase-in rules and a limited exception, the
rules of the NYSE require that the compensation committee and the
nominating committee of a listed company be comprised solely of
independent directors.
Audit Committee
Mr. Jelinek, Mr. Rubenstein and Mr. Vorhaus serve as members of our
audit committee. Our board of directors has determined that each of
Mr. Jelinek, Mr. Rubenstein and Mr. Vorhaus are independent under
the NYSE listing standards and applicable SEC rules. Under the NYSE
listing standards and applicable SEC rules, all the directors on
the audit committee must be independent. Each member of the audit
committee is financially literate and our board of directors has
determined that each of Mr. Jelinek and Mr. Vorhaus qualifies as an
“audit committee financial expert” as defined in applicable SEC
rules.
The audit committee is responsible for:
•meeting
with our independent registered public accounting firm regarding,
among other issues, audits, and adequacy of our accounting and
control systems;
•monitoring
the independence of the independent registered public accounting
firm;
•verifying
the rotation of the lead (or coordinating) audit partner having
primary responsibility for the audit and the audit partner
responsible for reviewing the audit as required by
law;
•inquiring
and discussing with management our compliance with applicable laws
and regulations;
•pre-approving
all audit services and permitted non-audit services to be performed
by our independent registered public accounting firm, including the
fees and terms of the services to be performed;
•appointing
or replacing the independent registered public accounting
firm;
•determining
the compensation and oversight of the work of the independent
registered public accounting firm (including resolution of
disagreements between management and the independent auditor
regarding financial reporting) for the purpose of preparing or
issuing an audit report or related work;
•establishing
procedures for the receipt, retention and treatment of complaints
received by us regarding accounting, internal accounting controls
or reports which raise material issues regarding our financial
statements or accounting policies;
•monitoring
compliance on a quarterly basis with the terms of the Initial
Public Offering and, if any noncompliance is identified,
immediately taking all action necessary to rectify such
noncompliance or otherwise causing compliance with the terms of the
Initial Public Offering; and
•reviewing
and approving all payments made to our existing shareholders,
executive officers or directors and their respective affiliates.
Any payments made to members of our audit committee will be
reviewed and approved by our board of directors, with the
interested director or directors abstaining from such review and
approval.
Nominating Committee
The members of our nominating committee are Ms. Khanna, Mr.
Rubenstein, and Mr. Vorhaus and Mr. Rubenstein serves as chairman
of the nominating committee. Our board of directors has determined
that each of Ms. Khanna, Mr. Rubenstein and Mr. Vorhaus is
independent.
The nominating committee is responsible for overseeing the
selection of persons to be nominated to serve on our board of
directors. The nominating committee considers persons identified by
its members, management, shareholders, investment bankers and
others.
Guidelines for Selecting Director Nominees
The guidelines for selecting nominees, which is specified in a
charter we adopted, generally will provide that persons to be
nominated:
•should
have demonstrated notable or significant achievements in business,
education or public service;
•should
possess the requisite intelligence, education and experience to
make a significant contribution to the board of directors and bring
a range of skills, diverse perspectives and backgrounds to its
deliberations; and
•should
have the highest ethical standards, a strong sense of
professionalism and intense dedication to serving the interests of
the shareholders.
The nominating committee will consider a number of qualifications
relating to management and leadership experience, background and
integrity and professionalism in evaluating a person’s candidacy
for membership on the board of directors. The nominating committee
may require certain skills or attributes, such as financial or
accounting experience, to meet specific board needs that arise from
time to time and will also consider the overall experience and
makeup of its members to obtain a broad and diverse mix of board
members. The nominating committee does not distinguish among
nominees recommended by shareholders and other
persons.
Compensation Committee
The members of our compensation committee are Ms. Khanna, Mr.
Jelinek and Mr. Sondhi, and Mr. Sondhi serves as chairman of the
compensation committee. Under the NYSE listing standards, we are
required to have a compensation committee composed entirely of
independent directors. Our board of directors has determined that
each of Ms. Khanna, Mr. Jelinek and Mr. Sondhi is independent. We
adopted a compensation committee charter, which details the
principal functions of the compensation committee,
including:
•reviewing
and approving on an annual basis the corporate goals and objectives
relevant to our Chief Executive Officer’s compensation, evaluating
our Chief Executive Officer’s performance in light of such goals
and objectives and determining and approving the remuneration (if
any) of our Chief Executive Officer based on such
evaluation;
•reviewing
and approving the compensation of all of our other Section 16
executive officers;
•reviewing
our executive compensation policies and plans;
•implementing
and administering our incentive compensation equity-based
remuneration plans;
•assisting
management in complying with our proxy statement and annual report
disclosure requirements;
•approving
all special perquisites, special cash payments and other special
compensation and benefit arrangements for our executive officers
and employees;
•producing
a report on executive compensation to be included in our annual
proxy statement; and
•reviewing,
evaluating and recommending changes, if appropriate, to the
remuneration for directors.
The charter also provides that the compensation committee may, in
its sole discretion, retain or obtain the advice of a compensation
consultant, legal counsel or other adviser and will be directly
responsible for the appointment, compensation and oversight of the
work of any such adviser.
However, before engaging or receiving advice from a compensation
consultant, external legal counsel or any other adviser, the
compensation committee will consider the independence of each such
adviser, including the factors required by the NYSE and the
SEC.
Compensation Committee Interlocks and Insider
Participation
None of our executive officers currently serves, and in the past
year has not served, as a member of the compensation committee of
any entity that has one or more executive officers serving on our
board of directors.
Code of Ethics
We have adopted a Code of Ethics applicable to our directors,
officers and employees. A copy of the Code of Ethics will be
provided without charge upon request from us. We intend to disclose
any amendments to or waivers of certain provisions of our Code of
Ethics in a Current Report on Form 8-K.
Conflicts of Interest
Under Cayman Islands law, directors and officers owe the following
fiduciary duties:
•duty
to act in good faith in what the director or officer believes to be
in the best interests of the company as a whole;
•duty
to exercise powers for the purposes for which those powers were
conferred and not for a collateral purpose;
•directors
should not improperly fetter the exercise of future
discretion;
•duty
to exercise powers fairly as between different sections of
shareholders;
•duty
not to put themselves in a position in which there is a conflict
between their duty to the company and their personal interests;
and
•duty
to exercise independent judgment.
In addition to the above, directors also owe a duty of care which
is not fiduciary in nature. This duty has been defined as a
requirement to act as a reasonably diligent person having both the
general knowledge, skill and experience that may reasonably be
expected of a person carrying out the same functions as are carried
out by that director in relation to the company and the general
knowledge skill and experience of that director.
As set out above, directors have a duty not to put themselves in a
position of conflict and this includes a duty not to engage in
self-dealing, or to otherwise benefit as a result of their
position. However, in some instances what would otherwise be a
breach of this duty can be forgiven and/or authorized in advance by
the shareholders, provided that there is full disclosure by the
directors. This can be done by way of permission granted in the
amended and restated memorandum and articles of association or
alternatively by shareholder approval at general
meetings.
HPS and certain of our officers and directors presently have, and
any of them in the future may have additional, fiduciary and
contractual duties to other entities. As a result, if any of HPS or
our officers or directors becomes aware of a business combination
opportunity which is suitable for an entity to which he or she has
then-current fiduciary or contractual obligations, then, subject to
their fiduciary duties under Cayman Islands law, he or she will
need to honor such fiduciary or contractual obligations to present
such business combination opportunity to such entity, before we can
pursue such opportunity. If these other entities decide to pursue
any such opportunity, we may be precluded from pursuing the same.
Our amended and restated memorandum and articles of association
provide that, to the fullest extent permitted by applicable law:
(i) no individual serving as a director or an officer shall have
any duty, except to the extent expressly assumed by contract, to
refrain from engaging directly or indirectly in the same or similar
business activities or lines of business as us; and (ii) we
renounce any interest or expectancy in, or in being offered an
opportunity to participate in, any potential transaction or matter
which may be a corporate opportunity for any director or officer,
on the one hand, and us, on the other.
HPS and its affiliates manage a number of HPS Funds, which may
compete with us for acquisition opportunities. If these HPS Funds
decide to pursue any such opportunity or have existing investments
in the issuer of such opportunity, we may be precluded from
pursuing such opportunities. In addition, investment ideas
generated within HPS, including by any director affiliated with
HPS, may be suitable for both us and for a current or future HPS
Fund and, in such a case, will be directed to such HPS Fund rather
than to us. Neither HPS nor, subject to their fiduciary duties
under Cayman Islands law, any members of our management team who
are also employed by HPS have any obligation to present us with any
opportunity for a potential business combination of which they
become aware. HPS and/or members of our management team, in their
capacities as officers, directors or employees of HPS or in their
other endeavors, may choose to present potential business
combinations to the related entities described above, current or
future HPS Funds, or third parties, before they present such
opportunities to us.
In addition, we may be limited in our ability to make investments
and to sell existing investments because HPS may have material,
non-public information regarding the issuers of the applicable
securities or as a result of an existing investment by HPS. We may
acquire a target from or, in which, one or more HPS Funds have an
existing investment (or makes an investment at the same time or
subsequently) at a different or overlapping level of the target’s
capital structure, creating a potential conflict between our
position and the applicable HPS Funds’ position especially in the
event of a bankruptcy. HPS, HPS employees and HPS Funds may also
have or make investments in, establish or serve on the boards of,
businesses that compete with, provide services to, transact with,
or otherwise have significant business relationships with the
businesses we invest or seek to invest in. We may also forego an
attractive investment opportunity as a result of an existing
investment in the target or a competitor of the
target by HPS, an HPS Fund or principals or employees of HPS, or to
otherwise mitigate any conflict of interest or the perception of
any conflict of interest.
HPS and our sponsor, officers and directors may sponsor, form or
participate in other blank check companies similar to ours during
the period in which we are seeking an initial business combination.
As a result, HPS and our sponsor, officers and directors could have
conflicts of interest in determining whether to present business
combination opportunities to us or to any other blank check company
with which they may become involved. Any such companies may present
additional conflicts of interest in pursuing an acquisition target,
particularly in the event there is overlap among investment
mandates.
We may, at our option, pursue an Affiliated Joint Acquisition
opportunity with one or more entities affiliated with HPS and/or
one or more HPS Funds and/or one or more investors in HPS Funds.
Such entity may co-invest with us in the target business at the
time of our initial business combination, or we could raise
additional proceeds to complete the acquisition by making a
specified future issuance to any such entity. Any participation by
such entity in a Joint Acquisition or co-investment may be under
terms that are different and more favorable to such entity than
those applicable to us. Expenses incurred in connection with any
Joint Acquisition or co-investment (including any broken deal
expenses) may get allocated between us and such entity, which
allocation is inherently subjective and creates a conflict of
interest between HPS and us.
Below is a table summarizing the entities to which our executive
officers and directors currently have fiduciary duties, contractual
obligations or other material management
relationships:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Individual |
|
Entity |
|
Entity's Business |
|
Affiliation |
Tom Wasserman(1)
|
|
Revolt Media and TV Holdings, LLC |
|
Media |
|
Director |
|
|
HPS Investment Partners, LLC(1)
|
|
Investments |
|
Principal |
Wendy Lai |
|
Natural Glacial Waters Inc. |
|
Bottled Water |
|
Director |
Payne D. Brown |
|
HPS Investment Partners, LLC |
|
Investments |
|
Managing Director |
Richard Jelinek |
|
Health Edge Technologies |
|
Healthcare Tech |
|
Director |
|
|
Czech One Capital Partners, LLC |
|
Investments |
|
Managing Director |
|
|
Advent International |
|
Private Equity |
|
Operating Partner |
|
|
Blackstone Group |
|
Private Equity |
|
Senior Advisor |
|
|
In Health MD Alliance |
|
Provider Delivery Organization |
|
Director |
|
|
RxBenefits |
|
Healthcare Services |
|
Director |
Roma Khanna |
|
HiddenLight Productions Limited |
|
Media |
|
Executive Chairman |
Michael Rubenstein |
|
Estrella Broadcasting, Inc. |
|
Media |
|
Director |
|
|
TVision Insights, Inc. |
|
Ad Measurement |
|
Advisor |
|
|
Teikametrics Inc. |
|
E-commerce |
|
Advisor |
Vijay K. Sondhi |
|
Network Merchants, LLC |
|
Software |
|
Chief Executive Officer |
|
|
Tangem AG |
|
Technology |
|
Director |
Michael Vorhaus |
|
Maestro |
|
Livestreaming |
|
Director, Chair |
|
|
Vorhaus Advisors |
|
Digital Media |
|
Chief Executive Officer |
|
|
Perion |
|
Ad Tech |
|
Board of Directors |
|
|
DraftKings |
|
Gaming |
|
Advisor |
|
|
Skillz |
|
Gaming |
|
Advisor |
|
|
Rewardify |
|
Gaming |
|
Director |
(1) Includes funds and accounts advised by HPS and
affiliates.
If any of the above executive officers or directors becomes aware
of a business combination opportunity which is suitable for any of
the above entities to which he or she has current fiduciary or
contractual obligations, he or she will honor his or her fiduciary
or contractual obligations to present such business combination
opportunity to such entity, and only present it to us if such
entity rejects the opportunity.
Potential investors should also be aware of the following other
potential conflicts of interest:
•Our
executive officers and directors are not required to, and will not,
commit their full time to our affairs, which may result in a
conflict of interest in allocating their time. We do not intend to
have any full-time employees prior to the completion of our initial
business combination. Each of our executive officers is engaged in
several other business endeavors for which he may be entitled to
substantial compensation, and our executive officers are not
obligated to contribute any specific number of hours per week to
our affairs.
•Our
Sponsor subscribed for founder shares and has purchased Private
Placement Warrants as part of the Initial Public
Offering.
•Our
Sponsor and each member of our management team have entered into an
agreement with us, pursuant to which they have agreed to waive
their redemption rights with respect to any founder shares and
public shares held by them in connection with (i) the completion of
our initial business combination, and (ii) a shareholder vote to
approve an amendment to our amended and restated memorandum and
articles of association (A) that would modify the substance or
timing of our obligation to provide holders of our Class A ordinary
shares the right to have their shares redeemed in connection with
our initial business combination or to redeem 100% of our public
shares if we do not complete our initial business combination
within 24 months from the closing of the Initial Public Offering or
during any extension period or (B) with respect to any other
provision relating to the rights of holders of our Class A ordinary
shares. Additionally, our Sponsor has agreed to waive its rights to
liquidating distributions from the Trust Account with respect to
its founder shares if we fail to complete our initial business
combination within the prescribed time frame. If we do not complete
our initial business combination within the prescribed time frame,
the Private Placement Warrants will expire worthless. Except as
described herein, our Sponsor and our directors and executive
officers have agreed not to transfer, assign or sell any of their
founder shares until the earliest of (A) one year after the
completion of our initial business combination and (B) subsequent
to our initial business combination, (x) if the closing price of
our Class A ordinary shares equals or exceeds $12.00 per share (as
adjusted for share subdivisions, share capitalizations,
reorganizations, recapitalizations and the like) for any 20 trading
days within any 30-trading day period commencing at least 150 days
after our initial business combination, or (y) the date on which we
complete a liquidation, merger, share exchange or other similar
transaction that results in all of our public shareholders having
the right to exchange their ordinary shares for cash, securities or
other property. Except as described herein, the Private Placement
Warrants will not be transferable until 30 days following the
completion of our initial business combination. Because each of our
executive officers and directors will own ordinary shares or
warrants directly or indirectly, they may have a conflict of
interest in determining whether a particular target business is an
appropriate business with which to effectuate our initial business
combination.
•Our
officers and directors may have a conflict of interest with respect
to evaluating a particular business combination if the retention or
resignation of any such officers and directors is included by a
target business as a condition to any agreement with respect to our
initial business combination. In addition, HPS and our Sponsor,
officers and directors may sponsor, form or participate in other
blank check companies similar to ours during the period in which we
are seeking an initial business combination. Any such companies may
present additional conflicts of interest in pursuing an acquisition
target, particularly in the event there is overlap among investment
mandates.
We are not prohibited from pursuing an initial business combination
with a company that is affiliated with our Sponsor, HPS, officers
or directors. In the event we seek to complete our initial business
combination with a company that is affiliated with our Sponsor or
any of HPS or our officers or directors, we, or a committee of
independent directors, will obtain an opinion from an independent
investment banking firm or another independent entity that commonly
renders valuation opinions that such initial business combination
is fair to our company from a financial point of view. We are not
required to obtain such an opinion in any other
context.
Furthermore, in no event will our Sponsor or any of our existing
officers or directors, or their respective affiliates, be paid by
us any finder’s fee, consulting fee or other compensation prior to,
or for any services they render in order to effectuate, the
completion of our initial business combination. Further, commencing
on the date our securities are first listed on the NYSE, we will
also reimburse an affiliate of our Sponsor for office space,
secretarial and administrative services provided to us in the
amount of $10,000 per month.
We cannot assure you that any of the above mentioned conflicts will
be resolved in our favor.
If we seek shareholder approval, we will complete our initial
business combination only if we obtain the approval of an ordinary
resolution under Cayman Islands law, being the affirmative vote of
a majority of the ordinary shares represented in person or by proxy
and entitled to vote thereon and who vote at a general meeting. In
such case, our Sponsor and each member of our management team have
agreed to vote their founder shares and public shares in favor of
our initial business combination.
Limitation on Liability and Indemnification of Officers and
Directors
Cayman Islands law does not limit the extent to which a company’s
memorandum and articles of association may provide for
indemnification of officers and directors, except to the extent any
such provision may be held by the Cayman Islands courts to be
contrary to public policy, such as to provide indemnification
against willful default, willful neglect, civil fraud or the
consequences of committing a crime. Our amended and restated
memorandum and articles of association provide for indemnification
of our officers and directors to the maximum extent permitted by
law, including for any liability incurred in
their capacities as such, except through their own actual fraud,
willful default or willful neglect. We will enter into agreements
with our directors and officers to provide contractual
indemnification in addition to the indemnification provided for in
our amended and restated memorandum and articles of association. We
have purchased a policy of directors’ and officers’ liability
insurance that insures our officers and directors against the cost
of defense, settlement or payment of a judgment in some
circumstances and insures us against our obligations to indemnify
our officers and directors.
Our officers and directors have agreed to waive any right, title,
interest or claim of any kind in or to any monies in the trust
account, and have agreed to waive any right, title, interest or
claim of any kind they may have in the future as a result of, or
arising out of, any services provided to us and will not seek
recourse against the trust account for any reason whatsoever
(except to the extent they are entitled to funds from the trust
account due to their ownership of public shares). Accordingly, any
indemnification provided will only be able to be satisfied by us if
(i) we have sufficient funds outside of the trust account or (ii)
we consummate an initial business combination.
Our indemnification obligations may discourage shareholders from
bringing a lawsuit against our officers or directors for breach of
their fiduciary duty. These provisions also may have the effect of
reducing the likelihood of derivative litigation against our
officers and directors, even though such an action, if successful,
might otherwise benefit us and our shareholders. Furthermore, a
shareholder’s investment may be adversely affected to the extent we
pay the costs of settlement and damage awards against our officers
and directors pursuant to these indemnification
provisions.
We believe that these provisions, the insurance and the indemnity
agreements are necessary to attract and retain talented and
experienced officers and directors.
Item 11. Executive Compensation
None of our executive officers or directors have received any cash
compensation for services rendered to us. Commencing on the date
that our securities are first listed on the NYSE through the
earlier of consummation of our initial business combination and our
liquidation, we will reimburse an affiliate of our Sponsor for
office space, secretarial and administrative services provided to
us in the amount of $10,000 per month. In addition, our Sponsor,
executive officers and directors, or their respective affiliates
will be reimbursed for any out-of-pocket expenses incurred in
connection with activities on our behalf such as identifying
potential target businesses and performing due diligence on
suitable business combinations. Our audit committee will review on
a quarterly basis all payments that were made by us to our Sponsor,
executive officers or directors, or their affiliates. Any such
payments prior to an initial business combination will be made
using funds held outside the Trust Account. Other than quarterly
audit committee review of such reimbursements, we do not expect to
have any additional controls in place governing our reimbursement
payments to our directors and executive officers for their
out-of-pocket expenses incurred in connection with our activities
on our behalf in connection with identifying and consummating an
initial business combination. Other than these payments and
reimbursements, no compensation of any kind, including finder’s and
consulting fees, will be paid by the Company to our Sponsor,
executive officers and directors, or their respective affiliates,
prior to completion of our initial business
combination.
After the completion of our initial business combination, directors
or members of our management team who remain with us may be paid
consulting or management fees from the combined company. All of
these fees will be fully disclosed to shareholders, to the extent
then known, in the definitive Proxy Statement furnished to our
shareholders in connection with a proposed initial business
combination. We have not established any limit on the amount of
such fees that may be paid by the combined company to our directors
or members of management. It is unlikely the amount of such
compensation will be known at the time of the proposed initial
business combination, because the directors of the post-combination
business will be responsible for determining executive officer and
director compensation. Any compensation to be paid to our executive
officers will be determined, or recommended to the board of
directors for determination, either by a compensation committee
constituted solely by independent directors or by a majority of the
independent directors on our board of directors.
We do not intend to take any action to ensure that members of our
management team maintain their positions with us after the
consummation of our initial business combination, although it is
possible that some or all of our executive officers and directors
may negotiate employment or consulting arrangements to remain with
us after our initial business combination. The existence or terms
of any such employment or consulting arrangements to retain their
positions with us may influence our management’s motivation in
identifying or selecting a target business, but we do not believe
that the ability of our management to remain with us after the
consummation of our initial business combination will be a
determining factor in our decision to proceed with any potential
business combination. We are not party to any agreements with our
executive officers and directors that provide for benefits upon
termination of employment.
Item 12. Security Ownership of Certain Beneficial Owners and
Management and Related Shareholder Matters
The following table sets forth information regarding the beneficial
ownership of our ordinary shares as of December 31, 2021
by:
•each
person known by us to be the beneficial owner of more than 5% of
our issued and outstanding ordinary shares;
•each
of our executive officers and directors that beneficially owns
ordinary shares; and
•all
our executive officers and directors as a group.
Beneficial ownership is determined in accordance with the rules of
the SEC. To our knowledge, each person named in the table below has
sole voting and investment power with respect to all of our
ordinary shares beneficially owned by them, except as otherwise set
forth in the notes to the table and pursuant to applicable
community property laws. Unless otherwise indicated, the address of
each person named in the table is c/o Altimar Acquisition Corp.
III, 40 West 57th Street, 33rd Floor, New York, NY
10019.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary Shares
Beneficially Owned |
|
|
Number |
|
Percent(2)
|
Directors and Executive Officers:
(1)
|
|
|
|
|
Payne Brown |
|
10,000 |
|
|
* |
Rick Jelinek |
|
10,000 |
|
|
* |
Roma Khanna |
|
10,000 |
|
|
* |
Wendy Lai |
|
— |
|
|
— |
% |
Michael Rubenstein |
|
10,000 |
|
|
* |
Vijay Sondhi |
|
10,000 |
|
|
* |
Michael Vorhaus |
|
10,000 |
|
|
* |
Tom Wasserman |
|
— |
|
|
— |
% |
All directors and executive officers as a group (8
persons) |
|
60,000 |
|
|
* |
5%
Shareholders: |
|
|
|
|
Altimar Sponsor III, LLC (our sponsor)
(3)
|
|
3,821,250 |
|
|
19.7 |
% |
|
|
|
|
|
|
|
|
|
* |
|
Less than one percent |
(1) |
|
Interests shown consist solely of founder shares, classified as
Class B ordinary shares. Such shares will automatically convert
into Class A ordinary shares at the time of our initial business
combination or earlier at the option of the holders
thereof. |
(2) |
|
The percentage of beneficial ownership of our ordinary shares is
based on a total of 15,525,000 Class A ordinary shares issued and
outstanding as of December 31, 2021. For the founder shares and
Altimar Sponsor III, LLC shares, the percentage of beneficial
ownership of our ordinary shares is based on a total of 15,525,000
Class A ordinary shares and 3,881,250 Class B ordinary shares
issued and outstanding as of December 31, 2021, and assumes
conversion of all Class B ordinary shares into Class A ordinary
shares |
(3) |
|
The shares reported above are held in the name of our sponsor. Our
sponsor is controlled by HPS. Based on a Schedule 13G filed with
the SEC on February 7, 2022, by Altimar Sponsor III, LLC. The
address of Altimar Sponsor III, LLC is 40 West 57th Street, 33rd
Floor, New York, New York 10019. |
Transfers of Founder Shares and Private Placement
Warrants
The founder shares and Private Placement Warrants and any Class A
ordinary shares issued upon conversion or exercise thereof are each
subject to transfer restrictions pursuant to lock-up provisions in
the agreement entered into by our Sponsor and management team. Our
Sponsor and each member of our management team have agreed not to
transfer, assign or sell any of their founder shares until the
earliest of (a) one year after the completion of our initial
business combination and (b) subsequent to our initial business
combination, (x) if the closing price of our Class A ordinary
shares equals or exceeds $12.00 per share (as adjusted for share
subdivisions, share capitalizations, reorganizations,
recapitalizations and the like) for any 20 trading days within any
30-trading day period commencing at least 150 days after our
initial business combination or (y) the date on which we complete a
liquidation, merger, share exchange or other similar transaction
that results in all of our public shareholders having the right to
exchange their Class A ordinary shares for cash, securities or
other property. The Private Placement Warrants and the respective
Class A ordinary shares underlying such warrants are not
transferable or salable until 30 days after the completion of our
initial business combination. The foregoing restrictions are not
applicable to transfers (a) to our officers or directors, any
affiliates or family members of any of our officers or directors,
any members or partners of our Sponsor or
their affiliates, any affiliates of our Sponsor, or any employees
of such affiliates, or any funds or accounts advised by our Sponsor
or its affiliates; (b) in the case of an individual, by gift to a
member of one of the individual’s immediate family or to a trust,
the beneficiary of which is a member of the individual’s immediate
family, an affiliate of such person or to a charitable
organization; (c) in the case of an individual, by virtue of laws
of descent and distribution upon death of the individual; (d) in
the case of an individual, pursuant to a qualified domestic
relations order; (e) by private sales or transfers made in
connection with the consummation of a business combination at
prices no greater than the price at which the founder shares,
Private Placement Warrants or Class A ordinary shares, as
applicable, were originally purchased; (f) by virtue of our
Sponsor’s organizational documents upon liquidation or dissolution
of our Sponsor; (g) to the Company for no value for cancellation in
connection with the consummation of our initial business
combination; (h) in the event of our liquidation prior to the
completion of our initial business combination; or (i) in the event
of our completion of a liquidation, merger, share exchange or other
similar transaction which results in all of our public shareholders
having the right to exchange their Class A ordinary shares for
cash, securities or other property subsequent to our completion of
our initial business combination; provided, however, that in the
case of clauses (a) through (f) these permitted transferees must
enter into a written agreement agreeing to be bound by these
transfer restrictions and the other restrictions contained in the
letter agreement.
Item 13. Certain Relationships and Related Transactions, and
Director Independence
On January 15, 2021, the Sponsor paid $25,000, or
approximately $0.001 per share, to cover certain of our offering
and formation costs in consideration of 3,881,250 Class B ordinary
shares, par value $0.0001. The founder shares (including the Class
A ordinary shares issuable upon exercise thereof) may not, subject
to certain limited exceptions, be transferred, assigned or sold by
the holder.
As more fully discussed elsewhere in this Annual Report, if any of
our officers or directors becomes aware of a business combination
opportunity that falls within the line of business of any entity to
which he or she has then-current fiduciary or contractual
obligations, he or she will honor his or her fiduciary or
contractual obligations to present such opportunity to such entity.
Our officers and directors currently have certain relevant
fiduciary duties or contractual obligations that may take priority
over their duties to us. We may, at our option, pursue an
Affiliated Joint Acquisition opportunity with an entity to which an
officer or director has a fiduciary or contractual obligation. Any
such entity may co-invest with us in the target business at the
time of our initial business combination, or we could raise
additional proceeds to complete the acquisition by making a
specified future issuance to any such entity.
We currently maintain our executive offices at 40 West 57th Street,
33rd Floor, New York, NY 10019. The cost for our use of this space
is included in the $10,000 per month fee we pay to an affiliate of
our Sponsor for office space, administrative and support services.
Upon completion of our initial business combination or our
liquidation, we will cease paying these monthly fees.
No compensation of any kind, including finder’s and consulting
fees, will be paid to our Sponsor, officers and directors, or their
respective affiliates, for services rendered prior to or in
connection with the completion of an initial business combination.
However, these individuals will be reimbursed for any out-of-pocket
expenses incurred in connection with activities on our behalf such
as identifying potential target businesses and performing due
diligence on suitable business combinations. Our audit committee
will review on a quarterly basis all payments that were made by us
to our Sponsor, officers, directors or their affiliates and will
determine which expenses and the amount of expenses that will be
reimbursed. There is no cap or ceiling on the reimbursement of
out-of-pocket expenses incurred by such persons in connection with
activities on our behalf.
Prior to the consummation of our Initial Public Offering, our
Sponsor agreed to loan us up to $300,000 to be used for a portion
of the expenses of the Initial Public Offering. The loan was repaid
upon the closing of the Initial Public Offering out of the offering
proceeds not held in the Trust Account.
In addition, in order to finance transaction costs in connection
with an intended initial business combination, our Sponsor or an
affiliate of our Sponsor or certain of our officers and directors
may, but are not obligated to, loan us funds as may be required. If
we complete an initial business combination, we may repay such
loaned amounts out of the proceeds of the trust account released to
us. In the event that the initial business combination does not
close, we may use a portion of the working capital held outside the
Trust Account to repay such loaned amounts but no proceeds from our
Trust Account would be used for such repayment. Up to $2,000,000 of
such loans may be convertible into warrants at a price of $1.00 per
warrant at the option of the lender. The warrants would be
identical to the Private Placement Warrants, including as to
exercise price, exercisability and exercise period. The terms of
such loans by our officers and directors, if any, have not been
determined and no written agreements exist with respect to such
loans. We do not expect to seek loans from parties other than our
Sponsor, its affiliates or our management team as we do not believe
third parties will be willing to loan such funds and provide a
waiver against any and all rights to seek access to funds in our
trust account.
After our initial business combination, members of our management
team who remain with us may be paid consulting, management or other
fees from the combined company with any and all amounts being fully
disclosed to our shareholders, to the extent then known, in the
definitive Proxy Statement, as applicable, furnished to our
shareholders. It is unlikely the amount of such compensation will
be known at the time of distribution of such definitive Proxy
Statement or at the time of a general meeting held to consider our
initial business combination, as applicable, as it will be up to
the directors of the post-combination business to determine
executive and director compensation.
We have entered into a registration and shareholder rights
agreement pursuant to which our Sponsor will be entitled to certain
registration rights with respect to the Private Placement Warrants,
the warrants issuable upon conversion of working capital loans (if
any) and the Class A ordinary shares issuable upon exercise of the
foregoing and upon conversion of the founder shares, and, upon
consummation of our initial business combination, to nominate three
individuals for appointment to our board of directors, as long as
the Sponsor holds any securities covered by the registration and
shareholder rights agreement, which is filed as Exhibit 10.2 to
this Annual Report. We will bear the expenses incurred in
connection with the filing of any such registration
statements.
Policy for Approval of Related Party Transactions
The audit committee of our board of directors has adopted a
charter, providing for the review, approval and/or ratification of
“related party transactions,” which are those transactions required
to be disclosed pursuant to Item 404 of Regulation S-K as
promulgated by the SEC, by the audit committee. At its meetings,
the audit committee shall be provided with the details of each new,
existing, or proposed related party transaction, including the
terms of the transaction, any contractual restrictions that the
Company has already committed to, the business purpose of the
transaction, and the benefits of the transaction to the Company and
to the relevant related party. Any member of the committee who has
an interest in the related party transaction under review by the
committee shall abstain from voting on the approval of the related
party transaction, but may, if so requested by the chairman of the
committee, participate in some or all of the committee’s
discussions of the related party transaction. Upon completion of
its review of the related party transaction, the committee may
determine to permit or to prohibit the related party
transaction.
Item 14. Principal Accounting Fees and Services
The firm of WithumSmith+Brown, PC (“Withum”) acts as our
independent registered public accounting firm. The following is a
summary of fees paid to Withum for services rendered.
Audit Fees.
During the period from January 11, 2021 (inception) through
December 31, 2021, fees for our independent registered public
accounting firm were approximately $110,725 for the services Withum
performed in connection with our Initial Public Offering, review of
the financial information included in our Forms 10-Q for the
respective periods and the audit of our December 31, 2021
financial statements included in this Annual Report on Form
10-K.
Audit-Related Fees.
During the period from January 11, 2021 (inception) through
December 31, 2021, our independent registered public
accounting firm did not render assurance and related services
related to the performance of the audit or review of financial
statements.
Tax Fees.
During the period from January 11, 2021 (inception) through
December 31, 2021, our independent registered public
accounting firm did not render services to us for tax compliance,
tax advice and tax planning.
All Other Fees.
During the period from January 11, 2021 (inception) through
December 31, 2021, there were no fees billed for products and
services provided by our independent registered public accounting
firm other than those set forth above.
Pre-Approval Policy
Our audit committee was formed upon the consummation of our Initial
Public Offering. As a result, the audit committee did not
pre-approve all of the foregoing services, although any services
rendered prior to the formation of our audit committee were
approved by our board of directors. Since the formation of our
audit committee, and on a going-forward basis, the audit committee
has and will pre-approve all auditing services and permitted
non-audit services to be performed for us by our auditors,
including the fees and terms thereof (subject to the de minimis
exceptions for non-audit services described in the Exchange Act
which are approved by the audit committee prior to the completion
of the audit).
PART IV
Item 15. Exhibits, Financial Statement Schedules
|
|
|
|
|
|
|
|
|
No. |
|
Description of Exhibit |
1.1 |
|
|
|
|
|
3.1 |
|
|
|
|
|
4.1 |
|
|
|
|
|
4.2 |
|
|
|
|
|
4.3 |
|
|
|
|
|
4.4 |
|
|
|
|
|
4.5* |
|
|
|
|
|
10.1 |
|
|
|
|
|
10.2 |
|
|
|
|
|
10.3 |
|
|
|
|
|
10.4 |
|
|
|
|
|
10.5 |
|
|
|
|
|
10.6 |
|
|
|
|
|
10.7 |
|
|
|
|
|
10.8 |
|
|
|
|
|
10.9 |
|
|
|
|
|
10.10 |
|
|
|
|
|
10.11 |
|
|
|
|
|
10.12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.13 |
|
|
|
|
|
10.14 |
|
|
|
|
|
10.15 |
|
|
|
|
|
10.16 |
|
|
|
|
|
31.1*
|
|
|
|
|
|
31.2*
|
|
|
|
|
|
32.1**
|
|
|
|
|
|
32.2**
|
|
|
|
|
|
101.INS* |
|
XBRL Instance Document |
|
|
|
101.SCH* |
|
XBRL Taxonomy Extension Schema Document |
|
|
|
101.CAL* |
|
XBRL Taxonomy Extension Calculation Linkbase Document |
|
|
|
101.DEF* |
|
XBRL Taxonomy Extension Definition Linkbase Document |
|
|
|
101.LAB* |
|
XBRL Taxonomy Extension Labels Linkbase Document |
|
|
|
101.PRE* |
|
XBRL Taxonomy Extension Presentation Linkbase Document |
|
|
|
104 |
|
Cover Page Interactive Data File (formatted as Inline
XBRL) |
|
|
|
|
|
|
* |
Filed herewith. |
** |
These certifications are furnished to the SEC pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, as amended, and
are deemed not filed for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended, nor shall they be
deemed incorporated by reference in any filing under the Securities
Act, except as shall be expressly set forth by specific reference
in such filing. |
Item 16. Form 10–K Summary
None.
SIGNATURES
Pursuant to the requirements of the Section 13 or 15(d) of the
Securities Exchange Act of 1934, as amended, the Registrant has
duly caused this annual report to be signed on its behalf by the
undersigned, thereunto duly authorized, in New York City, New York,
on the 8th day of March, 2022
|
|
|
|
|
|
|
|
|
|
ALTIMAR ACQUISITION CORP. III |
|
|
|
Date: March 8, 2022 |
By: |
/s/ Tom Wasserman |
|
|
Name: Tom Wasserman |
|
|
Title: Chief Executive Officer (Principal Executive Officer) and
Chairman of the Board of Directors
|
|
|
|
Date: March 8, 2022 |
By: |
/s/ Wendy Lai |
|
|
Name: Wendy Lai |
|
|
Title: Chief Financial Officer (Principal Financial
Officer) |
Pursuant to the requirements of the Securities Exchange Act of
1934, as amended, this annual report has been signed below by the
following persons in the capacities and on the dates
indicated.
|
|
|
|
|
|
|
|
|
Name |
Position |
Date |
|
|
|
/s/ Tom Wasserman |
Chief Executive Officer |
March 8, 2022 |
Tom Wasserman |
(Principal Executive Officer
and Chairman) |
|
|
|
|
/s/ Wendy Lai |
President, Chief Financial Officer |
March 8, 2022 |
Wendy Lai |
(Principal Financial Officer and Principal Accounting
Officer) |
|
|
|
|
/s/ Payne D. Brown |
Director |
March 8, 2022 |
Payne D. Brown |
|
|
|
|
|
/s/ Richard M. Jelinek |
Director |
March 8, 2022 |
Richard M. Jelinek |
|
|
|
|
|
/s/ Roma Khanna |
Director |
March 8, 2022 |
Roma Khanna |
|
|
|
|
|
/s/ Michael Rubenstein |
Director |
March 8, 2022 |
Michael Rubenstein |
|
|
|
|
|
/s/ Vijay K. Sondhi |
Director |
March 8, 2022 |
Vijay K. Sondhi |
|
|
|
|
|
/s/ Michael Vorhaus |
Director |
March 8, 2022 |
Michael Vorhaus |
|
|
Altimar Acquisition Corp... (NYSE:ATAQ)
Graphique Historique de l'Action
De Juil 2022 à Août 2022
Altimar Acquisition Corp... (NYSE:ATAQ)
Graphique Historique de l'Action
De Août 2021 à Août 2022